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Post-infectious (PIH) and post-hemorrhagic (PHH) hydrocephalus occur as sequalae of neonatal
sepsis or intraventricular hemorrhage (IVH) of prematurity, respectively. Together, PIH and PHH
represent the most common form of infantile hydrocephalus, the most common indication for
neurosurgery in children globally, and the leading cause of neurological morbidity and mortality
worldwide. The lack of understanding of the pathophysiology of PIH and PHH, particularly with
regards to the host central nervous system response to the antecedent infection and hemorrhage,
perturbation of differentiating neural stems in the ventricular (VZ) and subventricular (SVZ)
zones, and damage to periventricular white matter (PVWM) tracts carrying sensorimotor fibers,

xx

has hindered the identification of therapeutic targets to prevent these two debilitating conditions.
To this end, we hypothesized that PIH and PHH share a common pathophysiological mechanism
characterized by host immune response to infection or hemorrhage, activation of the
metalloprotease ADAM10 and cleavage of the cell-junctional protein, N-cadherin, which results
in impaired VZ/SVZ differentiation and PVWM damage. The studies presented in this dissertation
collectively explore novel overarching lines of scientific inquiry - the concept that there are unique
host immune responses to PIH and PHH, as well as ones that are common to both conditions that
underlie their observed clinical similarities.

To test the hypothesis, we leveraged the cerebrospinal fluid (CSF) of human PIH, PHH and
matched non-infectious non-hemorrhagic hydrocephalic control infants. First, we defined the
differentially expressed proteome and transcriptome of PIH using high throughput proteomics and
RNA-seq, respectively. The integration of proteogenomic techniques defined critical gene
networks and pathway level mechanisms of PIH pathophysiology. Second, our validated
proteomics pipeline was used to identify the common and unique molecular pathways that underlie
the pathophysiology of PIH and PHH. Third, our CSF findings were related to VZ/SVZ
development and PVWM microstructural damage with diffusion MRI (dMRI) in PHH and control
infants. Neurocytology of human postmortem brain tissues of PIH, PHH and controls was
performed to correlate the dMRI findings. Fourth, we defined the mechanistic triggers underlying
PIH and PHH pathogenesis utilizing a mouse in vitro cell culture model of periventricular VZ
cells. Finally, we developed in vivo animal models of PIH (mice) and PHH (ferrets), to recapitulate
our findings of VZ/SVZ disruption, neuroinflammation and PVWM injury in both PIH and PHH.

xxi

Through our comprehensive experiments, we determined the following: 1) human CSF profiles of
PIH and PHH reflect similar alterations in gene-activated pathways related to neuroinflammation
and cell-cell junction structure; 2) neuroinflammation-associated cell junction (VZ/SVZ)
disruption and PVWM injury is a pathophysiological mechanism that is common to both PIH and
PHH; 3) dMRI can non-invasively assess the VZ/SVZ region as well as differentiate and quantify
tract-specific patterns of PVWM injury. Therefore, it can distinguish direct effects on
axons/myelin from changes in the extracellular milieu to reflect neuroinflammation, axonal fiber
loss, and dysmyelination; 4) VZ/SVZ disruption in PIH and PHH is mediated by metalloprotease
(e.g., ADAM10) cleavage of cell junctional proteins (e.g., N-cadherin); and 5) pharmacologic
inhibition of ADAM10-mediated N-cadherin cleavage represents a viable therapeutic approach to
prevent PIH and PHH.

These novel insights into the pathophysiology of PIH and PHH may enable investigation of
ADAM10 inhibitors and other therapeutic strategies to minimize the developmental disability in
PIH and PHH patients. The biomarkers we identified can be further investigated as diagnostic
measures for monitoring and providing therapy to infants who develop neonatal sepsis or IVH to
prevent PHH/PIH. Finally, the in vitro and in vivo experimental models we generated are poised
for future preclinical and translational studies into the pathogenesis of these previously
inaccessible and debilitating conditions.
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Preface

This dissertation is original and independent work performed by the author, Albert M. Isaacs.
Some of the work has already been published, while others are in preparation for future
publications. At the beginning of each chapter, the papers adapted for the chapter are cited. With
permission from my supervisory committee, the majority of the text were verbatim from studies I
played major roles in, including idea conception, research methodology, data analysis, synthesis
and interpretation and writing of manuscripts. Permission from applicable sources, supervisors and
co-investigators have been sought for all figures and tables presented in this dissertation. In each
chapter, the institution or committee that provided ethics oversight for the specific studies are
provided.

In Chapter 2, the majority of experiments were part of a broader work by the P3H and CONSHA
consortiums led by Dr. Steven Schiff (Penn State University), investigating the neonatal
septisomes of Sub-Saharan Africa. While I was responsible for all the CSF proteomics work
performed at Washington University School of Medicine, I spent 6 weeks at the Center for
Personalized Medicine (Penn State University), where I learned the RNA-Seq wet lab techniques
presented in this dissertation. I also spent 6 weeks in Mbale, Uganda at the CURE Children’s
Hospital where our Sub-Saharan African CSF samples were obtained. While in Uganda, I learned
the workflow and observed surgical procedures performed on hydrocephalic infants, under the
supervision of Drs. John Mugamba, Peter Ssenyonga and Justin Onen. I was involved in the
logistical management of all proteomics samples. I designed the CSF proteomics workflows,
including allocation of ten-plexes and bookending with large volume samples for each plex. At
xxiii

the proteomics core (Washington University), I observed all the wet lab processes, both manual
and automated, and worked with the core’s statistician on post processing data quality assurance.
Upon receiving the protein raw counts, I performed all the proteomics data analyses presented
here, and wrote the first draft of all manuscripts included in this chapter. Dr. Steven Schiff and Dr.
David Limbrick oversaw and guided all my work. Dr. Joseph Paulson (Genentech Inc.) taught me
and supervised all bioinformatics and statistical analyses. I received incredible support and
guidance on proteomics wet lab and processing methodology from Dr. Reid Townsend and all
members of the Washington University proteomics core (Dr. Qiang Zhang, Ms. Petra Gilmore,
Mr. Jim Malone, Mr. Robert Sprung, and Ms. Yiling). Drs. Sarah Morton and Mercedeh
Movassagh (Harvard University) helped me with the transcriptomics and proteogenomics
integrative methodologies. Ms. Christine Henhly (Penn State University) trained me on the RNASeq wet lab, and Mr. Diego Morales (Washington University) helped coordinate the logistics of
the CSF samples.

In Chapter 3, except for patient recruitment and human dMRI acquisition, I personally performed,
or was heavily involved with all day to day experiments presented. Nevertheless, I received
incredible support from our collaborators and colleagues. Unless otherwise specified, all the work
and supervision were performed at Washington University. Indeed, all I learned in diffusion
imaging are a reflection of the invaluable teaching and continuous guidance I received from Drs.
Jeff Neil, Christopher Smyser, Victor Song, Josh Shimony, and David Limbrick. Drs. Joseph
Paulson (Genetech Inc.) and Yan Yan supervised my statistical analyses. Drs. Shimony and Roland
Han helped me with the design of our novel lateral ventricular perimeter segmentation algorithm.
Ms Tara Smyser, Ms Jeanette Kenley, Mr. Dimitrios Alexopolous and Ms. Rachel Lean from the
xxiv

Smyser lab helped with many aspects of dMRI data processing, logistics and troubleshooting. Drs.
Sun Peng, Harri Merisaari and Ajit George at the Song lab (Washington University) trained me on
DBSI fitting and methodology. Drs. Leandro Castaneyra-Ruiz, Pat McAllister and Sonika Dahiya
helped tremendously to perform, analyze, interpret and correlate our neurocytology findings with
dMRI.

In Chapter 4, I was involved in all and performed the majority of experiments presented.
Nevertheless, I had tremendous help from Dr. Leandro Castaneyra-Ruiz, who had developed the
cell culture model a year prior to my arrival at Washington University. Dr. Pat McAllister and Dr.
David Limbrick mentored me through those projects. Dr. Steven Brody provided us with the mice
and Dr. Juliane Bubeck-Wardenburg and her staff scientist, Dr. Kelly Tomaszewski, provided us
with the 𝛂-hemolysin and gave guidance on the experiments.

In chapter 5, developing the animal models required a large infrastructure at Washington
University and the University of Calgary. I was heavily involved in all experiments. I took part in
the surgeries, animal monitoring and immunohistochemistry. I performed the DBSI acquisition for
all the ferrets and performed all data analyses presented in this chapter. Dr. Pat McAllister
coordinated the day-to-day management of the ferret model. However, the ferret model was a
collective effort by the entire Limbrick-McAllister lab, including Diego Morales and our many
visiting students - Dr. Travis Crevecoeur, Alexis Hartman, Joel Brown, Sarah Zwick, and Brandon
Baksh. Members of the Garbow and Song labs, both at the Mallinckrodt Institute helped with the
neuroimaging, especially Dr. Xia Ge, John Engelbach, Dr. Harri Merisaari, Dr. Tsen-Hun Lin, Dr.
Victor Song and Dr. Joel Garbow. Dr. Philip Bayly provided us with the control ferret scans for
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comparisons. The mouse PIH model work was an extension of our animal model efforts at
Washington University, which was carried out at the University of Calgary. Drs. Jeff Dunn,
Castaneyra-Ruiz, McAllister and Limbrick were instrumental in the idea conception and provided
guidance throughout the experiments. Dr. Castaneyra-Ruiz helped me immensely with the
immunohistochemistry, especially during the Covid-19 pandemic. In Calgary, Dr. Jeff Dunn
provided me with all the necessary resources at the Experimental Imaging Center and mentored
me on this project. I had invaluable help from Dr. Ying Wu (who performed the mice
intraventricular injections), as well as Max Hamilton, Runze Yang, Kevin Lee, David Rushforth
and Tadeusz Foniok who helped with the neuroimaging and animal sacrifice. Dr. Bas Surewaard
provided us with all the alpha toxin and guided us on dosing
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1.1

Hydrocephalus

Hydrocephalus encompasses a heterogeneous group of complex neurological disorders
characterized by brain injury in the context of cerebrospinal fluid (CSF) accumulation and
abnormal dilatation of the cerebral ventricles. This can occur with or without an increase in
intracranial pressure (ICP) that arises from an imbalance between CSF production and clearance1,2.

1.1.1

Classification of hydrocephalus

There are several approaches to classify the “syndrome” of hydrocephalus3-7. The classic, most
common system dichotomizes hydrocephalus into communicating vs. non-communicating (or
obstructive) subtypes based on the absence or presence of an identifiable obstruction in the CSF
pathways, respectively3-8. An age-based classification stratifies hydrocephalus into neonatal,
infantile, pediatric, juvenile, transitional, adult and elderly forms2,9. From an etiological standpoint,
hydrocephalus may be classified as primary vs. secondary (or acquired), based on whether the
cause is unknown or a result of an identifiable antecedent neurologic event3-7. Examples of
secondary hydrocephalus include post-hemorrhagic hydrocephalus (PHH; occurs following
intraventricular hemorrhage (IVH) in neonates)2,10, post-infectious hydrocephalus (PIH; due to
perinatal sepsis)11,12, congenital hydrocephalus (caused by genetic aberrations)7,13-15, and spinabifida-associated hydrocephalus (seen in patients with myelomeningocele)16-18.
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1.1.2

Clinical presentation and diagnosis

The presenting signs and symptoms of hydrocephalus are often non-specific and may include any
combination of the following: tense fontanels, splaying of cranial sutures and irritability in infants
and headaches, nausea, vomiting, papilledema, cranial nerve abnormalities, seizures, depressed
level of consciousness, urinary incontinence and gait difficulties in all age groups2,19. The clinical
diagnosis of hydrocephalus requires both the presence of related clinical signs/symptoms and
confirmation of abnormal ventriculomegaly on neuroimaging defined by metrics such as the
frontal-occipital horn ratio and Evan’s Index20.

In preterm neonates, head ultrasounds are the most commonly used neuroimaging modality since
they can be performed at the bedside and require minimal handling of the infants. Computed
tomography (CT) scans may be utilized when feasible but their use in infants and children is
limited, especially in well-resourced countries due to the risk of exposure to ionizing radiation,
associated with developmental impairments and radiation-induced cancers later in life21. Magnetic
resonance imaging (MRI) is the preferred neuroimaging modality in infants because it does not
expose patients to this ionizing radiation. MRI is also ideal for identifying sites of obstruction to
CSF flow and hemorrhage that could contribute to hydrocephalus symptoms28,55. However,
standard MRIs have lengthy acquisition times and often require sedation or general anesthesia,
especially in neonates and uncooperative children, which subjects them to risks of anesthesiarelated complications22,23. Recently, the United States Food and Drug Administration
recommended against repeated elective exposure to anesthesia in young children24. Consequently,
fast brain MRI protocols have been implemented since 2002 to circumvent the need for sedation
in pediatric hydrocephalus patients. Fast brain MRIs utilize short pulse sequences to acquire MRI
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images in 2-3 seconds per slice, which are adequate for making prompt clinical decisions in most
pediatric hydrocephalus patients25,26. However, due to concerns of poor image quality and
susceptibility to motion artifacts, indications for fast brain MRIs in hydrocephalus are typically
limited to gross anatomical/structural and ventricular catheter placement assessments.

In addition to initial diagnosis, hydrocephalus patients undergo serial neuroimaging for a wide
range of indications, including assessment of response to treatment and workup for future
treatment failures27. However, the conventional symptomatologic-radiologic approach to
hydrocephalus often poses a diagnostic dilemma. The current metrics are neither sensitive nor
specific, and they do not provide any information on the pathophysiology or natural history of the
disease28.

1.1.3

Global burden of hydrocephalus

There is heterogeneity in the reported prevalence and incidence of hydrocephalus, often without
reference to age or etiology29. The global prevalence of hydrocephalus is often estimated as 1 in
500-1000 individuals2,30,31 with variations based on age, etiology, geography and economic
strata1,7. We performed the first systematic review and metanalysis of population-based studies
reporting prevalence of hydrocephalus in both pediatric and adult populations32. From a population
of approximately 172 million extracted from 52 studies, we found that the overall global
prevalence of hydrocephalus was 85 per 100 thousand [95% CI, 62-116]. The pooled prevalence
of hydrocephalus in the pediatric population was 72 per 100 thousand [95% CI, 58-89] without,
and 88 per 100 thousand [95% CI, 72-107] with spina bifida-associated hydrocephalus. The
prevalence of pediatric hydrocephalus between continents was almost two-fold higher in Africa
5

(104 per 100 thousand [95% CI, 33-325]), compared to North America (56 per 100 thousand [95%
CI, 41-75]) (Figure 1).

Figure 1: Global prevalence of pediatric hydrocephalus.
Assessment of the prevalence of pediatric hydrocephalus (HC) with and without spina bifida (SB)
stratified by continent shows majority of cases occur in continents with highest number of lowincome countries.

To assess the incidence of pediatric hydrocephalus, we analyzed annual reports from the
International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) database
spanning the most recent 11 year period33. ICBDSR, a World Health Organization affiliate,
collects data on birth defects including hydrocephalus and spina-bifida from 42 surveillance
programs, spanning 36 countries. We identified that the mean annual incidence of pediatric
hydrocephalus was 50 per 100 thousand [95% CI, 41-60] without and 81 per 100 thousand [95%
CI, 69-96] with spina-bifida associated hydrocephalus. In addition, countries with a higher level
of income were associated with a significantly lower mean incidence of hydrocephalus, 78 per 100
thousand [95% CI 65-92], when compared to low- and middle-income countries combined, 106
per100 thousand [95% CI, 76-148], p < 001 (Figure 2).
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Figure 2: Incidence of pediatric hydrocephalus.
The mean annual incidence of pediatric hydrocephalus (A) with or without spina bifida (SB)
remained steady from 2003 to 2014. (B) Countries with low- to medium-income status had
relatively higher annual incidences than those in the high-income stratum.

Postnatally acquired hydrocephalus, including PIH and PHH, were not included in our
hydrocephalus incidence analyses as those data are not reported to the ICBDSR. However, Dewan
et al. performed a similar but limited systematic review on the incidence of pediatric hydrocephalus
that included PIH and PHH populations34. Together, PIH and PHH represent the largest cause of
infantile hydrocephalus worldwide with a majority of PIH cases in low- and middle-income
countries34-37. As the largest single cause of childhood hydrocephalus and the need for neurological
surgery in children worldwide, PIH afflicts 60%37 of the estimated 300,000 infants who develop
hydrocephalus each year in low- to middle-income countries34. In sub-Saharan Africa alone, it is
estimated that 1 in every 200 infants will develop PIH, resulting in >100,000 affected infants in
that region each year38. On the other hand, PHH represents the most common cause of pediatric
hydrocephalus in Europe and North America, affecting 1 in every 1000 newborns39,40. PHH occurs
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in up to one half of infants who develop IVH39-41, the most frequent and severe neurological
complication of preterm birth, occurring in nearly 20% of preterm infants42-44. PHH causes
significant neurologic injury in patients. It is associated with some of the worst neurological
outcomes in newborn medicine, with persisting cognitive deficits in >85% and cerebral palsy in
70% of the affected infants41,42,44-46. Unfortunately, these alarmingly high reported global
incidences of PIH and PHH are likely an underestimation because most affected infants,
particularly in developing countries, die in early childhood without presenting to healthcare
facilities; therefore they are omitted from neonatal mortality surveillance47.

Hydrocephalus care results in a high financial burden for patients, their families, and healthcare
infrastructure because of the diagnostic process, treatment, follow-up and long-term management.
Inpatient care of pediatric hydrocephalus patients (predominantly PHH) is reported to cost
approximately $2 billion per year in the United States alone48. While already substantial, this does
not account for the considerable costs associated with out-of-hospital care48.

1.2

Post-infectious hydrocephalus (PIH)

PIH is a serious sequelae of neonatal sepsis and a major cause of morbidity with one million annual
deaths worldwide36,47,49,50. The PIH phenotype is complex with brain calcifications, seizures,
neurological injury and developmental impairments36, and a typical clinical picture of ventriculitis
without prior meningitis (Figure 3).
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Figure 3: Representative CT scans of post-infectious hydrocephalus.
Axial images showing (A) the normal lateral ventricles (LV) in a healthy infant in comparison to
(B & C) infants with post-infectious hydrocephalus who have severe ventriculomegaly with
loculated abscesses (as indicated by the stars).

PIH continues to be a major global health problem in spite of the recent clinical efforts to optimize
treatment51. Strategies to prevent PIH have been thwarted for several reasons. First, there is a lack
of identification of the key pathogens responsible for the underlying septic episodes that proceed
to PIH. Moreover, the environmental factors that drive the incidences of PIH vary from one region
to another12,52,53. For example, it is known that seasonal Neisseria meningitidis epidemics within
the African meningitis belt can produce PIH54. However, there have been reports of a tendency
toward gram negative coliform bacteria in infants in other Southern55 and Eastern12 African
locations where Neisseria meningitidis is uncommon. Another major systemic problem impeding
progress in the fight against PIH is the lack of diagnostic approaches. Whether lumbar puncture in
infants, especially those without meningeal infection, could be a diagnostic tool during their
neonatal sepsis evaluation is presently unknown. In addition, CSF cultures are difficult to employ
due to limited armamentarium in low- and middle-income countries where PIH is most common38.
Even in well-resourced regions where CSF analyses are readily available, the commonly tested
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indices (e.g., glucose, protein, cell count and differential, and gram stain) are often not reliable in
identifying an infection and cultures underappreciate the polymicrobial nature of PIH56.
Alternatively, high throughput and unbiased pan-microbial approaches may be required to detect
microbes in these complex PIH CSF samples, and to identify pathways toward more optimal
treatment and prevention of the proximate neonatal infections.

1.3

Post-hemorrhagic hydrocephalus (PHH)

Infants who are born preterm (< 37 weeks gestational age) often sustain spontaneous intracranial
hemorrhage within the germinal matrix44 which may extend into the cerebral ventricles to cause
IVH 57,58. IVH, in premature infants, is classified into four grades of severity (grades I to IV)57,59
(Figure 4). In grade I, the hemorrhage is restricted to the germinal matrix. The hemorrhage is
considered to be grade II or III when it extends beyond the germinal matrix into the lateral
ventricles and covers less than 50% or greater than 50% of the ventricular volume with associated
ventriculomegaly, respectively60,61. The severest form, grade IV, is defined as having the features
of grade III in addition to intraparenchymal hemorrhage60,61. Grades III and IV are grouped into a
“high grade IVH” category because they are associated with the most severe neuromotor and
cognitive impairments of preterm birth62. In approximately half of the infants who develop high
grade IVH, ventricular CSF dynamics are severely disrupted, which leads to the accumulation of
CSF, raised intracranial pressures, and PHH2,42.
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Figure 4: Representative cranial ultrasounds of intraventricular hemorrhage of prematurity.
The coronal sections show (A) the appearance of normal lateral ventricles (LV) and temporal horn
(TH) in a healthy infant in comparison to (B-D) preterm infants with IVH. (B) Grade I, (C) grade
II and (D) grade IV. Hemorrhages are outlined or identified by stars. Scale bars = 1 cm.

1.4

Current treatments of PIH and PHH

Timely treatment of hydrocephalus, particularly for acute cases with raised ICP is critical because
it is associated with progressive neurologic injury and high mortality rates ranging from 20 to
87%30,31,45,63,64. With a primary goal of decreasing ventricular size, resolving raised ICP, mitigating
patient symptoms and preventing further neurologic injury, the only effective treatment for
hydrocephalus is surgical CSF diversion2. CSF diversion may be performed as a temporary or
permanent intervention depending on the clinical indication51,65-68. Temporary procedures include
11

insertion of ventricular reservoirs or external ventricular drains69, which allow serial external CSF
removal. However, the timing and volume of CSF removal are highly variable with little evidencebased practice or guidelines. Patients who demonstrate a need for long term treatment typically
undergo ventriculoperitoneal (VP)70,71 or ventriculoatrial (VA)72-74 shunt insertion, which divert
CSF into the peritoneal cavity or right atrium of the heart, respectively74. Other extracranial
compartments such as the lungs75 and gallbladder76, capable of absorbing CSF into systemic
circulation may be used.

Shunts have been the mainstay of hydrocephalus treatment for over 60 years77. However, their
associated risks and complications remain unacceptably high, with 50% failing within the first two
years of implantation71, subjecting patients to multiple revision surgeries and poor quality of life.
An alternative approach to shunting is endoscopic third ventriculostomy (ETV), which establishes
a CSF pathway between the ventricles and the subarachnoid space through a fenestration made in
the floor of the third ventricle66,78,79. ETVs may be coupled with choroid plexus cauterization
(CPC) to gain added benefits of decreasing CSF production and dampening the negative effects of
choroid plexus pulsatility51,80-82. However, ETV with or without CPC have not been shown to be
more efficacious than shunting51,83.

Attempts at non-surgical treatment for hydrocephalus in humans have been unsuccessful, and there
is no effective medical therapy yet84-88. Decorin, a transforming growth factor beta (TGF-β)
inhibitor has been shown to prevent ventriculomegaly in rats with infantile communicating
hydrocephalus89,90 and PHH91,92. Magnesium sulfate has been shown to improve gait performance
and lower reactive astrocytosis in hydrocephalic rats93. In rat models of congenital hydrocephalus,
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intraperitoneal administration of minocycline reduced the markers of neuroinflammation and
increased cortical mantle thickness94-96. Intraventricular infusion of nimodipine, a calcium channel
antagonist has been shown to reduce white matter damage and improve sensorimotor function and
spatial learning in juvenile hydrocephalic rats 97,98. However, all the pharmacologic agents tested
to date have shown to be variable with limited short-term success, even in the animal models84-98,
and none have translated into an efficacious human hydrocephalus treatment88.

1.5

Current understanding of the pathophysiology of PIH/PHH

Although significant positive strides have been made in the context of advances in infection
control71,99, shunt hardware100,101, and surgical technique51,66,78-82,87,102-107, the outcomes of
hydrocephalus remain dismal71. Unfortunately, hydrocephalus surgery early in life is largely
palliative and at the time of diagnosis over 80% of the deleterious effects of hydrocephalus are
already established and are irremediable. Therefore, the most significant global health impact on
PIH and PHH will require directing efforts to defining disease pathophysiology to target both the
underlying causes and mechanisms of neurological injury12,52,56. Characterizing the
pathophysiology of PIH and PHH may also direct the discovery of biomarkers that will promote
early identification and diagnosis, predict treatment efficacy, alert treatment failure in a timely
fashion and facilitate the comparison of prevention strategies and treatment modalities in clinical
trials. Furthermore, if PIH/PHH pathophysiology is better characterized and understood, emphasis
could shift from palliation of CSF accumulation51 to prevention84,85,87.
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1.5.1

Embryological overview of the cerebral ventricular system

As mentioned above, characterization of the pathophysiology of PIH and PHH renders in the
development of diagnosis, treatment and prevention strategies. Knowledge of the ventricular
system, ependymal barrier, and choroid plexus, particularly in the context of the development of
the central nervous system (CNS) is essential to understand the PIH and PHH pathophysiology.

1.5.1.1 Ventricular development
Human development originates from the three-layer primitive embryonic structure: ectoderm,
mesoderm and endoderm. These are formed through purposeful cell movement and organization
following fertilization108. During neurulation, around the second week of embryonic development,
the neural plate thickens and invaginates into a neural groove along its midline which then fuses
into a rostro-caudal neural tube108,109. The neural tube momentarily remains in communication
with the surrounding environment via its rostral (anterior) and caudal (posterior) neuropores, until
they both eventually close off to form the ventricular system108 (Figure 5).
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Figure 5: Embryological origins of ventricular development.
During neurulation, the anterior and posterior neuropores close to isolate the ventricular system
from its embryonic environment. Formation of the complex five-vesicle structure and differential
expansion of regions around the neural tube flexures and the neural canal create the cerebral
ventricles.

Around the third week of embryonic development, the rostral end of the neural tube undergoes
rapid morphogenetic movement and expansion to develop three symmetric primary swellings: the
prosencephalon (forebrain), the mesencephalon (midbrain), and the rhombencephalon (hindbrain).
This three-vesicle stage is facilitated by a symmetric folding of the neural tube rostrally along its
lateral axis to form two flexures: the cephalic flexure which develops between the prosencephalon
and mesencephalon, and the cervical flexure, which divides the rhombencephalon and the spinal
cord108. Due to significantly restricted morphogenesis at the cephalic flexure in relation to the rest
of the prosencephalon, two distinct structures develop: the rostral telencephalon and the caudal
diencephalon. At approximately the sixth week, the pontine flexure develops to demarcate the
rhombencephalon into the myelencephalon and the metencephalon. Thus, by the seventh week,
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the three primary vesicles have developed into five secondary vesicles108, which are (from rostral
to caudal): telencephalon (future cerebral hemispheres), diencephalon (future thalami,
hypothalamic and optic cups) mesencephalon (future midbrain), metencephalon (future pons and
cerebellum) and myelencephalon (future medulla oblongata)108 (Figure 5).

Development of the ventricular system is a fascinating and clinically important topic in its own
right and is integral to understanding the complexities of ventricular-associated pathologies, such
as hydrocephalus. In the developed human brain, the ventricular system comprises of two lateral
(telencephalic) ventricles that connect through the foramen of Monro to the third (diencephalic)
ventricle, which in turn connects to the fourth (rhombencephalic) ventricle via the cerebral
aqueduct. Although the ventricular system is continuous with the central canal of the spinal cord
in development, and potentially thereafter, it communicates with the subarachnoid space through
the foramen of Magendie and foramina of Lushka at the level of the pons.

Embryonic ventricular development is heralded by the closure of the anterior and posterior
neuropores, which are connected at the midline by a CSF-filled lumen lined by ependymal cells
along the neural canal. Osmotic absorption of water by the cells lining the primitive ventricles and
secretion of fluid into the ventricular cavity from the choroid plexus lead to physical forces during
neural tube expansion. These forces and interactions mediate the development of the threedimensional ventricular structure from the primitive neural tube configuration. The segment of the
neural canal that spans the telencephalon develops into the lateral ventricles. The lateral ventricles
maintain a large inflated shape due to massive CSF production by the choroid plexus in those
regions. The C-shaped configuration of the lateral ventricles occurs as a result of bilateral
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ventromedial expansion of the ganglionic eminence bilaterally108. During the sixth week of
gestation, the initial slit-like communication between the diencephalon and bilateral telencephalon
vesicles enlarges forming the foramen of Monro. While the cavity in the diencephalon forms the
third ventricle, the cerebral aqueduct forms from the remnant of the neural canal at the level of the
mesencephalon. The fourth ventricle develops from the splaying of the pontine flexure. Unlike the
fourth ventricle, which enlarges during formation of the rostral neural tube structures, the cerebral
aqueduct is relatively large during early embryological stages but later narrows. The remainder of
the neural canal stretches inferiorly as the central canal of the spinal cord. Around weeks 10-12
the lateral ventricles and the fornices are separated into the left and right by a thin membranous
bridge; the septum pellucidum110. The septum pellucidum develops inextricably with the corpus
callosum and the anterior and hippocampal commissures from the basal medial portion of the
lamina terminalis known as the commissural plate110-112 (Figure 5).

From a bulk flow perspective, CSF moves rostro-caudally from the lateral ventricles, propelled by
the ependymal cilia, through the foramen of Monro into the third ventricle. It then moves through
the cerebral aqueduct and enters the spinal subarachnoid space via the foramina of Luschka and
Magendie. From the subarachnoid space, it has been traditionally thought that CSF is absorbed
into systemic circulation exclusively at the arachnoid granulations113-116. However, other pathways
including some cranial and dural routes113-116, and a glymphatic pathway117-121, have been recently
described. The glymphatic pathway is a glia-based paravascular route for the clearance of soluble
proteins and metabolic waste products from the brain to the lymphatic networks117-121.

17

1.5.1.2 Ependymal layer development
The inner perimeter of the cerebral ventricles is lined by the ependymal layer, a monolayer of
multiciliated cuboidal to columnar epithelial cells122 held together near the apical surface by cellcell junctional proteins. Embryonically, the ependymal layer is derived from the ventricular zone
(VZ), a single layer of monociliated neural stem cells (NSC) that populates the germinal matrix.
The VZ and the subjacent sub-ventricular zone (SVZ) are also the primary sites of neurogenesis
for the brain123. During fetal development, NSCs in the VZ migrate via radial glial cells123-126 to
differentiate either into neurons of the cerebral cortex or glia127,128 (e.g., ependymal cells)127. The
VZ spans the entire neural tube during neurulation. However, it is replaced by the ependymal layer
as the brain matures, and stem cells are largely limited to specific areas of the SVZ. These stem
cells retain restorative and repair capabilities; for example, they can regenerate neurons of the
olfactory bulb and dentate gyrus via the rostral migratory stream129,130. One major role of the
ependymal layer is to facilitate CSF flow through a highly coordinated beating of its apical cilia
to move debris. Another major role is to serve as a protective barrier that shields the juxtaposed
basal subependymal gray and white matter tissues from CSF toxins131. The predominant cell
junction proteins that connect ependymal cells to maintain their structural integrity and function
are adherens junctions (e.g., N-cadherin) and cell adhesion molecules (e.g., L1-CAM and NCAM1) (Figure 6). However, some gap junctional proteins, such as connexins132, and transitory
expression of tight junctions during fetal development133 have been identified. However, the
persistence of tight junctions in mature ependyma remains debatable.
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Figure 6: Schematic representation of ependymal layer and choroid plexus.
Mature multiciliated epithelial cells are structurally organized in a monolayer with intervening
cell-cell adherens junctional proteins to form a partial CSF-brain barrier. The choroid plexus on
the other hand comprises a monolayer of choroid plexus epithelial cells connected by tight
junctions.

1.5.1.3 Choroid plexus development
As development of the neural tube progresses, a shallow sulcus limitans at the caudal end
demarcates the roof and alar plates from the floor and basal plates. Further differentiation of nonneural tissue at the roof plate forms the highly vascularized choroid plexus that is found within
each cerebral ventricle134. After neural tube closure, the choroid plexus appears first in the fourth
ventricle, followed by the lateral ventricles synchronously, and lastly by the third ventricle135.
Despite their distinct appearance, the choroid plexuses in the lateral ventricles merge at the exit
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levels of foramina of Monro and fuse with the third ventricle plexus to form a continuous choroid
plexus structure135-137. The many functions of the choroid plexus, such as CSF secretion135,138,
solute transport139, and immune system regulation140, have been extensively described in the
literature. Histologically, the choroid plexus comprises a network of connective tissues and
fenestrated capillaries, surrounded by cuboidal epithelial cells that are held together by tight and
adherens junctions to form the blood-CSF barrier. A wide range of transporters, including
aquaporins, Na+-K+-ATPase, Cl--HCO3, Na+-K+-Cl- and glucose transporter 1 have been identified
as facilitators of the choroid plexus’ CSF production mechanism141.

1.5.2

Hydrodynamic and pulsatility concepts of hydrocephalus

The traditional pathophysiological perspective on hydrocephalus considers impairment of CSF
flow dynamics, i.e. CSF overproduction and/or impaired uptake as the primary mechanisms1,142,143.
CSF overproduction has been mainly attributed to hypersecretion due to alterations in choroid
plexus physiology144-147. In an Escherichia coli acute septic ventriculitis mouse model, Cardia et
al. reported ultrastructural changes of the choroid plexus epithelium that led to CSF overproduction
and PIH144. In an experimental obstructive hydrocephalus model, Karimy et al. demonstrated that
hydrocephalus was propagated by neuroinflammation-induced choroid plexus hypersecretion145.
In terms of CSF absorption impairment, the main theory is that CSF egress pathways, such as the
cerebral aqueduct and arachnoid granulations undergo gliosis and scarring that impair CSF flow
leading to CSF accumulation within the ventricles121.
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Once hydrocephalus is established, there are progressive effects on the biomechanical properties
of the brain. Di Rocco et al. demonstrated that ventricular dilation is likely propagated by abnormal
intracranial pulsatility148, which may be attributed to an increased cerebral capillary pulsatility
and/or the loss of an endogenous vascular dampening mechanism149-152. Increased capillary
pulsatility in hydrocephalus may have several pathophysiologic consequences, including the loss
of parenchymal microvessels153-156 and compromise of the blood-brain barrier157-159. Both of these
effects might explain the marked loss of cerebral perfusion that has been well documented in
clinical160-162 and experimental163-165 hydrocephalus. Importantly, it has been shown that excessive
pulsatile stress can impair hemodynamics through changes in endothelial cell homeostasis166
mediated by nitric oxide167,168. These examples all provide a compelling case for the importance
of CSF pulsatility in the pathogenesis of hydrocephalus.

As additional details of the biological mechanisms of CSF hydrodynamics and pulsatility emerge,
pharmacological targeting of these systems may be utilized to modulate CSF physiology in PIH
and PHH. Nevertheless, imbalances in CSF flow are only a part of a much more complex
pathophysiology of hydrocephalus. Indeed, recent experimental169-178 and clinical studies169,179-183
have confirmed the pathophysiology of hydrocephalus is multifactorial, encompassing a complex
interplay between neuroinflammation, edema, reactive gliosis, perturbations of the neurogenic
niche and other neurodevelopmental processes, distortion of brain parenchyma, cerebral hypoxia
and ischemia, axonal degeneration and demyelination, and neuroglial apoptosis87,102,184-190.
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1.5.3

Phenotypic similarities between PIH and PHH

For the purposes of this work, it is critical to note that PIH and PHH have very similar features
suggesting they may share common pathophysiological mechanisms. Clinically, the signs and
symptoms associated with PIH and PHH after their respective antecedent event are
indistinguishable. Radiologically, PIH and PHH are both classified as communicating
hydrocephalus with features of diffuse grey and white matter injury, such as T2-weighted
hyperintensities indicating tissue disruption191,192, susceptibility weighted imaging evidence of
petechial hemorrhages193-195, restricted diffusion representing tissue ischemia193-195, and disrupted
white matter water diffusivities on diffusion MRI (dMRI) suggesting PVWM damage. On gross
pathology and histology, both PIH and PHH are characterized by many features of inflammation
and basal cisterns fibrosis36,85-87,190,196,197. Interestingly, based on the many phenotypic similarities
between PIH and PHH, a recent review by Karimy et al. classified them collectively as an
“inflammatory hydrocephalus” subtype198. This is critical because the commonalities suggest that
in response to the antecedent neonatal sepsis or hemorrhage, neuroinflammation pathways are
activated to mediate similar patterns of brain injury seen in both PIH and PHH86,87,190,197.
Furthermore, it is also possible that host-mediated neuroinflammation causes diffuse brain scarring
and obstruction of CSF pathways, which results in hydrocephalus.

1.5.4

Role of neuroinflammation in PIH/PHH pathogenesis

Neuroinflammation, the host immune response to cues that threaten nervous tissue integrity, is a
consistent finding in many forms of hydrocephalus and likely underlies the chronic problems that
plague hydrocephalic patients due to glial scar formation199.
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In PIH, the role of neuroinflammation may be well-defined in the case of a systemic infection.
Typically, once a pathogen breaches a host’s epithelial barriers, innate immune mechanisms
eliminate the microbe. Sepsis, a systemic inflammatory response, occurs when the pathogen is not
effectively eliminated. With a persistent pathogenic material, multiple pathways including the
Toll-like receptor (TLR)200, Janus kinase/signal transducers and activators of transcription
(JAK/STAT)201,202 and NF-κB/TREM-1 signaling203 pathways are activated elevating
inflammation. Systemic inflammation typically makes the blood-brain barrier permeable to
microbes and other systemic inflammatory mediators that traverse into the subarachnoid space.
This leads to the activation of neuroinflammatory cascades, production of nitric oxide metabolites,
hypoxia, and decreased glucose metabolism in the brain and CSF204-206 culminating in brain injury
and subsequent PIH.

In PHH, the presence of blood and blood products in the CSF initiates TLR2 and complement
activation resulting in a release of cytokines (e.g., interleukins (IL) and tumor necrosis factors
(TNF)) and chemokines (e.g., Chemokines C-C (CCL) and C-X-C (CXCL)) that culminate in
ependymal gliosis, arachnoiditis, and fibrotic blockage of CSF pathways to cause
hydrocephalus85,196. Our group recently showed that the CSF of PHH infants contains significantly
higher levels of IL-1α, IL-4, IL-6, IL-12, TNF-α, CCL-3, CCL-19, and CXCL-10 compared to
healthy control infants207. Several other investigators have utilized targeted assays to demonstrate
strong associations between PHH and CSF inflammatory markers199,208-210.

Therefore, it is important to characterize the nature of the host-immune response in PIH and PHH
to understand the pathophysiology. This will allow us not only to address PIH and PHH as the
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most prevalent variants of hydrocephalus, but also to gain further insights into other forms of
hydrocephalus.

1.5.5

Effect of PIH and PHH on neurodevelopment

In humans, VZ/SVZ differentiation to form the ependymal layer continues into the third trimester
and newborn period211. During these critical periods, any perturbations in the VZ/SVZ, particularly
by IVH or infection, can have deleterious effects on brain development and CSF physiology.
McAllister et al. reported that VZ/SVZ disruption is a key feature of IVH in preterm human
infants197 and is characterized by alterations in NSCs, VZ/SVZ cell loss, neuroepithelial injury,
and gliosis in the affected areas. Blood and blood products, including iron, have also been shown
to elicit similar effects on neurogenesis in experimental models85,212-214. Yung and colleagues
reported that lysophosphatidic acid (LPA), a blood component that also plays a major role in
neurogenesis, neuronal differentiation, and apoptosis of neural progenitor cells, consistently
causes hydrocephalus when injected into the lateral ventricles of fetal mice214. LPA induction of
hydrocephalus depends strongly on expression of the LPA1 receptor by neural progenitor cells in
the VZ. Increased levels of LPA promotes the transfer of Yes-associated protein (Yap), a
transcriptional regulator involved in the maturation of ependymal cells, from the cytoplasm to the
nucleus in VZ cells. Nuclear Yap is associated with agenesis of ependymal cells leading to VZ
disruption and hydrocephalus215. VZ disruption in the pathogenesis of other forms of
hydrocephalus has been demonstrated by a series of studies on mice with genetic defects171,175177,216-220

.

Accumulating evidence suggests that the VZ/SVZ disruption and loss of NSCs in many forms of
hydrocephalus likely results from disruption of cell junctional proteins. For example, in congenital
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hydrocephalus, mutations in genes encoding proteins involved in intracellular trafficking and cell
junctional complexes have been identified169,172,176,215,221-224. In addition, many forms of human
congenital hydrocephalus result from genetic alterations of cellular adhesion proteins such as Ncadherin, connexin, and L1CAM169. A series of studies on hydrocephalus with hop gait (hyh)
mice175,177,216-219, which develop perinatal aqueductal stenosis also support the presence of a
genetic defect in cell junction complexes as an underlying cause of hydrocephalus. Furthermore,
impairment of cell-cell junctional complexes has been implicated in the subcommissural organ
alterations that lead to aqueductal stenosis170,225,226.

ADAM10, a metalloprotease, cleaves a wide range of cell-cell junctional proteins and regulates
cell-cell interaction227. For example, hyperactivity of ADAM10 induces disruption of lung
epithelial cells through the loss of cadherin-dependent junctions228. Preliminary results from in
vitro approaches (described in Chapter 4) provide strong support for a potential mechanistic role
of ADAM10 in the VZ/SVZ disruption observed consistently in PIH and PHH. It is quite possible
that cleavage of adherens junction proteins such as N-cadherin by ADAM10 could create
downstream effects on the neurogenic niche, such as ependymal denudation, eruption of neural
precursors into the CSF, and formation of heterotopia. However, whether this disruption stimulates
further inflammatory responses from astrocytes and microglia is another key question to be
answered. Overall, there is a critical association between genetic susceptibility, cell-cell junction
regulatory molecules, and hydrocephalus; therefore, setting the stage for exploring therapies that
can mitigate these processes.
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1.5.6

Periventricular white matter (PVWM) injury in PIH/PHH

One of the major effects of hydrocephalus is PVWM disruption. This disruption often presents as
T2 hyperintensities on MRI, and is histologically characterized by rarefactions, edema,
astrogliosis, dysmyelination, hemosiderin-laded macrophages, and decreased neurofilament
proteins175,178,197,229,230. Anatomically, the VZ/SVZ layer is juxtaposed by a thin layer of white
matter fibers medial to large bundles of PVWM tracts such as the corpus callosum, internal capsule
and optic radiations. When the VZ/SVZ and immediate PVWM fibers, a region we have
collectively termed as the lateral ventricular perimeter (LVP)231, are disrupted by
hydrocephalus232,233, the larger bundle of PVWM tracts, which carries ascending and descending
motor and sensory fibers, is at risk of injury by CSF toxins and neuroinflammation234.
Hydrocephalus-related PVWM injury has been associated with neuromotor and cognitive
developmental deficits in children131,187,235-239 and have been implicated in most of the debilitating
neurological symptoms in affected infants240-242. Because the LVP can also be damaged by the
expanding ventricles, PVWM tracts remain chronically vulnerable throughout the entire period of
progressive hydrocephalus. Therefore, characterization of the LVP and large bundle PVWM tracts
is indispensable for understanding PIH and PHH pathophysiology in addition to providing insights
on the relationships between LVP injury and PVWM-related neurological function.

1.6

Proposed strategies

While important strides have been made in defining the pathophysiology of hydrocephalus, there
remain unanswered questions in the field of PIH and PHH pathophysiology. Expert panelists at
hydrocephalus research workshops coordinated by the National Institute of Health (NIH) have
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outlined some of the significant gaps in hydrocephalus studies applicable to PIH and PHH
research87,102. For example, how does ventriculitis or IVH cause CSF dysregulation? And what
genetic mechanisms or pathology-induced epigenetic changes occur in the subset of patients who
progress to develop PIH or PHH? Secondly, what are the reversible and irreversible cellular
responses to inflammation and mechanical distortion by ventriculomegaly? Thirdly, which
biomarkers are most useful for the diagnosis, prognosis, and monitoring of PIH and PHH infants?
And can those biomarkers be used to predict hydrocephalus before it develops? Lastly, perhaps
more importantly, what pharmacologic strategies might be effective in reducing the myriad of
pathophysiologic changes or preventing the development of PIH and PHH?

To address some of these questions, this dissertation utilizes genomics, proteomics,
proteogenomics, dMRI, neurocytology and animal models as complementary approaches to
characterize the pathophysiology of PIH and PHH and to examine potential therapeutic targets.

1.6.1

CSF genomics and proteomics

The molecular composition of CSF reflects the physiological status of the neural structures it
bathes making it an indispensable medium for assessing changes that occur in the brain and for
identifying genetic and proteomic footprints of disease pathogenesis. CSF also harbors molecular
components necessary for neurodevelopment, neuromodulation and neurotransmission which may
also be altered by pathological processes. In hydrocephalus, the initial injury, raised ICP, and
ventricular stretch are all capable of initiating injurious cascades that can disrupt the CSF microand macro-environment39,87,102,185,187,189. Thus, the importance of CSF analyses in hydrocephalus
cannot be overstated142,143,207,243-249.
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There are several approaches to CSF analysis, including those done routinely to measure levels of
clinical metabolites250,251 and targeted assays238,245-247,249,252,253 such as enzyme-linked
immunosorbent assays (ELISAs) and western blots. While routine biochemical analyses and
targeted assays are informative, they both have inherent limitations, such as lack of sensitivity and
specificity, that preclude their utility for characterizing the multifactorial pathophysiology of and
differentiating between PIH and PHH. We recently performed a retrospective review of the routine
clinical lab CSF results of a cohort of 176 infants with CNS infections, IVH/PHH infants without
infection, and controls with no known neurological injury. We found that the CSF profile of noninfected PHH infants is indistinguishable from that of infants with bacterial CNS infections. Both
conditions presented with higher leukocyte counts, higher protein but lower glucose concentrations
relative to healthy controls. Recently, the use of targeted assays to analyze CSF in hydrocephalus
has gained momentum. Morales et. al. utilized ELISAs to analyze CSF samples obtained from
preterm IVH infants and control infants246. They reported an increase in amyloid precursor proteins
(APP) and APP-related peptides in PHH246,249 and a correlation between ventricular size reduction
and reduced levels of those markers245. Mounting evidence suggests that APP and its isoforms are
associated with neurodevelopment and synaptogenesis254-256, and their disruption invariably leads
to axonal injury257-259. As such, the elevated levels of APP and its isoforms in PHH may be
attributed to a cascade of axonal disruption caused by the inciting hemorrhagic insult and the
ventricular distension238,252. Presumably the reduction of APP levels following resolution of
ventriculomegaly245 signals a reversal of the pathologic process. CSF targeted assays have also
shown that infants with PHH have alterations in cell junction molecules including L1CAM,
NCAM-1 and N-cadherin247,253. Despite their utility, targeted assays require a priori knowledge of
which molecules to investigate, thus only permitting the isolation of a limited number of proteins
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instead of exploring the large CSF proteome of hydrocephalus207,245,246. These limitations
necessitate the need for using high throughput discovery-based strategies such as genomics and
proteomics to comprehensively define the molecular hallmarks of PIH and PHH pathophysiology.

A fundamental question in understanding any disease is the relationship between gene expression
and biological function. Large scale genomic studies have already provided some insights into the
role of genetics, especially those related to neurodevelopment in congenital hydrocephalus7,15.
Harnessing this genomic approach, Schiff and colleagues’ recent work involving Sub-Saharan
African infants with neonatal sepsis12,56 has offered evidence that genomics can be utilized to
define PIH and PHH pathophysiology. However, the literature search did not reveal any studies to
date that have used genomics to characterize the effect of hemorrhage, infection or PIH/PHH on
the CSF genomic profile of infants.

On the other hand, CSF proteomics has been utilized, mostly by our group, to explore candidate
protein biomarkers of hydrocephalus247. These biomarkers were subsequently examined with
targeted assays to outline their clinical implications as they pertain to ventricular size and
intracranial pressure245. Using tandem mass tagging (TMT)-10 proteomics, Morales et al.
identified over 400 human CSF proteins involved with various neurodevelopmental processes
including cell adhesion molecules, synaptogenesis, extracellular matrix and oxidative
metabolism247. However, these experiments were performed in a small cross-sectional cohort of
PHH infants and such level of detailed analysis has not yet been applied to PIH.
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1.6.2

Proteogenomics

Proteomics and genomics are important strategies for defining the pathophysiology of disease and
identifying biomarkers, individual genes, sets of genes and biologically functional proteins.
However, these approaches in isolation cannot comprehensively explain the clinical phenotype of
a disease260. Rather, disease pathogenesis involves the combinatorial interaction of regulatory
elements within the proteome, transcriptome, and other environmental factors261. Proteogenomics
is an emerging field that integrates deep-scale proteomics with next-generation genomic and
transcriptomic data to define network and pathway level linkages to probe molecular mechanisms
of disease262. Proteogenomic findings inform functional studies that lead to detailed insights into
the biology of disease and, ultimately, new therapeutic approaches and novel drugs. The nucleotide
sequencing data obtained from a proteogenomic study can be used to improve protein
identification through comprehensive protein sequence database construction. Proteomic data can
also be used to demonstrate the validity and functional relevance of novel findings based on large
scale RNA-seq and novel coding transcripts262.

Following proteogenomic integration, gene set enrichment analysis (GSEA) can be utilized to
perform signaling pathway analyses on proteogenomic data to identify dynamic interactions
among genes263-265. In GSEA, differentially expressed proteogenomes are layered atop knowledgebased physical or biochemical interaction scaffold networks265. In PIH and PHH, these functional
analyses can be carried out by ranking differentially expressed genes to calculate a score that
reflects the degree to which a given pathway is represented at the extremes of the entire ranked
list265. The significance of the gene set scores can be determined by using permutations of the
samples266. It is important to note that like other existing pathways analyses, GSEA focuses on the
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number of differentially expressed genes observed in a given pathway, but it is unable to either
address topology or assess the impact of perturbations on gene-gene interactions. To address these
important limitations, signaling pathway impact analysis (SPIA)267 may be used. SPIAs permit the
calculation of a global pathway significance p value, which factors a perturbation p-value into the
GSEA p-values to limit data noise in signaling pathways and increase their sensitivity and
specificity to the pathology of interest. To identify interactions beyond direct protein-protein
binding, differentially expressed genes in PIH and PHH can also be entered into the search tool
for the retrieval of interacting genes/proteins (STRING) database to capture functional links, such
as substrates that connect PIH/PHH-related proteins in a metabolic pathway or proteins that are
involved in large multi-protein assemblies268.

1.6.3

Diffusion magnetic resonance imaging (dMRI)

CSF perturbations due to an infection or hemorrhage invariably culminate in brain injury. This
injury can be seen on conventional MRI as global changes in grey and white matter, including
loculations, calcifications, necrosis and infarcts. However, conventional MRI is unable to examine
pathophysiologic, microstructural changes of brain tissue. In contrast, dMRI is capable of
delineating white matter integrity by assessing the magnitude and directionality of water molecules
within tissues269-271 to inform microstructure and detect aberrations in white matter tissues that
underlie PVWM injury272.
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1.6.3.1 Diffusion tensor imaging (DTI)
Diffusion tensor imaging (DTI) is a commonly used dMRI technique, with many clinical and
experimental applications. Standard DTI measures include: fractional anisotropy (FA), which
quantifies water diffusion anisotropy; axial diffusivity (AD), which assesses the rate of water
diffusion parallel to the direction of axons; radial diffusivity (RD), which assesses the rate of water
diffusion orthogonal to the direction of axons; and mean diffusivity (MD), which is an average of
AD and RD270,271,273. With FA, AD, RD and MD measurements, DTI can determine PVWM
integrity 271,273,274 and structural changes associated with hydrocephalus through its imaging of the
orientation-independent magnitude of water diffusion. DTI has been widely used to assess PVWM
integrity in hydrocephalus238,239,270,271,273,275-287 which has been shown to correlate with
neurodevelopmental outcomes in hydrocephalic children238,276,284,287,288. For example, Mangano et
al. showed that motor scores negatively correlated with MD scores in the internal capsule of
hydrocephalic patients, who also had significantly lower conceptual, practical, and social ABASII composite scores than healthy controls284. Higher diffusivity values in the corpus callosum have
also been associated with poor psychomotor development index scores at approximately two years
following hydrocephalus diagnosis289.

DTI measures have been shown to improve or normalize following shunt surgery284,287,290,291. For
example, we recently reported a reduction in internal capsule and corpus callosum MD indices in
PHH and congenital hydrocephalus infants to levels similar to controls following 15 months of
shunt surgery for hydrocephalus treatment292. Tan et al. demonstrated that higher FA measures
correlated with better clinical outcomes as assessed by the Headache Disability Inventory and the
Hydrocephalus Outcome Questionnaire among 21 adolescent and young adult patients who had
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been previously treated for hydrocephalus293. While these pieces of evidence suggest that serial
DTI may have both diagnostic and prognostic value294, there is an ongoing debate regarding the
utility of DTI as a clinical tool for managing hydrocephalus in patients. This is because of the
complete reliance on conventional high-resolution multi-sequence MRIs, which require long
acquisition times up to 60 minutes per scan. However, we recently developed a fast brain MRI
protocol that has an average entire brain acquisition time of approximately six minutes, from which
MD can be calculated. With our protocol, the diffusion tensor is computed by averaging the
diffusion measurement in three axial directions derived from the conservation of the trace of the
diffusion tensor under rotational transforms. We tested the feasibility of this protocol in 40 infants
with PHH or congenital hydrocephalus alongside healthy controls. The results demonstrated that
fast brain MRIs can be extended beyond anatomical assessments to evaluate the integrity of
PVWM in pediatric hydrocephalus patients, limiting the need for sedation for dMRI analyses292.

Despite its utility and many advantages, DTI has inherent limitations that make it challenging to
delineate white matter pathology with adequate sensitivity and specificity295-297. For example, DTI
is not capable of resolving crossing fibers296,298,299 or quantifying axonal density299,300.This is in
part because DTI utilizes a single tensor model in which the white matter fibers in a voxel are
represented as a single population, despite the fact that 60%-90% of white matter voxels contain a
more complex configuration of white matter fibers, including crossing fibers. Secondly, in multifaceted white matter pathologies such as PIH and PHH, each voxel may contain water populations
representing myelinated, dysmyelinated or unmyelinated axons. Moreover, DTI has been shown
to lack the sensitivity to quantify myelination under similar circumstances299,300. Furthermore,
neuroinflammation, which is a major pathophysiology in PIH and PHH, leads to multiple water
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compartments, including varying cell densities and morphologies due to reactive astrogliosis,
edema, and axonal loss207,208,230. There are alternative dMRI approaches296,297,301-308, such as
diffusion basis spectrum imaging (DBSI)307-312, that can address some of DTI’s limitations;
however, they have yet to be utilized for PIH, PHH or other forms of hydrocephalus.

1.6.3.2 Diffusion basis spectrum imaging (DBSI)
Diffusion basis spectrum imaging (DBSI) is a relatively new dMRI technique best suited for
examining complex multicompartmental cellular processes in the white matter. Unlike DTI, water
displacements in DBSI are represented as multiple diffusion tensors each representing different
water compartments. This allows separation of crossing fibers and estimation of crossing angles,
directional diffusivity of individual crossing fibers, and axonal loss307-313. In addition to anisotropic
diffusion compartments, DBSI includes isotropic tensors, which reflect water compartments in
inflammatory cells and edema water307,311,313. DBSI has been validated in clinical308-311 and
preclinical/phantom studies307,309,314-316 of multiple sclerosis307-309,311,314, epilepsy315, spinal cord
injury317, and cervical spondylotic myelopathy310. The extended capabilities of DBSI suggest that
it may provide more informative biomarkers than DTI for the differentiation and quantification of
PVWM integrity in hydrocephalus. There are several benefits of utilizing DBSI for the assessment
of hydrocephalus-related PVWM injury. First, DBSI may provide parameters that more directly
reflect underlying tissue microstructural changes. Second, DBSI may provide an opportunity to
comprehensively investigate complex aspects of structural brain development in hydrocephalus
and track their association with neurodevelopmental outcome. Third, DBSI may be used to
delineate the relationship between ventricular volume, which is readily modified with current
standard-of-care neurosurgical hydrocephalus treatments, and therapeutic response following
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surgical treatment of hydrocephalus. Lastly, DBSI may be used to inform clinical trials that assess
modalities focused on the clinical management or prevention of PVWM injury propagation.

1.6.4

Neurocytology

Immunohistochemistry is perhaps the most definitive modality for assessing the effects of
hydrocephalus on brain microstructure. General cellular structure is often assessed with
hematoxylin and eosin (H&E) stains. With a focus on neurodevelopment, neuroinflammation and
PVWM injury, single- and double-labeling immunohistochemistry with antibodies specific to cell
adhesion molecules, neural stem cells, ependymal cells, and glial activity are valuable tools that
can be leveraged to evaluate the effects of PIH/PHH on these processes. For example, anti-βIV
tubulin can be used to evaluate multiciliated ependymal cells and undifferentiated monociliated
cells, anti-N-cadherin for adherens junctions, anti-ADAM10 for metalloprotease activity, antiGFAP for immature ependymal cells and reactive astrocytes, and anti-Iba1 as a surrogate for
microglia-related products. Following staining, epifluorescence or confocal microscopy are
commonly used to visually examine cellular structure. VZ/SVZ damage are histologically
characterized by disrupted adherens junctions, reduced number of multiciliated (mature)
ependymal cells, radial glial cell disorganization, astrocytic proliferation, and ependymal rosette
formation142,197. PVWM damage is typically observed as rarefactions, edema, astrocytosis, gliosis,
dysmyelination, hemosiderin-laden macrophages, and decreased neurofilament proteins197,230,242.
Our group recently developed an in-house script that utilizes ImageJⓇ to quantify the numbers,
length, area, volume, intensity, shape, and texture of cells318. Immunohistochemistry can also be
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utilized to assess the brain regions of interests across species (i.e., humans vs. experimental
models).

1.6.5

Experimental models of hydrocephalus

Animal models offer an environment that is amenable to manipulations of biological, cellular, and
physiological processes to best understand the mechanisms of pathogenesis in human diseases and
trial therapeutic strategies87,102. In vitro models, which involve the isolation and cultivation of cells
or organ systems in specially formulated media provide micro-environments that can be precisely
controlled to focus on mechanisms of action in disease pathogenesis. To date, only a few studies
have utilized tissue cultures to investigate cellular processes involved in hydrocephalus. For
example, Smith et al. utilized tissue culture chambers to examine the effects of increased pressure
and to potentially slow stretch on ependymal and glial cells319. Other groups have examined
explanted shunt catheters in tissue culture media to assess growth as well as specific responses to
compression, stretch, and hypoxia. In several studies, Harris et al. have utilized a bioreactor to
demonstrate the immediate deposition of protein biofilms that form a substrate for macrophage
and glial cell attachment and provided evidence for cell surface modifications that reduce cell
adhesion on silicone catheters320-324.

A major drawback of tissue culture systems is that they cannot mimic all the physiologic conditions
of living organisms, necessitating the need for in vivo models. There is currently a plethora of in
vivo models of several forms of hydrocephalus. Mouse knockout models such as the hydrocephalus
with hop gait (hyh)176,216,217,219, hydrocephalus-3 (hy3)325-327, those with ciliopathies328-336 and mice
with mutations in SUMS/NP

337,338

, TGF-β1339-341, FGF-2342,343, L1-CAM344,345, Rnd-3346, and
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AQP-4

347,348

have provided valuable insights into the genetic basis of congenital

hydrocephalus15,338,349-351. In rats, the H-Tx352-356 and LEW/Jms357-360 models, which develop
aqueductal stenosis, have been widely used to investigate the pathophysiology of obstructive
hydrocephalus and, recently, to explore VZ/SVZ disruption, and the potential to transplant
neurospheres for replacement therapy169,170,361,362. Acquired hydrocephalus models on the other
hand, have mostly been achieved by an intraventricular injection of the substances depending on
the variant of hydrocephalus of interest. The most popular injected substance is kaolin. The inert
silicate is injected into the cisterna magna or the basal cisterns, to induce obstructive and
communicating hydrocephalus, respectively151,363-369.

The vast majority of the existing animal models of hydrocephalus are mice370,371 and rats84,372,373,
likely because of their reduced costs, ease of handling and availability of transgenic
models133,170,220,359,374,375. However, these small animals are phylogenetically less advanced,
usually develop severe ventriculomegaly rapidly and have a limited life span. Additionally, their
lissencephalic cerebral cortex often presents challenges when translating research results to
humans376. Recently, there has been an increasing focus on animals with gyrencephalic brains such
as ferrets, dogs, sheep and piglets377-380 since they are more similar to human brains.

In PHH models, IVH has historically been induced with intraventricular injections of blood (whole
or lysed) and blood products such as hemoglobin, iron and LPA85,212,213,223,242,372,381,382.
Ventriculomegaly in IVH models is believed to be related to mechanisms of neuroinflammation
and damage to the VZ/SVZ. However, it is worth noting that up to 50% of control animals,
typically injected with PBS intraventricularly, develop ventriculomegaly suggesting that the
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intraventricular injection itself can produce collateral tissue damage91,383. Other studies have
induced IVH and PHH via intraperitoneal injection of glycerol384, hemodynamic dysregulation and
asphyxia378,385 and endovascular perforation of subarachnoid vessels386 with limited success.

In terms of CNS infections, there is extensive knowledge and documentation on several animal
models387-391. However, the majority of these experiments were designed to study the virulence of
pathogens, passive immunization and the efficacy of antimicrobial therapy392-395; and none have
focused on PIH. A PIH model may be induced through inoculation of live bacteria or bacterial
toxins via several routes including intraperitoneal, intranasal, oral and intraventricular387-389,391393,396-398

. However, achieving meningitis/ventriculitis from bacteremia in animals is extremely

challenging and is associated with unacceptably high risks of mortality from septic shock and
multi-organ failure. Alternatively, direct intraventricular injection of toxins to cause ventriculitis
may be more feasible, with the caveat that it bypasses the primary routes of human neonatal
sepsis397,399-401.

1.7

Thesis objectives and aims

1.7.1

Objectives

With the long-term goal to improve patient outcomes by identifying targetable pathways to prevent
the development of PIH and PHH, this dissertation leverages a complementary, yet comprehensive
scientific approach that encompasses: 1) High throughput discovery-based analyses of human
infant CSF to identify differentially expressed genes and proteins in PIH and PHH; 2)
Proteogenomic integration of proteomic and transcriptomic data to define network and pathway
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level linkages to probe molecular mechanisms underlying PIH and PHH; 3) Characterization of
the effects of hydrocephalus on the VZ, SVZ and PVWM using dMRI modalities that complement
human hydrocephalus neurocytology; 4) Generation of experimental models of hydrocephalus to
mimic the human condition and characterize hydrocephalus-associated neurobiology; and 5)
examine the role of metalloprotease inhibition as a therapeutic strategy for abrogating PIH and
PHH pathology.

1.7.2

Central hypothesis

We hypothesized that VZ/SVZ disruption in PIH and PHH is caused by ADAM10-mediated Ncadherin cleavage. CSF protein profiling from PIH and PHH infants will demonstrate alterations
in

gene-activated

pathways

in

immune-response,

cell-cell

junction

adhesion,

and

neurodevelopment-neural injury. Pharmacologic inhibition of ADAM10 will represent a viable
therapeutic approach to preventing these disabling diseases.

1.7.3

Specific Aims

1.7.3.1 Specific Aim 1
Determine the gene-pathway alterations that are common and unique to PIH and PHH.
Working hypothesis: Expressomes and specific pathways define the immune responses and
dysregulation of neurodevelopmental mechanisms in PIH and PHH
Sub Aim 1: Quantify the PIH and PHH CSF expressome using high throughput mass spectrometry
(MS)/MS proteomics and RNA-seq transcriptomics
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Sub Aim 2: Identify differentially expressed genes and proteins in the CSF of human PIH and
PHH infants using deep scale proteomics and define activated pathways relative to controls

1.7.3.2 Specific Aim 2
Define PIH and PHH related microstructural VZ and PVWM injury in human infants using
advanced dMRI and immunohistochemistry.
Working hypothesis: VZ histopathology and abnormal diffusion metrics are associated with
neuroinflammation in the PVWM of PIH/PHH human infants
Sub Aim 1: Quantify VZ and PVWM diffusion properties in PHH infants and age-matched control
infants with dMRI.
Sub Aim 2: Determine the relationships between immune-associated PVWM microstructural
histopathology

and

VZ

disruption

in

human

PIH/PHH

postmortem

tissues

using

immunohistochemistry

1.7.3.3 Specific Aim 3
Evaluate N-cadherin expression as a marker of ADAM10 activity and VZ disruption in vitro and
examine the effect of ADAM-10 modulation on N-cadherin expression.
Working hypothesis: In vitro ADAM10-mediated cleavage of N-cadherin is associated with VZ
disruption, and pharmacological inhibition of ADAM10 will ameliorate VZ disruption
Approach: Quantify N-cadherin disruption in vitro by exposing VZ cells to alpha-toxin (PIH) or
whole blood (PHH). Then determine if treatment with the ADAM10 inhibitor G1254023X will
preserve N-cadherin expression
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1.7.3.4 Specific Aim 4
Evaluate hydrocephalus associated VZ disruption and PVWM injury in vivo using PIH mouse and
PHH ferret models.
Working hypothesis: N-cadherin is associated with VZ disruption and PVWM damage in the
pathogenesis of PIH and PHH
Approach: Develop PIH mouse and PHH ferret hydrocephalus models and utilize MRI and
immunohistochemistry to determine the relationships between N-cadherin expression,
neuroinflammation and VZ and PVWM microstructure.
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Chapter 2: Proteogenomics and the PIH-PHH Cerebrospinal Fluid Expressomes
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2.1

Introduction

PIH and PHH are both likely propagated through analogous, yet poorly characterized host-genome
interactions. While there is anecdotal understanding of their pathophysiology, there has been no
systematic exploration of the regulatory pathways that drive the disease phenotype87. This has
limited previous efforts in PIH and PHH research to develop biomarkers for the clinical
management and comparative effectiveness studies, in turn hindering progress in diagnosis,
monitoring of therapeutic efficacy, and providing information regarding long-term neurological
outcomes. With a working hypothesis that expressomes and specific pathways define the host
responses in PIH and PHH, the primary objectives of the experiments presented in this chapter
were to identify key causative activated gene regulatory pathways and related functional protein
products involved in the pathophysiology of PIH and PHH. To achieve this goal, we carried out
two major studies examining the CSF of a cross-sectional cohort of infants with PIH, PHH and
non-infectious non-hemorrhagic hydrocephalic controls. The first study examined the CSF
proteogenomic expressomes of PIH, utilizing concurrent high throughput deep-scale proteomics
and next-generation transcriptomics. Our proteogenomics pipeline (Figure 7), which leverages
message-passing strategies to integrate gene expression and protein-protein interactions was
utilized. The second study utilized isobaric labelling proteomics to define the proteome of PIH,
PHH and matched control infants to determine pathway alterations that are common to both
conditions and those that are specific to each.
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Figure 7. Schematic of proteogenomics experimental and data analysis workflow.
Output data from concurrent proteomics and RNA-Seq on the same samples were processed,
normalized, batch-controlled and explored independently. Differentially expressed transcriptomic
and proteomic data were integrated following dimension reduction and feature selection. Gene
ontology enrichment was evaluated and common reactome pathways were visualized to identify
prominent molecular pathways implicated in the pathophysiology of post-infectious
hydrocephalus.

2.2

Results

2.2.1

Concordant proteome and transcriptome of host immune response in PIH

In this study, ventricular CSF samples of 100 infants ≤ 3 months of age with PIH (n=64) and nonpost-infectious hydrocephalus, NPIH (n=36) were concurrently analyzed with TMT-10 proteomics
and Illumina-based RNA-Seq transcriptomics. Gene expression and protein abundance data were
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analyzed for functional enrichment. Downstream analysis of proteomics and RNA-Seq data
included dimension reduction, feature selection, gene ontology enrichment and reactome overrepresentation pathway analyses of the differentially expressed proteins and genes.

2.2.1.1 Pathogen identification

Prior to this study, we had identified a strain of Paenibacillus spp. in the CSF of our PIH infants
in a background of cytomegalovirus infection (CMV)402, utilizing an extensive pathogen detection
approach including Sanger sequencing, next generation sequencing, quantitative polymerase chain
reaction (PCR), and VirCapSeq® 403. The Paenibacillus spp. strain we identified (which has been
since named the “Mbale strain”) had a 99% identity and a whole-genome average nucleotide
identity value of 97% to a known Paenibacillus thiaminolyticus strain NRRL B-4156T (=JCM
8360T, GenBank accession CP041405 – “Reference strain”)404. In our cohort, presence of the
Mbale strain in CSF inversely correlated with age and was associated with poorer clinical signs
including seizures febrile episodes, and worse neuroimaging metrics assessing the presence of
brain abscesses, calcifications loculations and debris on cranial CT scans. In 21-28-day old
C57BL/6J mice, intraperitoneal inoculation of the Mbale strain lead to a 93% mortality rate, and
was associated with acute tubular necrosis in the kidneys, bone marrow myeloid hyperplasia, and
lymphocyte apoptosis in the splenic periarteriolar sheaths. There were no significant lesions in the
brains or hydrocephalus402. Similar inoculation with the Reference strain was associated with no
adverse effects402. We are presently working on characterizing the pathogenicity of the Mbale
strain, utilizing RNA-Seq and label-free data-dependent acquisition proteomics.
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2.2.1.2 Patient characteristics

Informed by our findings of Paenibacillus spp. and CMV in the CSF of our cohort402, patients
were sub-categorized as “Paeni-positive” or “Paeni-negative”, and “CMV-positive” or “CMVnegative”, respectively. Comparison of baseline characteristics between Paeni-positive and Paeninegative patients: Paeni-positive patients had higher peripheral (p=0.002), and CSF (p<.001),
white blood cell (WBC) counts, and lower hemoglobin (p=0.039) compared with Paeni-negative
patients. There were no significant differences in age and gender between the groups. (Table 1).
Table 1. Demographics and clinical characteristics of PIH patients and controls
All
patients;
n=100

Paeni-negative; n=62
NPIH; n=36

Paenipositive;
n=38

PIH; n=26

Age in days, mean (SD)
57 (24)
43 (27)
75 (11)
59 (17)
Sex
Male (%)
51 (51)
16 (44)
14 (54)
21 (55)
Female (%)
49 (49)
20 (56)
12 (46)
17 (45)
CSF CMV Status, + (-)
8 (92)
0 (36)
2 (24)
6 (32)
CSF WBC [1.0 x 103]/µL, mean (SD)
30 (62)
5 (0.5)
5 (0.0)
72 (86.0)
Peripheral blood
10.3 (3.6)
8.8 (2.6)
9.8 (3.0)
11.9 (4.1)
WBC [1.0 x 103]/µL, mean (SD)
Hemoglobin g/dl, mean (SD)
11.5 (2.2)
13.0 (2.8)
10.5 (1.3)
10.8 (1.3)
Hematocrit %, mean (SD)
36.8 (7.4)
41.6 (9.3)
33.6 (4.2)
34.4 (4.1)
SD: Standard deviation, CSF: Cerebrospinal fluid, CMV: Cytomegalovirus; PIH: post-infectious
hydrocephalus; NPIH: non-post-infectious hydrocephalus; Paeni-positive: Cerebrospinal fluid (CSF)
Paenibacillus spp. positive; Paeni-negative: CSF Paenibacillus spp. negative.
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Supplementary Figure 1. Patient baseline characteristics
Composite of CT scans from all patients grouped by post-infectious hydrocephalus (PIH, upper
groupings) and non-post-infectious (NPIH, lower group) hydrocephalus. The PIH group is further
clustered by Paenibacillus spp. negative (left) and positive (right). Yellow and red stars indicate
if a patient was PCR positive for cytomegalovirus (CMV) in the CSF and blood respectively. Two
other patients met criteria for a bacterial identification for a putative pathogen, indicated as group
B Streptococcus (GBS) in a case that was also Paenibacillus spp. positive, and one case with
Bacillus sp. in the NPIH group. Two patients in the NPIH group were positive for Paenibacillus
spp. (Paeni) using V1-V2 analysis. Note that no patient in the NPIH group that was CMV positive
in the blood had CMV detected in the CSF.

2.2.1.3 Proteomics demonstrate neuroinflammation and cell junction disruption in PIH

Multi-dimensional scaling of proteomic data demonstrated clustering of PIH and NPIH infants and
distinguished Paeni-positive from Paeni-negative patients. Of 616 proteins identified, 292 were
differentially expressed based on Paenibacillus spp. status, with 144 upregulated and 148 proteins
downregulated in the Paeni-positive group, respectively. Adjusting for CMV status did not change
the differentially abundant proteins. (Figure 8).
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Figure 8. Proteomic profile of PIH and NPIH infants
The proteomics profiles of infants with (PIH) and without (NPIH) post-infectious hydrocephalus
are based on 16s rRNA-determined Paenibacillus spp. status. (A) Multi-dimensional scaling
(MDS) of normalized protein abundances demonstrating clustering of Paenibacillus spp. positive
(Paeni-positive) infants from the remaining groups. The axes of the scatter plot of individual
participants represent the first and second components. Each oval (not drawn to scale) encircles
majority of patients belonging to the color-matched group, with orange as infants in the NPIH
group, green as Paeni-negative PIH infants (Non-Paeni PIH), and purple as Paeni-positive infants
(Paeni PIH). (B & C) Volcano plots demonstrating differential expression of genes between Paenipositive and Paeni-negative infants. The vertical dashed lines demarcate fold changes of 1 and -1
respectively, and the horizontal dashed line represents an alpha significance level of 0.05. Each
point represents a differentially expressed protein and those with an absolute fold change greater
than 1 that met the significance level (red points) were selected for gene set enrichment analyses.
(B) Differential expression of proteins based on Paenibacillus spp. status was similar with or
without adjusting for CMV status (B). (C) There were no differentially expressed proteins based
on CMV status alone that met fold change (blue points) and statistical significance (grey points)
criteria.
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Gene set enrichment analysis of the differentially expressed proteins demonstrated the most
predominantly enriched functional gene sets identified were neuroinflammation related,
particularly neutrophil-mediated inflammation, and negative regulation of proteolysis and
peptidase activity, and modulation of extracellular matrix and structure (Figure 9).

Figure 9. Gene ontology analyses based on cerebrospinal fluid assay.
Differentially expressed (A) proteins and (B) RNA transcripts between infants with post-infectious
hydrocephalus (PIH) and those without (NPIH) is based on 16s rRNA-determined Paenibacillus
spp. status. In both proteomics and RNA-Seq, there was enrichment for functions associated with
neuroinflammation, extracellular matrix structure and cell-cell adhesion. The abscissae of the dot
plots correspond to the number of proteins/genes per total number of genes (gene ratio), and the
size of each circle reflects the relative number of proteins/genes expressed that are enriched for the
corresponding function (ordinates).
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2.2.1.4 RNA-Seq demonstrates neuroinflammation and cell junction disruption in PIH

Principal component analysis (PCA) of genes identified with RNA-Seq demonstrated clustering
of PIH and NPIH infants. Of the 11,114 genes expressed in the cohort, 2,161 were differentially
expressed, and hierarchical clustering of those genes distinguished a subset of Paeni-positive from
Paeni-negative patients (Figure 10). Gene ontology analysis of the differentially expressed genes
based on Paenibacillus spp. status demonstrated an enrichment for genes related to response to
bacteria, host immune regulation, and cell motility, migration and adhesion (Figure 9).

Figure 10. Transcriptomic profile of PIH and NPIH infants
The transcriptomic profiles of infants with post-infectious hydrocephalus (PIH) and those without
(NPIH) based on 16s rRNA-determined Paenibacillus spp. status. (A) Principal component
analysis of normalized protein abundances demonstrating clustering of PIH from NPIH. The axes
of the scatter plot of individual participants represent the first and second components. Each oval
(not drawn to scale) encircles majority of patients belonging to the color-matched group, with
green as infants in the NPIH group, and blue PIH infants. (B) Heatmap of the 500 most
differentially expressed genes, with the dendrogram demonstrating hierarchical clustering on
Euclidean distance of gene identified in infants based on Paenibacillus spp. status.
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Adjusting for CMV status did not significantly alter the gene ontology enrichment based on
Paenibacillus spp. status. Sixty-four genes were differentially expressed based on CMV status,
and those genes were enriched for functions related to host response to virus. PCA using RNA
abundance of all genes was not able to separate samples based on CMV status. (Supplementary
Figure 2)

Supplementary Figure 2: Transcriptome profile of patients with CMV infection.
Role of CMV infection on the genomic profile of infants with post-infectious hydrocephalus (PIH)
and those without (NPIH), based on 16s rRNA-determined Paenibacillus spp. status. There were
64 differentially expressed genes between Paeni-positive and Paeni-negative infants based on
CMV status, and (A) those genes were enriched for functions related to host response to virus
demonstrated on the interactome. Genes are represented by grey circles and interactions are noted
by lines between genes, clustered by their respective labelled gene ontology biological processes
(cantaloupe circles). (B) However, there was no clustering of patients based on CMV status as
shown on the PCA plot, where the axes of the scatter plot of individual participants represent the
first and second components.
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2.2.1.5 Clinical traits correlate with CSF gene expression in PIH

Using weighted correlation network analysis (WGCNA), 2 gene sets (Modules 1-2) were identified
within a subset of 33 patients clustered by expression of differentially expressed genes between
the Paeni-positive and Paeni-negative cohorts. These modules were assessed for correlation with
5 clinical variables: WBC counts and Paenibacillus spp. status in both CSF and peripheral blood,
and, CSF CMV status in CSF (Figure 11). Module 1 contained all but 11 of the genes differentially
expressed with Paenibacillus spp. status and was positively correlated with CSF cell count, and
negatively correlated with Paenibacillus spp. status. Module 2 was positively correlated with
Paenibacillus spp. status, but those 11 genes were not enriched for any gene ontologies, indicating
no specific functional enrichment for the small number of genes within this module.

Figure 11. Weighted correlation network analysis (WGCNA) of gene modules
WGNCA gene modules identified within RNA-Seq data for post-infectious (PIH) and non-postinfectious (NPIH) hydrocephalus cohorts demonstrate Module 2 (A) was positively correlated
with CSF cell count and negatively correlated with age and (B) was enriched for host immune
responses, including leukocyte and neutrophil functions.
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2.2.1.6 Proteogenomic expressome of host immune response in PIH

Unsupervised gene ontology analyses of concatenated differentially expressed proteins and genes
assayed from proteomics and RNA-Seq respectively, recapitulated enrichment for the immune
system, metabolism, response to oxidative stress, cell-cell junction interactions and extracellular
matrix structure in association with peptidase activity. (Figure 12).

Figure 12. Prominent Gene Ontological (GO) functions and interactions.
The Alluvial plot demonstrate GO functions enriched for the pathophysiology of post-infectious
hydrocephalus (PIH) between Paenibacillus spp. positive and Paenibacillus spp. negative infants.
Each ontological clustering occupies a column in the diagram and is horizontally connected to
preceding and succeeding significance clustering by stream fields, representing similar gene
involvement. Each stacked bar is color-coded based on the assay being assessed, with blue
representing RNA-Seq data, orange for proteomics and green for genes common to both RNA-Seq
and proteomics. The ordinate shows the number of genes represented in each cluster.
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There were 33 genes that were common to both proteomics and RNA-Seq. Pathway enrichment
analysis of those genes demonstrated an enrichment for functions predominantly associated with
the immune system, particularly interleukin (IL)-4, IL-12, IL-13, interferon signalling, and genes
involved with neutrophil activity and the Janus kinase/signal transducers and activators of
transcription (JAK-STAT) pathway. In addition, there was enrichment for processes involved with
response to platelet activating factors and host recognition of microbes including antigen
presentation and Class I MHC antigen processing (Figure 13).

Figure 13. Pathway analysis of differentially expressed markers in RNA-seq and proteomics
Post-infectious and non-post-infectious hydrocephalus infants are stratified by cerebrospinal fluid
16s rRNA Paenibacillus spp. status. Corresponding pairs of upregulated (red boxes) and
downregulated (green boxes) proteins (blue columns) and genes (purple columns) in the
Paenibacillus spp. positive group that were identified with proteomics and RNA-Seq respectively
are listed on the x-axis. The 33 common genes demonstrated predominant involvement of the
immune system, particularly the innate system and those associated with neutrophil-mediated
activity, interleukins, interferon and the Janus kinase/signal transducers and activators of
transcription (JAK-STAT) pathway (y-axis). Differential expression was defined as log2 fold
change of >1 or <-1 at an alpha significance level of 0.05.
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Interactome analysis405 demonstrated these 33 proteins had high physical protein-protein
interactions with regards to their chromosome neighborhood, gene fusion, phylogenetic cooccurrence, homology, co-expression, experimentally determined interactions, database
annotation and automated text mining405 (Figure 14).

Figure 14. Interactome analysis of cross-omic differentially expressed markers.
Comparing the CSF profiles of Paenibacillus spp. positive post-infectious hydrocephalus infants
compared to Paenibacillus spp. negative infants, the network nodes represent proteins produced
by a single, protein-coding gene locus and first shell of interactors. Filled and empty nodes imply
the 3D structure of the protein is known or unknown, respectively. Edges represent protein-protein
associations determined from known interactions (curated and experimentally determined),
predicted interactions (related to gene neighborhood, fusions and co-occurrence) and other
interactions including text mining, co-expression and protein homology. The colors of edges, as
demonstrated on the key, reflects the interactions. Shaded regions depict groupings into their
predominant gene ontology function with grey, purple and orange regions representing those
involved with the immune system, cytokine-mediated immune response and factors associated
with platelet activity.
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2.2.2

Activated gene pathways in PIH and PHH

Integration of RNA-Seq and proteomics was a useful approach to characterize PIH
pathophysiologic mechanisms. Neuroinflammation and extracellular organization are critical
processes in the pathophysiology of PIH and may also play a role in development of PHH. This
study focused on parsing activated gene networks that are common to PHH and PIH, and just as
importantly, those that are unique to each condition. We utilized our existing proteomics pipeline
to assess ventricular CSF samples from PIH, PHH and non-infectious, non-hemorrhagic
hydrocephalic infants (Controls).

2.2.2.1 Patient characteristics
There were 125 participants, which included 64 PIH, 17 PHH and 44 control infants. Parents of
all participants provided informed consent. Among the PIH group, 38 were Paenibacillus spp.
positive (Paeni-pos PIH) and 26 were Paenibacillus spp. negative (Paeni-neg PIH). The PHH and
8 control samples were obtained from infants from North America, whereas the PIH and 36 control
samples were from Sub-Saharan Africa; regions where the conditions are most prevalent,
respectively. All infants were less than 3 months of age and there was no difference in sex between
groups.
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2.2.2.2 Protein expression patterns in PIH and PHH

A z-log protein expression score was calculated as a ratio of the measured expression level to that
of the common reference pool. These scores were then normalized, including batch correction and
quantile normalization of z-log protein expression scores for each of 2,841 proteins identified.
Multi-dimensional scaling of proteomic data demonstrated clustering of patients based on groups.
As we identified in the previous experiments, controls clustered with Paeni-neg PIH, while Paenipos PIH clustered with PHH. To assess for differential expression of proteins between groups, we
performed a linear modelling that included three sets of comparisons: PIH vs. controls; PHH vs.
controls; and PIH vs. PHH. 1,832 proteins (64%) were differentially expressed between groups.
(Figure 15).

Figure 15. Proteomic profiles of infants with PIH, PHH and non-PHH non-PIH controls
The proteomic profiles of post-infectious (PIH) and post-hemorrhagic (PHH) hydrocephalus and
those with non-infectious non-hemorrhagic hydrocephalus (Controls). Panel A is a multidimensional Scaling of normalized protein abundances demonstrating clustering of Controls and
Paenibacillus spp. negative (Paeni-neg PIH) from Paenibacillus spp. positive (Paeni-pos PIH)
infants. The abscissa and ordinate of the scatter plot of individual participants represent the first
and second components, respectively. Each oval (not drawn to scale) encircles majority of patients
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belonging to the color-matched group. Panel B is a Euler diagram demonstrating counts of
differentially expressed proteins among infants with PIH, PHH and Controls. Each branch (circle)
is proportional to the number of proteins differentially expressed between the labelled pair-wise
comparisons, with each intersection isolating proteins exclusive to the respective subgroup
comparisons. Upregulated (↑) and downregulated (↓) counts of proteins are color-coded with red
and blue, respectively.

Directed by our objective to identify activated pathways that are common or unique to PIH and
PHH, the following specific protein clusters from the linear model were selected for downstream
analyses: 1) the proteins that were differentially expressed between PIH and PHH but not
differentially expressed independently with controls (PIH-PHH group; n=84); 2) the proteins that
were differentially expressed between PHH and controls (PHH-Control group; n=143) and those
between PIH and controls (PIH-Control; n=59), respectively, but not differentially expressed
between PIH and PHH. The former evaluated common pathways between PIH and PHH while the
latter evaluated pathways that are uniquely activated in each condition. The nested F-test
approach406 was utilized to achieve consistency between all related contrasts while ensuring
proteins that were expressed in equal proportions between pairs of samples (log2 fold change of 0)
were not excluded. (Figure 16). At all levels of the model, unsupervised hierarchical clustering of
the differentially expressed proteins resulted in groups with PHH generally clustering separately
from other groups. Two separate PIH populations also emerged, one of which is distinct from other
groups, while the second shows some overlap control participants (Figure 16; Supplementary
Figures 3 and 4).
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Figure 16. Differentially expressed proteins between PIH, PHH and control infants
Protein expression profiles between post-infectious hydrocephalus (PIH), and post-hemorrhagic
(PHH) hydrocephalus and control infants. (A) Heatmap demonstrating hierarchical clustering on
Euclidean distance of proteins identified in the respective conditions. (B) Volcano plot
demonstrating differential expression of proteins uniquely expressed in PIH and PHH infants, and
not differentially expressed between either and controls. The vertical lines demarcate fold changes
of 1 and -1, and the horizontal line represents an alpha significance level of 0.05.

Supplementary Figure 3. Differentially expressed proteins between PIH and control infants
Proteomic profile of infants with post-infectious hydrocephalus (PIH) and control infants with
non-infectious non-hemorrhagic hydrocephalus (control). (A) Heatmap demonstrating hierarchical
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clustering on Euclidean distance of proteins identified in the respective conditions. (B) Volcano
plot demonstrating differential expression of proteins uniquely expressed in PIH and Control, and
not differentially expressed between PHH and post-hemorrhagic hydrocephalus. The vertical lines
demarcate fold changes of 1 and -1, and the horizontal line represents an alpha significance level
of 0.05.

Supplementary Figure 4. Differentially expressed proteins between PHH and control infants
Proteomic profile of infants with post-hemorrhagic hydrocephalus (PHH) and control infants with
non-infectious non-hemorrhagic hydrocephalus (Control). Panel A is a heatmap demonstrating
hierarchical clustering on Euclidean distance of proteins identified in the respective conditions.
Panel B is a volcano plot demonstrating differential expression of proteins uniquely expressed in
PHH and Control, and not differentially expressed between PHH and post-infectious
hydrocephalus. The vertical lines crossing the positive and negative abscissae demarcate fold
changes of 1 and -1, and the horizontal line represents an alpha significance level of 0.05.

2.2.2.3 The independent proteomes of PIH and PHH

Gene set enrichment analysis of the differentially expressed proteins in the PIH-control and PHHcontrol groups independently demonstrated that inflammation and processes associated with
extracellular structure, in association with protein metabolism, were predominantly enriched with
minor variations. In PHH, expression markers of enrichment for inflammation was limited to acute
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immune responses including neutrophil activity and platelet degranulation. Extracellular
organization gene enrichment was associated with regulation of peptidases and hydrolases. As
expected, there was also enrichment for factors related to blood coagulation and hemostasis.
(Figure 17).

Figure 17. Proteins unique to PHH and controls
Proteins uniquely expressed between post-hemorrhagic hydrocephalus (PHH) and controls. (A)
Volcano plot demonstrating the differentially expressed proteins between infants with PHH and
controls, that are not differentially expressed in post-infectious hydrocephalus. The vertical lines
demarcate fold changes of 1 and -1, and the horizontal line represent an alpha significance level
of 0.05. (B) Interactome of the differentially expressed proteins that met criteria (Panel A, red dots)
demonstrating enrichment for processes predominantly involved with inflammation, extracellular
organization, coagulation and wound healing. The size of each circle reflects the relative number
of proteins expressed that are enriched for the corresponding function.

Similar to PHH, inflammatory responses enriched in PIH included those related to neutrophil
activity and platelet degranulation. However, complement activation was also enriched.
Enrichment for extracellular organization processes occurred in the context of proteolysis, as well
as in response to wound and wound healing (Figure 18).
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Figure 18. Proteins unique to PIH and controls
Analysis of proteins that are differentially expressed between infants with post-hemorrhagic (PIH)
and controls, that are not differentially expressed in post-hemorrhagic hydrocephalus. (A) Volcano
plot demonstrating differential expression of proteins. The vertical lines demarcate fold changes
of 1 and -1, and the horizontal line represent an alpha significance level of 0.05. (B) Dot plot from
gene set enrichment analysis of the differentially expressed proteins that met criteria (Panel A, red
dots) demonstrating enrichment for processes predominantly involved with inflammation,
extracellular organization, and wound healing. Each dot corresponds to the number of proteins per
total number of proteins (gene ratio), and its size reflects the relative number of proteins expressed
that are enriched for the corresponding function.

2.2.2.4 Neuroinflammation is a common process in PIH and PHH pathophysiology

Proteins that were uniquely differentially expressed in PIH or PHH were subjected to downstream
analyses. Gene set enrichment analysis demonstrated that those proteins were also predominantly
enriched for inflammation, but included both acute and humoral immune responses, complement
activation and platelet degranulation. Neuroinflammation occurred in association with
extracellular structure organization processes, which occurred in the context of protein activation
cascades. (Figure 19).
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Figure 19. Gene ontology interactome of proteins common to PIH and PHH
Differentially expressed proteins that are common to infants with post-infectious (PIH) and posthemorrhagic (PHH) hydrocephalus, but not differentially expressed in non-hemorrhagic noninfectious hydrocephalic infants were analyzed. Each point on the interactome represents a
differentially expressed protein with an absolute fold change greater than 1. There is enrichment
for functions associated with neuroinflammation and extracellular organization, occurring in the
context of protein activation cascades. The size of each circle reflects the relative number of
proteins expressed that are enriched for the corresponding function.

Having established neuroinflammation and extracellular organization as processes that are central
to the pathophysiology of PIH and PHH, reactome analysis407 was performed to identify
potentially targetable markers. Markers common to both the innate and adaptive systems that had
a concomitant effect on cellular organization were of particular interest. Of 32 inflammation63

related proteins, five (CDC42, PSMB10, LGMN, NCF2 and TOM1) were common to both
immune systems. CDC42 and PSMB10 are downstream markers involved with cytokine signaling
(Figure 20). KEGG pathway analyses408 (not shown) were performed independently on CDC42,
PSMB10, LGMN, NFC2, and TOM1 to identify their interactors. All but TOM1 were involved in
various protein cascades reflecting their potential effects on extracellular organization.

Figure 20. Reactome pathway analyses of proteins common to PIH and PHH
Differentially expressed inflammation related proteins unique to post-infectious (PIH) and posthemorrhagic (PHH) hydrocephalus when compared to non-infectious non-hemorrhagic
hydrocephalic controls were subjected to reactome analyses. CDC42, PSMB10, LGMN, NCF2
and TOM1 were found to common to the innate and adaptive systems. CDC42 and PSMB10,
DDX58 and PRPS1 are involved with cytokine signalling in the immune system.
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2.3

Discussion

2.3.1

Summary of findings

PIH and PHH are the most debilitating neurological sequelae of neonatal sepsis and
intraventricular hemorrhage, respectively.35,36,42,409 The overarching goal of the many experiments
presented in this chapter was to identify critical genes involved in the pathophysiology of PIH and
PHH and map those genes onto their activation pathways to define the common and unique
pathophysiological mechanisms underlying both conditions. To circumvent some of the major
independent limitations of proteomics and RNA-Seq, proteogenomics was utilized to integrate
protein and gene data. Hierarchical clustering identified that PIH and PHH patients had differential
expression of genes or proteins involved in neuroinflammation and extracellular matrix
organization. Differential expression of host immune response genes and proteins in PIH (those
with Paenibacillus spp. in CSF) was predominantly related to the innate immune system (i.e.,
neutrophil activity, IL-4, IL-12, IL-13 and interferon signaling, the JAK-STAT pathway, and
platelet response/activating factors) when compared to controls. In addition, there was enrichment
for processes involved with host recognition of microbes including Class I MHC antigen
presenting complex in PIH. Similarly, host immune response in PHH was predominantly
associated with enrichment of processes involving neutrophil activity and platelet degranulation.
However, gene sets involved in complement activation were enriched in PHH, as well as those
involved in blood coagulation and hemostasis. In both PIH and PHH, protein cascades and
processes such as proteolysis and hydrolysis were enriched, all within the context of extracellular
matrix and cellular structural organization.
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2.3.2

Proteogenomics as an approach for defining PIH and PHH pathophysiology

Large scale proteomics and genomics studies have been instrumental in the discovery of important
biomarkers and have provided insights to the pathophysiology of central nervous system disease.
CSF proteomics have previously identified clinically useful protein biomarkers such as amyloid
precursor protein and cell adhesion molecules in PHH.245,247 RNA-Seq of CSF has been widely
used to study infectious diseases.410,411 Disease pathogenesis involves the combinatorial
interaction of elements within the proteome, transcriptome, and environmental factors.260,412
Therefore, integrative methods that combine proteomic and genomic data into a network model
are essential for understanding human disease.262 Our group is the first to utilize proteogenomics
to characterize gene regulatory networks involved in PIH and PHH. Here we utilized clustering,
reactome and interactome pathways, and gene ontology enrichment methodologies at the RNA
and protein levels to unravel the underlying mechanisms involved in host response to PIH and
PHH. Through this effort we have identified the putative genes and pathway responses in the host
involved in the pathophysiology of PIH due to Paenibacillus spp. Important future work will test
the generalizability of host response observed in this study to other pathogens and other variants
of hydrocephalus.

2.3.3

Host-immune responses in PIH and PHH

In addition to ventriculomegaly, both the PIH and PHH phenotype is characterized by granular
ependymitis, ependymal gliosis, arachnoiditis, calcifications, and multi-loculated infiltrates36
suggesting that severe inflammation occurs locally during the antecedent neonatal sepsis or
hemorrhage. Indeed, infants with PIH due to Paenibacillus spp. had ten-fold more calcifications,
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abscesses, loculations and debris on head CT402. Collectively, these findings underscore the
importance of characterizing the nature of the host-immune response in PIH and PHH.

Typically, once a pathogen breaches a host’s epithelial barriers, immune mechanisms are activated.
Although there is rapid progression of immunologic competence after birth, the innate immune
system is the primary active defense against pathogens in infants less than 3 months of age since
they lack the antigenic exposure required to develop acquired immunity. Consequently, the host
immune response to microbial pathogens, mounted by the infants involved in this study, involved
antigen-independent immune components such as neutrophils, phagocytes, natural killer and
antigen presenting cells.201,413-416 However, complement activation, which has crossover with the
adaptive immune system is a major mediator of host response to infection. Thus, it was not
surprising to find that our PIH cohort had differential expression of proteins involved with the
complement system. Immune response to non-infectious triggers such as hemorrhage in PHH
would also involve activation of the innate immune system in response to endogenously released
markers of cellular damage.

Our results support the role of the immune response in PIH and PHH pathophysiology. Persistent
inflammation in the CSF of infants in our study may be pathologic rather than physiologic as they
were remote from the original infection or hemorrhage and were already clinically well for surgery.
While host-immune response is necessary for clearing pathogens or non-infectious toxins,
prolonged or overstimulated immune activation may be detrimental to the host.417 In terms of PIH
and PHH, it is likely that the same host immune activity that clears pathogens also causes
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hydrocephalus by damaging local tissues. Of the three cytokines we identified in PIH, IL-12 is the
most diverse and is typically involved in augmentation of CD8+ T cell cytotoxicity. Upregulation
of MHC Class I in our PIH cohort could be an indication of presentation to cytotoxic CD8+ cells
and IL-12 activity.418 Further, IL-4 and IL-13 typically work synergistically to decrease
inflammation and counteract the IL-12 activity, and thus may be upregulated in response to IL-12
upregulation. IL-4 has also been associated with Staphylococcus aureus infections, which like
Paenibacillus spp. is gram-positive. One hypothesis is that the balance of IL-12 and IL-4/IL-13
within the CSF contributes to risk of developing PIH. In Chapters 4 and 5, we present further
evidence that inoculation of a gram-positive bacterial toxin in vitro and in vivo in experimental
models is associated with neuroinflammation and disruption of the ependymal CSF-brain barrier,
likely as an antecedent process to developing hydrocephalus.

2.3.4

Inflammation and barrier integrity in PIH and PHH

The activated immune pathways found in PIH and PHH support the perspective that neonatal
immune response to toxins such as infection or hemorrhage inadvertently causes hydrocephalus
through ependymal denudation, scarring of CSF conduits and disruption of CSF physiology to
cause hydrocephalus. Our finding of differential abundance of RNA and protein involved in cellcell integrity in PIH and PHH infants is also consistent with recent evidence from both
experimental170,172,175-177,419 and clinical181-183,419 studies. In those studies, immune response is
associated with ependymal cell-cell junction protein disruption as a critical pathogenetic
mechanism of hydrocephalus. In a human postmortem histological study, McAllister et al.
attributed the diffuse ependymal damage they identified in PHH infants to disruption of cell-cell
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junctional proteins, which had occurred in the context of GFAP over-expression, a non-specific
surrogate marker of neuroinflammation and glial scarring.197 Together, our findings and these
evidences underscore the critical interplay between neuroinflammation and ependymal cellular
structure in the pathogenesis of PIH and PHH.

2.3.5

Limitations

Limitations to this study include small cohort size for subset analyses such as in the case of the
CMV positive participants, low RNA abundance in the control samples, and reduced availability
of clinical covariates to assess for correlation with gene abundance patterns. Identifying CMV in
some of the infants in our cohort402 raises the important question of whether the host-immune
response we observed was at least in part attributable to CMV. While there were differentially
expressed transcripts at the genome level in response to viruses, we did not detect any functional
proteins associated with CMV, nor was there any effect of CMV status on the differential
expression of host-immune markers at the gene or protein level. It is possible that our inability to
detect a CMV-related host-immune response was limited by having only a few (8/100) CMVpositive infants. Another possibility is that CMV tend to cycle through dormant and active state in
affected individuals420, thus point sampling of CSF may not have captured an active state.
Therefore, it remains unknown whether CMV was a risk factor for developing Paenibacillus spp.
infection or PIH in the first place, whether CMV can be implicated in the persistent host-immune
response we observed, and whether it will have any long-term effects in these infants.
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2.4

Materials and Methods

2.4.1

Patients and recruitment

PIH and NPIH infants were recruited at the CURE Children's Hospital of Uganda (CCHU), a
pediatric neurosurgery hospital that serves as the largest referral center for patients with
hydrocephalus in Uganda. Ethics oversight for those patients was provided by the CCHU
Institutional Review Board (IRB), Mbarara University of Science and Technology Research Ethics
Committee, the Ugandan National Council on Science and Technology, and the Pennsylvania State
University (PSU) IRB. A United States Centers for Disease Control permit for importation of
infectious materials covered the transfer of specimens from CCHU to PSU. PHH and NPHH
infants were recruited from the St. Louis Children’s Hospital (SLCH), a large tertiary pediatric
hospital in St. Louis, Missouri. Ethics oversight for the PHH and NPHH infants was provided by
the Washington University Human Research Protection Office (HRPO #s 201101887 and
201203126). Verbal informed consent was obtained from the parent(s) of each subject.

Each PIH infant had a history of febrile illness and/or seizures preceding the onset of
hydrocephalus and/or ventriculitis, as detected by physical examination, endoscopy, or
neuroimaging. No PIH infants had hydrocephalus at birth. NPIH infants were selected based on
need for neurosurgical intervention of congenital hydrocephalus due to an obstructive aqueduct
lesion, Dandy-Walker cyst, or other congenital malformation of the nervous system.
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The PHH group included preterm infants (age < 35 weeks estimated gestational age) admitted to
the SLCH Neonatal Intensive Care Unit who sustained IVH which was diagnosed with head
ultrasound within the first month of life. Patients underwent weekly head ultrasounds for
monitoring of ventricular size and were eventually deemed to require implantation of a ventricular
access device (VAD). Well-established Hydrocephalus Clinical Research Network criteria were
applied for the diagnosis of PHH and need for and timing of hydrocephalus interventions421. All
PHH infants included in this study underwent permanent CSF diversion surgery (ETV +/- CPC or
VP shunt). The NPHH group included age and gender matched infants who needed neurosurgical
intervention congenital or aqueductal stenosis hydrocephalus who had no evidence of
intraparenchymal or intraventricular hemorrhage on their head ultrasound.

Inclusion criteria for all patients were age less than 3 months and weight greater than 2.5 kg at
time of CSF sampling. Exclusion criteria for all subjects were prior surgery on the nervous system
or evidence of communication of nervous system with skin. Additionally, PHH patients with a
history of systemic infection were excluded. Clinical patient information including demographics,
computed tomography (CT) neuroimaging, CSF cell counts, and CSF culture results were obtained
from review of the medical records.

2.4.2

CSF Samples

Sterile CSF samples were acquired directly from the cerebral ventricles of all patients at the time
of surgery for treatment of hydrocephalus. After collection, samples were RNA shielded (Zymo
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Research, Irvine CA) to preserve nucleic acid and protein contents when possible, then rapidly
frozen and maintained in liquid nitrogen prior to shipment for final -80℃ storage until proteomics
and/or RNA-Seq was performed. In all cases, the CSF microbiological cultures sent at the time of
collection remained sterile. Any NPIH, PHH or NPHH that had gram stain or microbial cultures
suggestive of a CNS infection was excluded.

2.4.3

Transcriptomics

2.4.3.1 RNA Extraction

All reagents and consumables required for RNA extraction were UV-treated in a polymerase chain
reaction (PCR) workstation for 15 minutes. A TRIzol™ LS Reagent and Direct-zol™ RNA
MiniPrep Plus kit was used for all extractions. Each batch of extraction included a water control
in which 500 μL of elution buffer was put through all extraction steps. CSF samples thawed at
room temperature were processed with two aliquots of 250 μL mixed with 750 μL of TRIzol™ LS
Reagent. After bead lysis, 200 μL of chloroform was added, incubated at room temperature for 15
minutes then centrifuged at 12,000g for 15 minutes at 4oC. Once separated the aqueous layers from
the two aliquots were put into the same tube. Then each organic layer was re-suspended in 400 μL
of water and centrifuged again for 5 minutes. The 1.6 mL of aqueous phases were combined with
1.6 mL of 100% ethanol and put through the Zymo-Spin™ IC Column twice and proceeded per
manufacturer’s protocol.
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2.4.3.2 RNA Sequencing

Following RNA extraction, Illumina® TruSeq® Stranded RNA Sequencing kit was used for rRNA
depletion and fragmentation, first strand cDNA synthesis, second strand cDNA synthesis,
adenylate 3’ ends, adapters ligation, and DNA fragment enrichment following the manufacturer’s
protocol. It was expected that due to the nature of low cell counts in CSF, varying concentrations
of RNA would be extracted. Indeed, in our samples, majority of the RNA concentrations fell below
the recommended input of 100 ng so a standard 10 ul of total RNA was used for input ranging
from 10-150 ng of RNA. Using biotinylated, target-specific oligos combined with Ribo-Zero
ribosomal RNA (rRNA) removal beads of divalent cations and high temperatures (60 – 100oC).
Ribosomal RNA was then depleted from the total RNA and the remaining RNA was purified,
fragmented, and primed for cDNA synthesis. The cleaved RNA fragments were then copied into
first strand cDNA using reverse transcriptase (Part # 18064-014) and random hexamers. A second
strand cDNA synthesis was obtained by removing the RNA template, synthesizing a replacement
strand, and incorporating dUTP in place of dTTP to generate the ds (double stranded) cDNA, using
DNA Polymerase I and RNaseH. A single 'A' nucleotide was then added to the 3' ends of the blunt
fragments and a corresponding single 'T' nucleotide was added on the 3' end of the adapter.
Multiple indexing adapters were then ligated to the ends of the ds cDNA fragments to prepare
them for hybridization. Polymerase chain reaction (PCR) was used to enrich the DNA fragments
which was done without dUTP to ensure only the first strand was enriched. The libraries were
quantified by fluorometry and size and quality checked on an Agilent Technologies 2100
Bioanalyzer. Libraries were then pooled to 4 nM, diluted and sequenced on the NovaSeq 6000
using the S2 flowcell with 2x100 reads aiming for 25 million reads per sample.
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2.4.3.3 Data Analysis

All RNA-Seq data analyses were performed with R v.3.5TM (http://www.R-project.org) utilizing
the following packages: clusterProfiler422, edgeR423, RSEM424, STAR425, YARN426. Pair-end RNASeq were first mapped to the human reference genome hg38 using STAR425. Then RSEM424 was
used for estimating gene and isoform expression levels from mapped RNA-Seq data. Gene read
counts from all samples were combined into matrix for further analysis. YARN426 was used to
create normalized gene expression sets from the RNA-Seq matrix data. edgeR423 was used to
calculate differential expression between groups using a Genewise Negative Binomial Generalized
Linear Model. Differentially expressed genes were selected based on Benjamini-Hochberg
adjusted p-value cutoff of 0.05 and absolute log fold change of 1 and were mapped to Gene
ontology terms and assessed for enrichment using clusterProfiler422. Pathway enrichment analysis
was performed utilizing Reactome Pathway Enrichment analysis and Database for Annotation,
Visualization and Integrated Discovery (DAVID v6.8)427.

2.4.4

Proteomics

2.4.4.1 Sample preparation and mass spectrometry

A standard validated proteomics workflow was utilized428. Briefly, the top six most abundant
proteins in CSF (albumin, IgG, antitrypsin, IgA, transferrin and haptoglobin) were removed using
a reproducible affinity method247. Samples were then enzymatically digested with trypsin, and
peptides were isobarically labeled using a ten-channel peptide mass tagging (TMT-10) robotic
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solid phase extraction system429,430. Labeled peptides were analyzed by high-resolution liquid
chromatography-mass spectrometry (LC-MS) using a Q-Exactive Plus instrument coupled to an
EASY-nanoLC 1000 system (Thermo-Fisher Scientific). The pooled samples in batches of ten
were loaded onto a 75 µm i.d. × 25 cm Acclaim® PepMap 100 RP column (Thermo-Fisher
Scientific). Peptide separations were started with 95% mobile phase A (0.1% FA) for 5 min and
increased to 30% B (100% ACN, 0.1% FA) over 180 min, followed by a 25-min gradient to 45%
B, a 5-min gradient to 95% B and washed at 90% B for 7 min, with a flow rate of 300 nL/min.
Full-scan mass spectra were then acquired using the Orbitrap mass analyzer in the mass-to-charge
ratio (m/z) of 375 to 1400 and with a mass resolving power set to 70,000. Fifteen data-dependent
high-energy collisional dissociation (HCD) were performed with a mass resolving power set to
35,000, a fixed first m/z 100, an isolation width of 0.7 m/z, and the normalized collision energy
setting of 32. The maximum injection time was 50 ms for parent-ion analysis and 105 ms for
product-ion analysis. Target ions already selected for mass spectrometry (MS)/MS were
dynamically excluded for 30 s. An automatic gain control target value of 3 x 106 ions was used for
full MS scans and 1 x105 ions for MS/MS scans. Peptide ions with charge states of one or greater
than six were excluded from MS/MS interrogation.

2.4.4.2 Protein identification

MS raw data were converted to peak lists using Proteome Discoverer (version 2.1.0.81, ThermoFischer Scientific) with the integration of reporter-ion intensities of TMT-10-plex at a mass
tolerance of ±3.15 mDa431. MS/MS spectra with charges +2, +3 and +4 were analyzed using
Mascot search engine432 (Matrix Science, London, UK; version 2.6.2). Mascot was set up to search
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against a SwissProt database of human (version June 2016, 20,237 entries) and common
contaminant proteins (cRAP, version 1.0, 116 entries). With trypsin as the digestion enzyme, four
was the maximum allowed missed cleavages. The searches were performed with a fragment ion
mass tolerance of 0.02 Da and a parent ion tolerance of 20 ppm. Carbamidomethylation of cysteine
was specified in Mascot as a fixed modification. Deamidation of asparagine, formation of pyroglutamic acid from N-terminal glutamine, acetylation of protein N-terminus, oxidation of
methionine, and pyro-carbamidomethylation of N-terminal cysteine were specified as variable
modifications. Peptide spectrum matches (PSM) were filtered at 1% false-discovery rate (FDR)
by searching against a reversed database and the ascribed peptide identities were accepted. The
uniqueness of peptide sequences among the database entries was determined using the principal
of parsimony. Protein identities were inferred using a greedy set cover algorithm from Mascot and
the identities containing ³ 2 Occam’s razor peptides were accepted433.

2.4.4.3 Protein quantification

All protein quantification and data analyses were performed with R v.3.5TM (http://www.Rproject.org) utilizing the following packages: clusterProfiler422, Limma434, mixtools435. The
processing, quality assurance and analysis of TMT data were performed with our tidyversebased436 in-house pipeline, ProteoQ (version 1.0.0.0). Briefly, reporter-ion intensities under 10plex TMT-10 channels were first obtained from Mascot®, followed by the removal of PSM entries
from shared peptides or with intensity values lower than 1E3. Intensity of PSMs were converted
to logarithmic ratios at base two, relative to the average intensity of reference samples within a 10plex TMT. Under each TMT channel, Dixon’s437 outlier removals were carried out recursively for
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peptides with greater than two identifying PSMs. The median of the ratios of PSM that can be
assigned to the same peptide was first taken to represent the ratios of the incumbent peptide. The
median of the ratios of peptides were then taken to represent the ratios of the incumbent protein.
To align protein ratios under different TMT channels, likelihood functions were first estimated for
the log-ratios of proteins using finite mixture modelling, assuming two-component Gaussian
mixtures using the mixtools435. The ratio distributions were then aligned in that the maximum
likelihood of the log-ratios are centered at zero for each sample. Scaling normalization was
performed to standardize the log-ratios of proteins across samples. To discount the influence of
outliers from either log-ratios or reporter-ion intensities, the values between the 5th and 95th
percentile of log-ratios and 5th and 95th percentile of intensity were used in the calculations of the
standard deviations.

2.4.4.4 Data analysis

All proteomics data analyses were performed with R v.3.5TM utilizing the following packages:
clusterProfiler422, edgeR423, and YARN426. Batch differences were visualized with MDS and
Principal Component Analyses (PCA) of the protein z-log ratios. YARN426 was then used to filter
genes and correct for batch effects, while preserving group specificity. The data was then quantile
normalized in a group-aware manner, accounting for global differences in protein distribution.
(Supplementary Figure 5). Next, empirical Bayes moderation were carried out to ensure variances
were no longer dependent on mean protein expression levels438 Log fold change values of the
protein abundances between groups were calculated by comparing mean expression levels using
the Limma. The number of differentially expressed proteins were examined with significance set
77

at a Benjamini-Hochberg adjusted p-value cutoff of 0.05. Proteins that were differentially
expressed in multiple comparisons were extracted and examined from smallest to largest adjusted
p-value with their associated protein log fold changes. For assessing differentially expressed
proteins common and unique to PIH and PHH, the nested F-test approach was used, and log fold
change cut-off was set to zero in order to achieve better consistency between related contrasts
while preserving proteins that were expressed at similar levels between groups. ClusterProfiler422
was then used to map differentially expressed proteins to their respective Gene ontology terms to
assess for enrichment. Proteins enriched for similar and closely overlapping biological processes
were further subjected to interactome405, reactome overrepresentation407 and KEGG408 pathway
analyses.
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Supplementary Figure 5. Proteomics and RNA-Seq data preprocessing and quality control
Representative (A and C) multi-dimensional scaling and (B and D) protein density plots grouped
by tandem mass tagging (TMT)-10 batches of proteomics experiments. The z-log normalized data
had batch effects demonstrated as sparse patient samples in (A) first and second components and
heterogeneity (“noise”) on the (B) density plot. After filtration of poor-quality samples, quantile
normalization and correction for batch effects, (C) sparsity and (D) noise are reduced, while
preserving group specificity. Each circle and spike represent a patient sample color-coded by the
TMT-10 batch. Batch pos and Batch neg were CSF samples obtained from infants not in this study,
whose CSF was used to bookmark all TMT-10 batches to act as batch controls, and to which each
TMT-plex was normalized to obtain the z-log scores. The Batch pos samples were combined from
a PIH and a PHH patient and Batch neg was from a non-infectious non-hemorrhagic control infant.
Similar approach was used to assess RNA-Seq data prior to data analyses.

79

2.4.5

Proteogenomics

Integration of proteomics and transcriptomics data was performed following dimension reduction
and feature selection of differentially expressed proteins and genes. Gene ontology enrichment
using DAVID427 and reactome over-representation pathway analysis were performed by
concatenating differentially expressed proteins and genes with a set Log fold change of < -1 and >
1 and a false discovery rate < 1 at an alpha of 0.05. In-house parsing scripts for data visualization
and gene/pathway/GO enrichment commonality analyses were performed on the integrated data.
Physical and functional protein-protein interactions of the genes common to both proteomics and
RNA-Seq were assessed using the STRING405 online tools. Gene-gene relationships between
differentially expressed genes were quantified by assigning a composite score to each pairwise
comparison. Between each pair of genes, the composite score reflected their chromosome
neighborhood, gene fusion, phylogenetic co-occurrence, homology, co-expression, experimentally
determined interactions, database annotation and automated text mining405. The higher the
composite score (i.e. closer to 1), the stronger the predicted gene-gene relationship405.
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3

Chapter 3: Diffusion MRI Characterization of VZ/SVZ and PVWM Injury

3.1

Introduction

Adapted from
1. Isaacs AM, Han RH, Smyser CD, Limbrick DD, and Shimony JS. Semi-automated
segmentation of the lateral periventricular regions using diffusion magnetic resonance
imaging. MethodsX 2020. MEX-S-19-01180. (Under Review)
2. Isaacs AM, Neil JJ, McAllister JP, Dahiya S, Castaneyra-Ruiz L, Merisaari H, Botteron
HE, Alexopoulos D, George A, Peng S, Song SK, Limbrick DD, Smyser CD. Evaluating
white matter injury in posthemorrhagic hydrocephalus via diffusion basis spectrum
imaging. Brain 2020. (Submitted).
3. Isaacs AM, Smyser CD, Lean RE, Alexopoulos D, Han RH, Neil JJ, Zimbalist SA, Rogers
CE, Yan Y, Shimony JS, and Limbrick DD, Jr. MR diffusion changes in the perimeter of
the lateral ventricles demonstrate periventricular injury in post-hemorrhagic hydrocephalus
of prematurity. NeuroImage Clinical 2019. 24

In the previous chapter, we leveraged human CSF to establish that the pathophysiology of postinfectious (PIH) and post-hemorrhagic (PHH) hydrocephalus are similar, in that they are both
propagated by inflammation-related disruption of the ependymal barrier. However, it is important
to note that the infection and hemorrhage that herald PIH and PHH typically occur at a neonatal
age when neural stem cells in the VZ and SVZ are actively differentiating to form the ependymal
barrier. Therefore, to gain further insights into the pathophysiology of PIH and PHH, it is
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imperative to characterize the ventricular zone (VZ) and subventricular zone (SVZ) in PIH/PHH
infants. There is considerable histological evidence from human post-mortem tissues and animal
models to support our CSF findings that the VZ and SVZ are critical regions in hydrocephalus
pathophysiology133,175,197,318. However, there are presently no human studies that have been able
to examine those regions in vivo. The ability to examine the VZ/SVZ non-invasively, would
advance the diagnosis, care, monitoring, and prognostication of infants who develop perinatal
infections and IVH. Additionally, non-invasive characterization of the VZ/SVZ will afford a
foundation for future studies of therapeutic interventions which address the effects of
hydrocephalus on those regions.

While diffusion tensor imaging (DTI) offers a unique opportunity to assess the VZ and SVZ
regions in granular detail, it has not been utilized to date for characterizing those regions. Perhaps
the biggest hurdle to utilizing any neuroimaging modality for these purposes has been the
seemingly insurmountable challenge of overcoming volume averaging effects at the margin of the
ventricle where the VZ and SVZ reside.

In this chapter, we present two major studies. The first study presents a novel semi-automated
dMRI segmentation algorithm, which we developed, that can delineate the VZ, SVZ, and thin layer
of PVWM to a high precision of 1.2 mm3 voxels (a region we have since named the Lateral
Ventricular Perimeter, LVP). We established the feasibility of our algorithm in human preterm
infants who developed PHH or non-hydrocephalic IVH in comparison to preterm and full-term
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infants with no brain injury. DTI characterization of the LVP helped gain further insights into the
pathophysiology and deleterious effects of hydrocephalus on ependymal CSF-brain barrier.

There is evidence that disruption of the LVP exposes the subjacent large bundle PVWM to injury
by toxin-laden CSF. PVWM injury, especially in tracts such as corpus callosum (CC),
corticospinal tracts (CST), and optic radiations (OPRA), has been implicated in the majority of the
debilitating neurological impairments seen in hydrocephalic infants. Therefore, our second study
focused on assessing the effect of PHH on the CC, CST, and OPRA of our patient cohort. In that
study, we used diffusion basis spectrum imaging (DBSI) instead of DTI for three principal reasons.
First, DTI has been extensively used by our group and others to study PVWM in various forms of
hydrocephalus. Second, unlike DTI, DBSI can separate anisotropic tensors to model and resolve
crossing fibers, assess injured axons and demyelination, and parse the isotropic tensor spectrum
into components to reflect cellularity and edema. Third, DBSI related dMRI findings to histology,
which not only helped to co-validate the dMRI findings but also provided further evidence for the
associations between LVP disruption and PVWM injury.
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3.2

Results

3.2.1

Segmentation of the lateral ventricular perimeter (LVP) on diffusion MRI

3.2.1.1 Segmentation requires minimal user input

Here we detail the semi-automated delineation of the LVP in infants whose DTI data were
extracted from LVP to elucidate the role of VZ/SVZ disruption in the pathophysiology of PHH.
In MATLAB, the algorithm was set up to first read standard processed DTI files. Images showing
mean diffusivity (MD) were then sequentially displayed to allowed us to select slices centered on
the foramen of Monro. Once the central slice was determined, the algorithm automatically selected
three total axial slices (one rostral and one caudal to the center slice) for further analysis. The MD
image was used since it provides a sharp demarcation between the brain parenchyma and the CSF.
The script then displayed a bimodal histogram of the MD values with the lower peak representing
MD values in the brain parenchyma, and the higher peak representing CSF spaces. Based on the
histogram, we determined a threshold value that best separated the parenchyma and CSF MD
values. Following this, the script produced an image showing voxels with MD values above the
threshold. Through automated sequential erode and dilate steps, the selected regions were
smoothed, and small extraneous spaces were removed.

The algorithm was capable of automatically calculating the number of objects in each slice and the
area of each object (blob analysis), then displaying the information. A predetermined minimum
size (we used 10 voxels) was applied to display only areas likely to be involved in the ventricular
system. The script also determined the center of mass of each object, with the assumption that true
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ventricular objects will be close to the center of the brain. At this stage, the number of objects to
be further processed was selected, including all objects that represent ventricular spaces. An image
of all objects greater than the minimum size was then produced by the script, allowing us to click
near the center of mass of each object to be included in the final selection. Once the relevant objects
were selected, they were automatically saved, and extraneous objects were removed from further
analysis. This process was repeated for each of the three contiguous slices automatically.

3.2.1.2 The frontal and occipital horns of the lateral ventricle can be independently assessed
In our cohort, we independently segmented the anterior (frontal) and posterior (occipital) horns of
the lateral ventricle. To select only the frontal and occipital horns (FOHP), the previously
segmented LVP objects were modified as follows: 1) The center point of the LVP in the anteriorposterior (A-P) direction was calculated, dividing the brain into an anterior and posterior segment;
2) The algorithm then located the most anterior and most posterior voxels that were already
included in the LVP, to select all voxels that were within a predetermined A-P distance from the
most extreme points for inclusion in the frontal and occipital horn perimeters.

3.2.1.3 Semi-automated algorithm strongly corelates with manually segmented LVP
With minimal user input as previously described, the algorithm automatically isolates
periventricular voxels by performing two sequential dilation steps, incorporating voxels that are
one and two spaces away from the ventricles and then subtracting the original ventricle objects
from the dilated objects (Figure 21). Extraction of DTI data from the LVP was performed by
applying numerical thresholds to MD maps to isolate the lateral ventricles as being central
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structures with high MD values. To assess for potential differences between the algorithm and
manually placed ROIs, dMRI of 20 neonates of varying ventricular morphologies were selected
and manual ROIs were placed by an independent expert rater. Pearson correlation analyses
between dMRI measures from both approaches indicated a strong positive association between the
automated and manual segmentations fractional anisotropy (r (20) = .91, p <.001) and MD (r(20)
= .89, p <.001) measures.

Figure 21: Segmentation of Regions of Interest (ROIs)
Representative contiguous axial mean diffusivity maps of infants with variable ventricular
morphologies demonstrating segmentation of the lateral ventricular perimeter (top row) and
frontal and occipital horn perimeter (bottom row).

3.2.2

Region-specific dMRI-derived LVP disruption underlies PHH pathophysiology

3.2.2.1 Patient characteristics

This study leveraged a large cohort of prospectively recruited very preterm infants with/without
IVH/PHH and full-term healthy control infants in order to assess the effects of PHH on LVP. The
first group included infants born ≤30 weeks gestational age with no or low-grade IVH (very
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preterm, VPT group). The second group (high-grade intraventricular hemorrhage, HG-IVH
group), was comprised of age-matched VPT infants who developed grade III/IV IVH identified on
cranial ultrasound within the first month of life. The third group (post-hemorrhagic hydrocephalus,
PHH group), was comprised of VPT infants who sustained grade III/IV IVH identified on cranial
ultrasound within the first month of life and required neurosurgical treatment for hydrocephalus.
The fourth group (full-term, FT group) were healthy infants born at 38–42 weeks gestational age,
who were identified from a larger cohort undergoing neonatal neuroimaging scans as part of a
contemporaneous fetal monitoring study. All patients underwent dMRI at term equivalent age.

A total of 206 infants (FT=76, VPT=91, HG-IVH=20, PHH=19) with DTI data were screened for
possible inclusion in the study. Reasons for study exclusion across the groups included: acidosis
(FT=8), positive maternal urine drug screen (FT=5, VPT=1, HG-IVH=1), atypical pattern of brain
injury/abnormal MRI finding (FT=2, VPT=2). (Figure 22).

Figure 22: Flowchart of subjects screening and enrolment for study
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Of the 158 infants (77 males and 81 females) included in the final study cohort, there were 56 FT,
72 VPT, 17 HG-IVH, and 13 PHH infants. Median frontal-occipital horn ratios were higher in
PHH (0.50 ± 0.06) > HG-IVH (0.41 ± 0.04) = VPT (0.41 ± 0.02) > FT (0.37 ± 0.02) (Table 2;
Figure 23). All 13 PHH infants had undergone reservoir placement prior to their study MRI, with
6 of these infants also undergoing shunt placement prior to their MRI scan. There were no
significant differences in MD or FA values either in the FOHP or LVP between PHH infants who
underwent their shunt surgery before vs. after their MRI scan. Of the 13 PHH infants, 12 had
reservoirs and 2 had subgaleal shunts placed prior to VP shunt or ETV surgery. For permanent
hydrocephalus treatment, 10 infants had VP shunts placed and 2 underwent ETV surgery. As
expected, the median ventricular size of the ETV infants was larger (0.60±0.01) than that of the
VP shunt infants (0.49±0.05) (p=0.008). Nevertheless, in this limited cohort, there was no
difference in dMRI measures between infants who underwent ETV vs. VP shunt in both the LVP
and FOHP regions. One infant underwent treatments for hydrocephalus with a reservoir but did
not require permanent CSF diversion.

Table 2: Characteristics of 158 infants in a prospective study to assess the effects of IVH/PHH on
dMRI measures of the lateral ventricular layer
FT
VPT
HG-IVH
PHH
# of patients
56 (35.4%)
72 (45.6%)
17 (10.8%)
13 (8.2%)
Sex (# of Male/Female)
27 /29
30 /42
7/9
13/0
Birth gestational age (weeks)
39.0±1.2
27.0±1.7
25.0±2.0
24.0±2.1
Term age equivalent (weeks)
39.0±1.2
37.0±1.5
38.0±2.1
39.0±1.1
Birth weight (g)
3229.50±461.14
940±257.67
735±266.50
780±216.27
Clinical risk index score
0.00±0.00
1.00±1.87
3.00±1.69
3.00±2.33
Frontal-occipital horn ratio
0.37±0.02
0.41±0.02
0.41±0.04
0.50±0.06
All measures within the respective groups are medians ± standard deviations where necessary
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Figure 23: Assessment of ventricular size
Ventricular size was determined by the frontal and occipital horn ratio. Axial T2W image of a
normal neonate (left) and an infant with hydrocephalus (right). Ventricular size is determined by
the frontal and occipital horn ratio which was calculated as (𝛼 + β)/2𝛿 or by the Evan’s Index
calculated as (α/ 𝛿). Box and whisker diagram demonstrating the PHH group had the largest
frontal-occipital horn ratio among 158 infants (p <.001, ***). There was no difference in
ventricular size between the VPT and HG-IVH infants, although both groups had median
ventricular sizes that were larger than that of the FT control infants.

3.2.2.2 PHH is associated with segmental aberration of dMRI measures in the LVP

In the LVP, family-wise comparisons with Benjamini-Hochberg correction revealed that PHH had
consistently lower fractional anisotropy (FA) and higher mean (MD) and radial (RD) diffusivities
than FT and VPT infants (p<.050). While PHH FA was lower, and PHH RD was higher than that
of HG-IVH (p<.050) in the LVP, the MD and AD values did not differ (Tables 3 and 4; Figure
24). In the FOHP, Benjamini-Hochberg corrected family-wise comparisons revealed PHH infants
had lower FA and higher RD than FT and VPT infants in the FOHP (p<.010) (Tables 3 and 4;
Figure 25). Similar to the LVP, PHH FA was lower than that of HG-IVH (p<.001) in the FOHP.
Except for MD and RD in the LVP region, there were no differences in dMRI measures between
the HG-IVH and VPT infants. Among the PHH group, there was no difference in dMRI measures
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between the ETV and VP shunt treated infants (p>.050) in both the LVP and FOHP regions. While
the magnitude of PHH AD was consistently less than AD measures in the other groups, in both the
LVP and FOHP pairwise comparisons were not significant (p>.050). Comparison of LVP/FOHP
dMRI measures to those of adjacent CST and OPRA revealed tract-specific associations between
dMRI measures. Among the HG-IVH infants, dMRI metrics in both the LVP and FOHP were
associated with OPRA microstructure, but no associations were found with the CST. In contrast,
few associations were found for the PHH group.

Table 3: Median dMRI measures among 157 full- and pre-term infants with/or without IVH/PHH
FT
VPT
HG-IVH
PHH
Sig.
Lateral ventricular perimeter
FA
0.27±0.05
0.23±0.04
0.21±0.04
0.16±0.05
<0.001*
2
MD (μm /s)
1.46±0.09
1.47±0.08
1.55±0.11
1.58±0.15
<0.001*
2
AD (μm /s)
1.88±0.12
1.85±0.15
1.93±0.18
1.82±0.25
0.031*
RD (μm2/s)
1.24±0.15
1.29±0.12
1.38±0.10
1.48±0.15
<0.001*
Frontal-occipital horn perimeter
FA
0.29±0.07
0.22±0.06
0.20±0.05
0.13±0.04
<0.001*
2
MD (μm /s)
1.59±0.11
1.66±0.19
1.73±0.14
1.77±0.24
<0.001*
AD (μm2/s)
2.13±0.14
2.09±0.27
2.11±0.21
1.94±0.32
0.173
2
RD (μm /s)
1.33±0.17
1.45±0.18
1.56±0.15
1.66±0.24
<0.001*
All measures within the respective groups are medians ± standard deviations where necessary; One-way
ANOVA was performed with Kruskall-Wallis test (Sig.). All p-values are Benjamini-Hochberg corrected
with alpha level set at p <0.050 (*). FA = fractional anisotropy; MD = mean diffusivity; AD = axial
diffusivity; RD = Radial diffusivity; PHH = post hemorrhagic hydrocephalus; HG-IVH = high grade
intraventricular hemorrhage; VPT = very preterm; FT = full term
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Table 4: Groupwise comparisons between 157 full- and pre-term infants with/or without IVH/PHH
FT:VPT FT:HG-IVH FT:PHH
VPT:HG-IVH
VPT:PHH
HG-IVH:PHH
Lateral ventricular perimeter
FA <0.001*
<0.001*
<0.001*
0.100
<0.001*
0.004*
2
MD (μm /s)
1.000
0.011*
0.027*
0.008*
0.034*
1.000
AD (μm2/s)
0.299
1.000
1.000
0.055
1.000
0.869
2
RD (μm /s)
0.057
0.003*
<0.001*
0.014*
<0.001*
0.048*
Frontal-occipital horn perimeter
FA <0.001*
<0.001*
<0.001*
0.349
<0.001*
<0.001*
2
MD (μm /s)
0.022*
0.003*
0.102
0.213
0.700
1.000
2
AD (μm /s)
1.000
1.000
0.281
1.000
1.000
0.567
RD (μm2/s)
0.002*
<0.001*
0.007*
0.118
0.007*
0.869
All groupwise comparisons performed by Wilcoxon signed rank family-wise comparisons. All p-values are
Benjamini-Hochberg corrected with alpha level set at p <0.050 (*). FA = fractional anisotropy; MD =
mean diffusivity; AD = axial diffusivity; RD = Radial diffusivity; PHH = post hemorrhagic hydrocephalus;
HG-IVH = high grade intraventricular hemorrhage; VPT = very preterm; FT = full term

Figure 24: dMRI measures of the lateral ventricular perimeter (LVP)
The LVP demonstrated increasing severity of brain injury corresponds with decreasing fractional
anisotropy (FA) and increasing mean (MD) and radial (RD) diffusivities. No significant changes
were observed in axial diffusivity (AD) measures between groups.
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Figure 25: dMRI measures of the frontal occipital horn perimeter (FOHP)
The FOHP demonstrated increasing severity of brain injury corresponds with decreasing fractional
anisotropy (FA) and increasing mean (MD) and radial (RD) diffusivities. No significant
differences were observed in axial diffusivity (AD) measures between groups.
3.2.2.3 The FOHP region is more severely injured than the rest of the LVP

A linear mixed effects model, adjusted for term equivalent age at scan, revealed regional FA and
RD differences between the FOHP and LVP [F (3,153) = (FA (19.46), MD (0.98), AD (1.88), RD
(3.16); p<.001)]. In the FT infants, FA, MD, AD and RD measures in the FOHP were higher than
the LVP, which reflects baseline differences between the two regions among healthy infants in this
cohort. However, in the PHH group, while MD, RD and AD measures in the FOHP were higher
than the LVP, FOHP FA was less than the LVP, directly opposite to the observed findings in the
healthy infants. (Table 5; Figure 26). Nevertheless, directionality of the principal eigenvectors in
both LVP and FOHP generally did not differ between groups (Figure 27).
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Table 5: Region-specific dMRI measures examining between-group differences among 158 infants
Lateral ventricular perimeter
Frontal occipital horn perimeter Mean difference
(LVP-FOHP)
Estimate Lower
Upper
Estimate
Lower
Upper
Fractional anisotropy
FT
0.26
0.24
0.27
0.29
0.27
0.30
-0.03
VPT
0.22
0.21
0.24
0.22
0.21
0.23
0.00
HG-IVH
0.20
0.18
0.23
0.20
0.17
0.23
0.00
PHH
0.15
0.12
0.18
0.12
0.09
0.15
0.03
2
Mean diffusivity(μm /s)
FT
1.46
1.42
1.50
1.60
1.56
1.63
-0.13
VPT
1.47
1.44
1.51
1.63
1.60
1.67
-0.16
HG-IVH
1.55
1.49
1.62
1.73
1.66
1.80
-0.17
PHH
1.58
1.51
1.66
1.73
1.65
1.81
-0.15
Axial diffusivity(μm2/s)
FT
1.88
1.82
1.93
2.11
2.05
2.16
-0.23
VPT
1.82
1.77
1.86
2.02
1.97
2.07
-0.20
HG-IVH
1.90
1.80
2.00
2.10
2.00
2.20
-0.20
PHH
1.77
1.66
1.88
1.92
1.81
2.03
-0.15
Radial diffusivity(μm2/s)
FT
1.26
1.22
1.31
1.35
1.31
1.39
-0.09
VPT
1.31
1.27
1.35
1.45
1.41
1.49
-0.14
HG-IVH
1.38
1.30
1.46
1.54
1.46
1.62
-0.16
PHH
1.51
1.42
1.60
1.65
1.56
1.74
-0.14
Summary of least square means from a linear mixed effects model. PHH = post hemorrhagic
hydrocephalus; HG-IVH = high grade intraventricular hemorrhage; VPT = very preterm; FT = full term.
Lower and upper values are confident intervals

Figure 26: Effects of region of segmentation on dMRI measures
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Between groups the FOHP in PHH infants had higher MD, AD and RD as well as lower FA
measures than the LVP, an indication the FOHP is more disrupted than the LVP. Error bars are
standard error means.

Figure 27: Representative principal eigenvector maps of white matter orientation
The eigen vector analyses of the periventricular white matter in healthy full-term (FT) and post
hemorrhagic hydrocephalus (PHH) infants demonstrated orientation of the direction of maximum
water displacements (arrows) along the perimeter of the ventricles (V) was generally preserved
between groups in spite of the reduced anisotropy in the PHH group.
3.2.2.4 Ventricular size correlates with dMRI measures in the LVP and FOHP

Spearman’s rho revealed that frontal-occipital horn ratio correlated with dMRI measures in the
LVP. Ventricular size had negative correlation with FA (rs=-0.41 p<.001), with anticipated
positive correlations with MD (rs=0.26, p=.005) and RD (rs=0.36, p<.001) in the LVP (Figure 28).
Relatively stronger relationships were found in the FOHP in that ventricular size was negatively
correlated with FA (rs=-0.47, p<.001) and positively correlated with MD (rs=0.35, p<.001) and
RD (rs=0.42, p<.001) (Fig. 29). AD measures did not correlate with ventricular size in either the
LVP or FOHP segmentation analyses (rs=-0.05, p=1.000).
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Figure 28: dMRI-ventricular size correlations in the LVP
Spearman correlation analyses demonstrated that larger ventricular size was associated with higher
MD and RD and lower FA, suggesting ventricular enlargement is associated with dMRI-measured
LVP disruption.

Figure 29: dMRI-ventricular size correlations in the FOHP
Spearman correlation analyses demonstrated larger ventricular size was associated with higher
MD and RD and lower FA, suggesting ventricular enlargement is associated with dMRI-measured
FOHP disruption.
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3.2.3

DBSI differentiates PVWM pathology in PHH

3.2.3.1 Subject characteristics

Prospectively recruited infants assessed between May 2007 and August 2016 were categorized
into four groups: full term (FT), very preterm (VPT), intraventricular hemorrhage (IVH) and posthemorrhagic hydrocephalus (PHH). A total of 206 infants (FT=76, VPT=91, IVH=20, PHH=19)
with dMRI data were assessed for possible inclusion. Sixty-six patients did not meet inclusion
criteria for the reasons outlined in Figure 30, which included having a positive maternal urine drug
screen, atypical pattern of brain injury/abnormal MRI finding that precluded accurate
segmentation of ROIs, and dMRI data that could not be fitted with DBSI due to having less than
25 diffusion-encoding directions and/or b-values.

Figure 30: Flowchart of patient enrolment and selection for study inclusion
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Among 140 infants (70 males, 70 females) who underwent dMRI, 45 FT, 68 VPT, 15 IVH and 12
PHH infants were included in the analyses. The median term age equivalent of dMRI acquisition
was 38±2 weeks. By definition, the PHH group had larger ventricles than the remaining groups
(median frontal-occipital horn ratio of 0.52±.10 vs. 0.40±.04). The median clinical risk scores of
IVH and PHH infants were similar and significantly higher than that of the VPT and FT infants.
(Table 6; Figure 31). Prior to their dMRI scan, all PHH infants (n=12) had undergone a temporary
ventricular access device placement for serial CSF removal, with 10 of these infants eventually
undergoing permanent shunt placement and two undergoing ETV to treat hydrocephalus. There
were no differences between the shunt- and ETV-treated infants on all measures.
Table 6: Characteristics of infants in a prospective study to assess DBSI indices in PVWM
Full term
45

Very preterm
68

IVH
15

PHH
12

# of patients
Sex
# of male infants
22
29
7
12
# of female infants
23
39
8
0
GA at birth (weeks)
39.0±2.0
27.0±2.8
25.0±3.0
24.5±4.0
TEA at dMRI acquisition (weeks)
39.0±2.0
37.0±1.0
38.0±4.0
39.0±1.0
Birth weight (g)
3195±714.0
932.5±350.0
740.0±330.0
807.5±304.5
Frontal-occipital horn ratio
0.36±0.03
0.41±0.03
0.41±0.04
0.52±0.10
Clinical risk score
0±0
1±3
3±2
3±4
All continuous variables are reported as median ± interquartile range within the respective groups. IVH =
intraventricular hemorrhage; PHH= post-hemorrhagic hydrocephalus; GA = gestational age; TEA = term
equivalent age
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Figure 31: Ventricular size measurement and regions of interest segmentation
Representative axial T2W of a preterm infant with post-hemorrhagic hydrocephalus (PHH) (top
row). Ventricular size was determined by the frontal-occipital horn ratio which was calculated as
(a + c)/2b 20. The Box and whisker diagram demonstrate the PHH group had the largest ventricular
size among 140 infants (p<.001, ***). There was no difference in ventricular size between the
VPT and IVH infants, although both groups had median ventricular sizes that were larger than that
of the FT control infants. Bottom row demonstrates representative contiguous axial fractional
anisotropy maps of infants with demarcation of the segments of the white matter bundles of interest
within the corpus callosum, bilateral corticospinal tracts and bilateral optic radiations.

3.2.3.2 Neuroinflammation and reduced fiber density in the corpus callosum

In the CC, PHH infants had the lowest FA and highest RD (p<.001), suggesting they had more
severe white matter disruption than non-PHH infants. Quantification of fiber density demonstrated
that the PHH group had 71%, 70% and 53% less white matter fiber density than the FT, VPT and
IVH groups, respectively (p<.001). However, the IVH group also had lower FA, higher RD and
32% and 38% lower fiber density in comparison to the FT and VPT infants, respectively (p<.01).
This indicates hemorrhage had an independent detrimental effect on white matter integrity, albeit
exacerbated by hydrocephalus. Isotropic diffusion metrics revealed the PHH group had the highest
restricted fraction, suggesting cellular infiltration when compared to the non-PHH groups
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(p<.001). Hypercellularity would be expected to be associated with reduced FA and AD measures,
and, indeed, fiber level analyses confirmed the PHH group had the lowest FFA and FAD (p<.001).
FRD and the non-restricted fraction (a marker of edema) did not differ between groups (Figure
32). Across tracts, dMRI measures and p values for one-way and groupwise comparisons are
presented in Tables 7 and 8, respectively.
Table 7: dMRI measures of PVWM in full term and preterm infants with/or without IVH/PHH and
their frontal-occipital horn ratio-dMRI correlations
Measures
Ventricular size-dMRI
PHH
IVH
VPT
FT
Rho
P-value
FA
0.11 ± 0.11 0.34 ± 0.40 0.42 ± 0.44 0.43 ± 0.57
-0.34
<0.001*
AD
2.02 ± 1.48 2.25 ± 1.03 2.18 ± 0.94 2.15 ± 1.61
-0.06
0.474
RD
1.61 ± 1.39 1.20 ± 0.89 1.08 ± 1.03 1.01 ± 1.59
0.28
0.001*
MD
1.73 ± 1.42 1.56 ± 0.77 1.43 ± 0.81 1.38 ± 1.29
0.22
0.011*
FFA
0.46 ± 0.32 0.70 ± 0.48 0.71 ± 0.29 0.69 ± 0.50
-0.14
0.106
CC
FAD 1.80 ± 1.30 2.42 ± 1.19 2.21 ± 1.19 2.18 ± 1.27
-0.20
0.018*
FRD 0.71 ± 0.59 0.57 ± 0.38 0.56 ± 0.59 0.58 ± 0.61
-0.02
0.847
FF
0.17 ± 0.30 0.36 ± 0.47 0.53 ± 0.66 0.58 ± 0.77
-0.28
0.001*
RF
0.53 ± 0.56 0.34 ± 0.74 0.28 ± 0.72 0.22 ± 0.71
0.32
<0.001*
NRF 0.28 ± 0.80 0.29 ± 0.80 0.16 ± 0.58 0.18 ± 0.75
0.05
0.547
FA
0.39 ± 0.34 0.51 ± 0.36 0.51 ± 0.22 0.56 ± 0.40
-0.10
0.236
AD
1.58 ± 0.55 1.77 ± 0.62 1.75 ± 0.25 1.76 ± 0.52
0.16
0.054
RD
0.84 ± 1.02 0.69 ± 0.84 0.72 ± 0.35 0.66 ± 0.40
0.14
0.109
MD
1.13 ± 0.87 1.05 ± 0.68 1.03 ± 0.28 1.02 ± 0.17
0.14
0.109
FFA
0.65 ± 0.40 0.71 ± 0.57 0.71 ± 0.38 0.76 ± 0.31
-0.25
0.003*
CST FAD 1.45 ± 0.86 1.92 ± 1.11 1.96 ± 0.42 1.87 ± 0.49
0.21
0.011*
FRD 0.66 ± 0.22 0.42 ± 0.44 0.48 ± 0.61 0.42 ± 0.37
0.21
0.011*
FF
0.49 ± 0.52 0.59 ± 0.65 0.62 ± 0.44 0.65 ± 0.56
-0.09
0.273
RF
0.39 ± 0.44 0.29 ± 0.42 0.25 ± 0.43 0.27 ± 0.57
0.00
0.973
NRF 0.05 ± 0.73 0.03 ± 0.23 0.02 ± 0.10 0.03 ± 0.19
0.06
0.493
FA
0.24 ± 0.68 0.36 ± 0.32 0.37 ± 0.22 0.38 ± 0.23
-0.18
0.032
AD
2.04 ± 1.03 1.91 ± 0.91 1.95 ± 0.35 1.81 ± 0.72
0.48
<0.001*
RD
1.41 ± 1.41 1.21 ± 0.60 1.21 ± 0.54 1.20 ± 0.60
0.16
0.056
MD
1.65 ± 1.04 1.48 ± 0.55 1.45 ± 0.42 1.39 ± 0.61
0.29
0.001*
FFA
0.63 ± 0.32 0.68 ± 0.28 0.67 ± 0.25 0.72 ± 0.26
-0.18
0.031*
OPRA
FAD 2.53 ± 0.62 2.18 ± 0.92 2.22 ± 0.54 2.01 ± 0.54
0.47
<0.001*
FRD 0.74 ± 0.72 0.76 ± 0.45 0.74 ± 0.47 0.65 ± 0.33
0.28
0.001*
FF
0.36 ± 0.41 0.51 ± 0.33 0.53 ± 0.33 0.45 ± 0.38
-0.02
0.798
RF
0.53 ± 0.66 0.40 ± 0.44 0.41 ± 0.34 0.41 ± 0.44
-0.03
0.700
NRF 0.10 ± 0.28 0.04 ± 0.34 0.03 ± 0.24 0.05 ± 0.24
0.13
0.135
All continuous variables are reported as median ± standard deviation within the respective groups. IVH =
intraventricular hemorrhage; PHH= post-hemorrhagic hydrocephalus; Groupwise comparisons were
done with the Wilcoxon signed rank test. Ventricular size- diffusion MRI (dMRI) correlations were assessed
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with Spearman Rho correlations. All p-values were Bonferroni corrected and significant p-values (p<.050)
are asterisked (*).

Table 8: Levels of significance for one-way and groupwise comparisons of dMRI measures in full
term and preterm infants with/or without IVH/PHH
Groupwise comparisons
OnePHH vs
PHHPHHPHHIVHIVHVPTway Non-PHH
FT
VPT
IVH
FT
VPT
FT
FA
<.001
<.001
<0.001* <0.001* <0.001*
0.004*
0.002*
0.462
AD
0.489
0.278
0.394
0.314
0.196
0.379
0.235
0.854
RD
<.001
<.001
<0.001* <0.001*
0.026*
0.003*
0.001*
0.313
MD 0.002
0.023
0.024*
0.018*
0.428
0.005*
0.005*
0.192
FFA <.001
<.001
<0.001* <0.001* <0.001*
0.612
0.867
0.221
CC
FAD <.001
<.001
<0.001* <0.001* <0.001*
0.158
0.240
0.377
FRD 0.480
0.160
0.213
0.152
0.367
0.973
0.606
0.522
FF
<.001
<.001
<0.001* <0.001*
0.002*
0.003*
0.001*
0.585
RF
<.001
<.001
<0.001* <0.001*
0.016*
0.002*
0.035*
0.010*
NRF 0.127
0.145
0.305
0.070
0.683
0.446
0.086
0.208
FA
<.001
<.001
0.002* <0.001* <0.001*
0.102
0.438
0.114
AD
<.001
<.001
0.001* <0.001* <0.001*
0.919
0.745
1.000
RD
<.001
<.001
<0.001* <0.001* <0.001*
0.543
0.069
0.022*
MD <.001
<.001
<0.001* <0.001*
0.003*
0.117
0.504
0.114
FFA <.001
<.001
<0.001* <0.001*
0.025*
0.163
0.864
<0.001*
CST FAD <.001
<.001
<0.001* <0.001* <0.001*
0.139
0.329
<0.001*
FRD <.001
<.001
<0.001* <0.001* <0.001*
0.407
0.372
<0.001*
FF
<.001
<.001
0.004* <0.001*
0.002*
0.488
0.623
0.483
RF
0.001
<.001
0.038* <0.001*
0.012*
0.906
0.179
0.344
NRF <.001
0.080
<0.001*
0.152
0.879
0.047*
0.001*
0.005
FA
0.004
0.001
0.001*
0.001*
0.015*
0.397
0.692
0.092
AD
<.001
0.037
0.009
0.135
0.069
0.242
0.042*
<0.001*
RD
0.139
0.029
0.066
0.026*
0.109
0.477
0.489
0.498
MD 0.005
0.016
0.018*
0.019*
0.134
0.060
0.582
0.007*
FFA <.001
0.012
0.005*
0.025*
0.121
0.028*
0.701
<0.001*
OPRA
FAD <.001
<.001
<0.001* <0.001*
0.001*
0.005*
0.674
<0.001*
FRD <.001
0.307
0.031*
0.729
0.959
<0.001*
0.854
<0.001*
FF
<.001
<.001
0.022* <0.001*
0.003*
0.417
0.295
0.009*
RF
0.025
0.004
0.018*
0.003*
0.024*
0.467
0.799
0.338
NRF <.001
0.001
0.042* <0.001*
0.027*
0.761
0.154
0.008*
All continuous variables are reported as median ± standard deviation within the respective groups. IVH =
intraventricular hemorrhage; PHH= post-hemorrhagic hydrocephalus; Groupwise comparisons were
done with the Wilcoxon signed rank test. All p-values were Bonferroni corrected and significant p-values
(p<.050) are asterisked (*).
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Figure 32: dMRI measures of the corpus callosum (CC)
The CC dMRI metrics demonstrated PHH infants had the most severe white matter disruption,
which was marked by having the lowest fiber level FA and AD indices when compared to IVH,
VPT and FT infants. PHH was also associated with a reduced white matter fiber density (Fiber
Fraction), and the relatively highest measures of cellular infiltration (Restricted Fraction) in the
CC. No differences were observed in fiber RD and markers of edema (Non-restricted Fraction)
between groups. ***represents p-value<.001; FT=full term; VPT= very preterm;
IVH=intraventricular hemorrhage; PHH=post-hemorrhagic hydrocephalus; FA= fractional
anisotropy; AD=axial diffusivity; RD=radial Diffusivity.

3.2.3.3 Neuroinflammation, reduced fiber density, and demyelination in corticospinal tracts

In the CST, the PHH group again had the lowest FA, lowest AD and highest RD, implying more
severe white matter disruption than in PHH compared to non-PHH infants (p<.001). Fiber-specific
metrics demonstrated PHH had the lowest FFA and FAD, and the highest FRD when compared to
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the non-PHH groups (p<.001). White matter fiber density quantification showed the PHH group
had 25%, 21% and 17% less fibers than the FT (p=.004), VPT (p<.001) and IVH (p=.002) groups,
respectively. The PHH group also had the highest measures of restricted fraction, suggesting a
higher cellular infiltration than in the non-PHH groups (p<.001). Non-restriction fraction, a marker
of edema, only differed between the PHH and VPT groups (p<.001). (Figure 33).

Figure 33: dMRI measures of the corticospinal tracts (CST)
The CST dMRI metrics demonstrated PHH infants had the most severe white matter disruption,
which was marked by having the lowest fiber level FA and AD indices, as well as highest measures
of RD when compared to IVH, VPT and FT infants. PHH was also associated with reduced white
matter fiber density and the highest measures of cellular infiltration in the. No between group
differences were observed in non-restricted fraction, a marker of vasogenic edema. ***, ** and *
represents p-value <.001, <.01 and <.05, respectively; FT=full term; VPT= very preterm;
IVH=intraventricular hemorrhage; PHH=post-hemorrhagic hydrocephalus; FA= fractional
anisotropy; AD=axial diffusivity; RD=radial Diffusivity.
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3.2.3.4 Neuroinflammation, reduced fiber density, and edema in optic radiations

The OPRA in the PHH group also demonstrated disruption when compared to the non-PHH
groups. However, the pattern differed from that of the CC and CST. Specifically, while the PHH
group had the lowest FA values (p=.001), their AD and RD measures did not differ from the nonPHH groups. Fiber level analysis showed that FFA in the PHH group was lower than that of the
FT (p=.005) and VPT (p=.025) but did not differ from the IVH group (p=.12). FFA of the IVH
and VPT groups were lower than that of the FT group (p=.028 and p<.001, respectively), but did
not differ from each other (p=.70). Fiber level RD was lower in FT than very preterm infants: PHH
(p=.03), IVH (p<.001), and VPT (p<.001). Together, these findings suggest hemorrhage and
preterm birth were independent contributing factors to impaired white matter disruption in the
OPRA. White matter fiber density quantification demonstrated the PHH infants had 20%, 32%
and 29% less fibers than the FT (p=.02), VPT (p<.001) and IVH (p=.003) infants, and the PHH
group had the highest measures of fiber level AD (p<.001). Isotropic tensor analyses demonstrated
evidence of inflammation in the OPRA of PHH infants, given their increased measures of white
matter edema (NRF; p=.001) and cellularity (RF; p=.004) compared to non-PHH groups (Figure
34).
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Figure 34: dMRI measures of the optic radiations (OPRA)
The OPRA dMRI metrics demonstrated PHH infants had the most severe white matter disruption,
which was marked by having the lowest fiber level FA when compared to IVH, VPT and FT
infants. PHH was also associated with reduced white matter fiber density (Fiber Fraction) and the
highest measures of fiber level AD. In addition, the PHH group demonstrated evidence of severe
inflammation marked by the highest measures of vasogenic edema (Non-restricted Fraction) and
cellular infiltration (Restricted Fraction). ***, ** and *represents p-value <.001, <.01 and <.05,
respectively; FT=full term; VPT= very preterm; IVH=intraventricular hemorrhage; PHH=posthemorrhagic hydrocephalus; FA= fractional anisotropy; AD=axial diffusivity; RD=radial
diffusivity.

3.2.3.5 Ventricular size correlates with magnitude of PVWM disruption

Across all three white matter bundles, greater ventricular size demonstrated varying correlation
strength with poorer dMRI measures with variable patterns. In the CC, ventricular size related
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negatively with FA (p<.001) and fiber density (p=.001) and positively with RD (p<.001) and
cellular infiltration (p<.001). In the CC, FAD negatively correlated with ventricular size (p=.018),
while in the CST (p=.01) and OPRA (p<.001) positive correlations were observed. This likely
reflects differences between the CC and CST/OPRA at this developmental stage including
myelination and compactness of the respective white matter fiber bundles. (Figure 35).

Figure 35: Ventricular size-dMRI correlations
Spearman correlation analyses demonstrated increase in ventricular size was correlated with
poorer dMRI measures, but in variable patterns across the corpus callosum (CC), corticospinal
tracts (CST) and optic radiations (OPRA). In the CC, as ventricular size increases, a decrease in
fiber AD and white matter fiber density and an increase in cellular infiltration are observed.
However, in both the CST and OPRA, increases in ventricular size were associated with decreases
in fiber FA and AD and increases in fiber RD. Ventricular size was obtained with frontal occipital
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horn ratio approach20. Significant correlations are represented by bold image borders where ***,
** and * represents p-value <.001, <.010 and <.050 respectively; FT=full term; VPT= very
preterm; IVH=intraventricular hemorrhage; PHH=post-hemorrhagic hydrocephalus.

3.2.3.6 Postmortem tissue neurocytology relates DBSI metrics to VZ disruption

Immunohistochemical analyses of the CC from postmortem tissues validated the dMRI findings.
In comparison to controls, PHH infants demonstrated white matter tracts with relatively higher
cellularity, reflecting their high restricted fractions seen on dMRI. In addition, the PHH infants
had decreased synaptophysin staining suggesting decreased neuropil and synaptic processes,
which reflects their low fiber fractions on dMRI. While variable amount of cytoplasmic
vacuolation suggesting edema was seen on histology, the dMRI correlate, non-restricted fractions
did not differ between PHH and non-PHH groups, presumably the non-restricted fractions reflect
interstitial or extracellular edema (Figure 36).

Figure 36. Representative neurocytology of post-mortem PVWM tissue
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Representative histological staining of post-mortem tissue from corpus callosum (CC) of preterm
infants. (A & B) H&E and (C & D) synaptophysin of preterm infants (A & C) without or (B & D)
with PHH. PHH infants had relatively increased cellular infiltration (B & D) and vacuolation of
their cytoplasm to suggest edema (B). Decreased axonal staining in PHH (D) suggests a relatively
decreased fiber density in comparison to controls (C). The CC is not myelinated at term equivalent.

Analyses of the VZ/SVZ and adjoining PVWM demonstrated that IVH, and to a greater extent
PHH, were associated with hemorrhage as well as VZ/SVZ disorganization, as characterized by
variable granular ependymitis on H&E staining. IVH/PHH was associated with a 20-30% relative
increase in VZ disruption when compared with (p=.016) and FT infants (p=.011). In addition,
IVH/PHH was associated with disruption of radial glial cells in the VZ, characterized by loss of
their basal projections and VZ lattice. Furthermore, there was relatively increased expression of
GFAP and IBA1, representing reactive astrocytosis and microglia/macrophage-associated
inflammation in the VZ/SVZ regions of IVH/PHH when compared to FT infants. (Figure 37).
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Figure 37. Representative immunohistochemistry of postmortem brain tissue
In the full term, FT (A, E, H, K), very preterm, VPT (B, F and I) and infants with intraventricular
hemorrhage or post-hemorrhagic hydrocephalus, IVH/PHH (C, G, J, and L), the H&E images (AC) demonstrate an intact ventricular zone (VZ) with normal multiciliated ependymal cells (A), a
region undergoing early VZ disruption with protrusion of the VZ toward the ventricular space with
preserved cilia (B) and an established VZ disruption with denuded ependyma that has no cilia (C).
(D) Percent VZ disruption, quantified as the cumulative length of the disrupted ependymal regions
as a factor of the entire length of VZ available on the same slide, demonstrate IVH/PHH is
associated with the severest VZ damage than VPT and FT infants (p<.05). Adjacent slides of the
same infant’s double-labeled with anti-GFAP and anti-dapi demonstrates the characteristic shape
of radial glial cells (E) with basal projections undergoing progressive changes in the pattern of
GFAP expression, (F) initially showing a lack of basal projections and subsequently a proliferation
of GFAP-positive
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3.3

Discussion

3.3.1

The LVP is a critical region in PHH pathophysiology

Many of the debilitating symptoms of IVH and PHH have been attributed to PVWM injury
241,242,439,440

. As such, the anatomical, physiological and molecular relationships between the LVP

and PVWM have several critical research and clinical implications133,175,197,318. First, IVH/PHH in
preterm infants typically occurs during a critical developmental period of VZ/SVZ differentiation,
interfering with neural stem cell maturation and ependymal layer formation. Impairment in
ependymogenesis leads to denuded regions that expose PVWM to injury from CSF contents,
ciliopathy that impairs CSF circulation and overall dysregulation of cerebral homeostasis,
immunologic response to injury and other normal cellular processes

232,233

. In addition, the

irritation effects of blood, ferritin and reactive oxidative species likely propagates injurious
mechanisms of neuroinflammation, hypoxia and ischemia 131,197 that further compromises the LVP
barrier and damages PVWM 122,133,184. Thus, examining LVP with dMRI in PHH patients may help
focus future research on strategies that enhance LVP barrier properties in preterm infants to avert
PVWM injury and its neurological sequalae. Second, in PHH, the ventricular dilatation exerts
mechanical pressure on both the LVP and PVWM

39,185

, which may exacerbate ependymal

denudation and axonal dysfunction due to direct axonal stretch and/or compression. Further, from
a hydrocephalus treatment standpoint, CSF diversion surgery is typically performed to relieve the
mechanical pressure, thereby preventing further damage and permitting recovery

284,287,291

.

Therefore, using dMRI metrics to assess the relationships between ventricular size and LVP
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integrity in IVH patients with or without PHH may help define the compounding effect of PHH
on PVWM on top of IVH, and the role of therapeutic ventricular decompression.

3.3.2

Delineating the LVP for dMRI analyses

There are numerous technical challenges to using dMRI in neonates and high-risk clinical
populations. From an acquisition perspective, specialized medical facilities, equipment, protocols
and staff who are experienced in handling neonates and performing population-specific procedures
implemented for collection of high-quality dMRI data are imperative 441,442. Moreover, since the
majority of neonatal MRIs are acquired without sedation, there can be excessive motion leading
to severe signal dropouts that compromise dMRI anisotropy. Furthermore, the relative differences
in infant head sizes, cortical gyrification, and anatomical heterogeneity resulting from different
forms/severities of brain injury also pose significant challenges to image acquisition and analyses
441

. Thus, standard dMRI analysis pipelines (usually for adults) will typically fail when applied to

neonatal data, compelling development of tailored pipelines that are able to account for those
factors.

The LVP has been challenging to study with dMRI because of partial volume effects that may
occur when adjacent or surrounding structures are included in the segmentation. This is because,
in addition to being in close proximity to ventricular CSF and other tissues of varying signal
intensities, the thickness of the LVP is only a few cell layers. Indeed, the ependymal layer is a
single layer of epithelial cells (~5μm thickness), and the VZ/SVZ comprise a mix of radial glial
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and neuroblast cells,123,133 which makes it technically challenging to segment a homogeneous ROI
for the LVP. In this study, we developed a novel MATLAB-based algorithm capable of
segmenting the innermost layer of the LVP and its adjoining PVWM with a spatial resolution of
1.2 mm3. This voxel size is larger than the SVZ. As a result, the ROIs likely contain a mixture of
SVZ and subjacent white matter. The ROIs had nonzero diffusion anisotropy, and evaluation of
Eigen vector maps (Fig. 26) showed fiber orientation parallel to the walls of the lateral ventricles,
consistent with the orientation of white matter in these areas. In contrast, the SVZ would be
expected to have isotropic diffusion or a primary orientation of maximum water displacements
orthogonal to the walls of the lateral ventricles. Thus, the measured diffusion parameters likely
reflect those of white matter, and injury to the SVZ was inferred through evidence of injury to the
adjacent white matter. Further, the ROIs were generated with an automated algorithm, which
helped eliminate manual and inter-/intra-rater related errors. In addition, the ROIs were averaged
from three contiguous axial slices to increase signal to noise and to reduce through-plane partial
volume averaging effects.

3.3.3

Cellular basis of dMRI-measured LVP injury in PHH

During typical white matter development, PVWM FA increases, while MD, RD and AD decrease
in a time-dependent fashion

443,444

. Our finding of lower FA and higher MD and RD in VPT

compared to FT infants is consistent with previous studies showing that preterm birth is associated
with dMRI-measured tissue abnormalities 445-447 and poor neurological outcomes, which have been
attributed to disrupted neuronal proliferation, migration and synaptogenesis

448

. In HG-IVH and

PHH the premature brain’s sensitivity to perturbations in normal cellular processes by hemorrhage
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and hydrocephalus contributes significantly to their poorer neurological outcomes when compared
to non-IVH preterm infants and healthy full term controls

439,440,449

. Our finding of more prominent

abnormalities in FA, MD and RD in HG-IVH and PHH infants recapitulates the patterns of
IVH/PHH-associated tissue injury that have been previously reported by dMRI studies of large
bundle PVWM tracts such as the corpus callosum and internal capsules 272,284,450-452. In Chapter 4
we propose a molecular mechanism for LVP injury in the setting of IVH. Using cell cultures of
VZ cells from the LVP to demonstrate VZ disruption occurs as a result of cleavage of adherens
junctions proteins

318

, thereby exposing the PVWM to severe inflammation and gliosis

197,318

.

Several other histopathological studies have shown that IVH is associated with LVP tissue
damage, which is characterized by ependymal denudation, heterotopia and rosette formation,
radial glial cell disorganization, and astrocytic proliferation in the VZ and SVZ 175,178,197.

3.3.4

PHH-associated myelin injury

Diffusion anisotropy data in white matter are typically interpreted in terms of changes to myelin,
with an increase in RD thought to represent injury to myelin with relative sparing of axons. In the
present context, this interpretation is complicated by the fact that most of PVWM is not myelinated
at term equivalent 453. While white matter tracts associated with primary motor and sensory areas,
particularly CST and OPRA, are myelinated at term equivalent and do show greater values for
diffusion anisotropy than unmyelinated areas 443, the majority of PVWM is unmyelinated at this
stage of development

453

. Thus, for this study, the relative increase in RD compared with AD

suggests greater spacing of axons, possibly related to transependymal migration of CSF, and/or an
increase in axonal membrane permeability, perhaps related to stretching and injury
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454-456

. The

influence of these unmyelinated axons on the diffusion measurement is supported by the finding
that the orientation of the direction of maximum water displacements (which indicates the
orientation of white matter fiber tracts) was generally preserved in spite of the reduced anisotropy,
suggesting that the axons were still present (Figure 26). Nevertheless, disruption of the LVP may
be associated with subsequent abnormalities of myelination through injury to oligodendrocyte
progenitor cells that are present in this region at term equivalent. Indeed studies of the CC of older
hydrocephalic children after myelination 238,450 show MD changes driven by changes to RD rather
than to AD, indicating myelin disruption. Other studies have identified morphological defects in
oligodendrocytes, which occur as a result of hemorrhage and other multifactorial mechanisms
including neuroinflammation and ischemia-induced excitotoxity

457-462

. In addition, PHH likely

compounds oligodendrocyte disruption and PVWM dysmyelination through its compressive
effects on oligodendrocyte progenitor cells in the LVP 457,458,461.

3.3.5

FOHP sustains a greater magnitude of injury than the rest of the LVP

Across the LVP, there are regional differences in the cytoarchitecture of the VZ and organization
of neural stem cells within the subjacent SVZ

133,197,463

. While radial glial cells are sequentially

replaced by ependymal cells along the LVP during fetal development, the lateral wall of the frontal
horn is the only region that retains these stem cells into infancy

463

, which may contribute to

adverse neurodevelopmental outcomes when those regions are damaged by PHH. Indeed, in our
cohort, the FOHP demonstrated more prominent evidence of injury than the LVP. These findings
are consistent with the more prominent patterns of FOHP than LVP injury seen on conventional
MRI scans of hydrocephalus patients, which is characterized by T2W periventricular
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hyperintensities

449,464

, petechial hemorrhages on susceptibility weighted imaging

193-195

and

restricted diffusion on diffusion weighted imaging 465. There is also a disproportionate distribution
of stress and strain on the stem cell rich FOHP in patients with hydrocephalus 466-468. For example,
relative to the LVP, the FOHP region is subjected to higher stress and strain in the setting of
hydrocephalus because of its concave geometry and acute anterolateral angles, which in turn
expands the extracellular spaces in the FOHP and facilitates water extravasation and tissue edema
466-468

. It is important to note however, that in this study, all PHH infants had undergone

intervention for hydrocephalus, and their intracranial pressure was expected to have normalized at
the time of dMRI acquisition. Nevertheless, we suspect the dMRI disruptions seen in the PHH
group may reflect complex pathology from the initial IVH, injury from raised intracranial pressure
sustained prior to their shunt/ETV treatment, and the subsequent associated secondary injury.

Several clinical and experimental studies have shown that PHH is strongly associated with
significant neurological disabilities, which are mediated in part by impaired cerebral white
matter289,469-475. Conventional dMRI has been widely employed to characterize alterations in
cerebral development45,476 and to assess white matter disruptions in PHH, but the microstructural
basis underlying the reported diffusion changes are not resolved307,309,311. DBSI, an innovative
analysis technique uniquely capable of simultaneously modeling anisotropic and isotropic
tensors307,309,311 was utilized in this study to quantify and differentiate white matter pathologies in
prospectively collected dMRI data obtained at term equivalent age of preterm infants with PHH,
those who sustained IVH but did not develop PHH and those who had no identifiable neurologic
events (VPT), and full term healthy infants (FT). DBSI anisotropic diffusion tensors resolved
fibers to assess axonal and myelin injury as well as white matter fiber density, while isotropic
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tensor analyses reflected cellularity and edema. Three clinically relevant white matter tracts, the
CC, OPRA and CST were assessed. Correlations between ventricular volume and DBSI measures
were assessed. It is important to emphasize that the dMRI images in this cohort were acquired at
term equivalent age, when some but not all white matter tracts are expected to have been
myelinated, therefore, the findings are interpreted in the context of whether the assessed white
matter is myelinated (CST and OPRA) or unmyelinated (CC).

3.3.6

DBSI extends dMRI capabilities to delineate white matter cellular pathology

Several clinical and experimental studies have shown that PHH exhibits multifactorial white
matter disruption that encompasses a mix of axonal and myelin disruption, as well as multicompartmental microstructural processes such as inflammation, hypercellularity and edema. These
nuances are beyond the capabilities of DTI to accurately parse out. Advanced post-processing
computational methods such as DBSI address some of DTI limitations without need for
dramatically changing data acquisition307-312. DBSI utilizes standard high-resolution dMRI data
(with 25 diffusion encodings or more) and extracts multiple diffusion tensors across
microstructural compartments307-313. These diffusion tensors then enable the separation of crossing
fibers, estimation of crossing angles, recovery of directional diffusivity of individual crossing
fibers, assessment of axonal loss, distinction of myelinated, dysmyelinated, or unmyelinated
axons,

and

modelling

crossing

fibers,

extra-axonal

inflammation,

cellularity

and

edema307,308,311,313,314. DBSI has been validated experimentally in preclinical mouse models of
white matter injury307,309,314,315,477 and used to investigate white matter pathology across clinical
populations in adults308-311. It lends itself as a uniquely powerful, non-invasive neuroimaging tool
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with high sensitivity for delineating white matter alterations in the developing brain, both normal
and in PHH pathology.

Beyond the LVP, the white matter aberrations we identified in the CC, CST and OPRA with DBSI
in PHH infants are all factors that have been associated with impaired neuromotor and cognitive
development. This is likely because PHH disturbs processes that underlie early white matter
development, engendering local and widespread effects through direct cellular mechanisms and
disruption of subsequent cerebral development240,478-482. Collectively, LVP injury, characterized
by the loss of progenitor cells and impaired neuroblast migration215,223,318,325,483, further impacted
by pressure-related structural deformation, ischemia, oxidative stress, inflammation, and other
phenomena86,185, has brain-wide effects, impacting both cortical and subcortical regions and the
development of critical white matter tracts123-126.

3.3.7

dMRI variability of white matter structure and development

Across all fibers examined with DBSI, both conventional FA and fiber level FA were lower in the
PHH group, indicating white matter injury. However, when assessing white matter integrity in
infants, especially in PHH, variabilities in the stages of white matter development, as well as their
response to injury must be taken into consideration. This is particularly important for this study
because in conventional dMRI, RD is typically regarded as a marker of myelin integrity and the
higher the RD, the worse the myelin injury. Yet, in this study, there was significant variability in
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RD indices, which were subject to different interpretations in the presence or absence of myelin in
the fiber tracts of interest.

In large bundle tracts, myelination begins and ends at variable ages among different white matter
bundles. In general, myelination in the CST and OPRA starts at 38- and 40-weeks’ gestation,
respectively484, whereas myelination in the CC does not begin until after 2 months
postnatally484,485. Kinney et. al.485 examined human postmortem tissues obtained less than 24 hours
after expiration using immunohistochemistry and biochemical measurements of different lipids
and observed that sphingomyelin, cerebroside, and sulfatide were not detectable until early infancy
and myelin basic protein staining was not detectable until the 2nd postnatal month485 in the CC,
similar to Sarnat et al.’s observations484. DTI RD in the unmyelinated CC of PHH infants in this
study was significantly higher than non-PHH infants, but fiber level RD, while still highest in
PHH, was not statistically significantly different. This suggests that the higher RD detected with
DTI was related to increased fiber spacing rather than direct axonal injury, which is consistent
with the roughly 70% reduction in fiber density found with DBSI and supported by histology. In
contrast, the myelinated CST consistently demonstrated higher RD in the PHH than non-PHH
group, suggesting myelin disruption/injury. For the myelinated OPRA, on the other hand, RD
findings were not consistently different between groups. This may be attributed to intrinsic
variabilities in myelination of segments within the OPRA that were not detected with dMRI. To
complicate matters further, there is variability in the effects of PHH on different segments of the
PVWM, even along the uniform lateral ventricular perimeter. Using a segmentation algorithm that
quantified dMRI measures in the 1 mm layer subjacent to the ventricular wall along the lateral
ventricular perimeter, Isaacs et al. demonstrated that the frontal and occipital horns of the lateral
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ventricle had the worst dMRI-measured PVWM injury231. Anatomically, the OPRAs are in very
close proximity to the occipital horns, which are subjected to the highest mechanical pressures and
transependymal flow injury in PHH, leading to significant water extravasation and tissue edema
in those regions.466-468 (Figure 38)

Figure 38: Schematic rendering of postulated pathology underlying different PVWM bundles
Diffusion MRI voxels from healthy myelinated and unmyelinated white matter are shown in the
top row. Bottom row shows voxels from the corpus callosum (CC), corticospinal tracts (CST) and
optic radiations (OPRA) of PHH infants, drawn to same scale as the healthy voxels, to demonstrate
relative fiber density, inflammatory cells, and estimated inter-axonal spacing. The CC is not
myelinated at this developmental stage76,77, depicted by the lack of myelin sheath. Relative to
healthy white matter, there was significantly reduced fiber fraction and increased cellularity in the
CC, CST and OPRA of PHH infants in comparison to healthy white matter. In the CST, increased
radial diffusivity suggests likely myelin injury, which is represented as reddish sleeves around the
axons.
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3.3.8

Ventricular size correlates with magnitude LVP and large bundle PVWM injury

Although ventricular size appears to be a central risk factor for neurodevelopmental impairment
in PHH, and early surgical decompression may improve outcomes, little is known regarding the
link between ventricular size and white matter integrity. Collectively, the tensile and compressive
forces of enlarged ventricles in PHH on the LVP and distant PVWM such as the CC, CST and
OPRA leads to impairment of arterial blood flow and venous stasis, which may cause axonal
disruption and dysmyelination that sets off a cascade of ischemia-induced white matter injury
458,486,487

. These findings beg the question whether ventricular size can be used as a surrogate

marker for disease severity in PHH patients. In assessing the LVP/FOHP, ventricular size
correlated negatively with FA and positively with MD and RD, suggesting that expanded
ventricular size likely has a negative effect on dMRI-measured LVP/FOHP tissue integrity.
In the CC, CST and OPRA, DBSI parsed the relationships between ventricular size and white
matter at the cellular level. In the CC, increases in ventricular size correlated with increases in
hypercellularity and reduction fiber density, which may have been secondary to reactive cellular
infiltration extracellularly and axonal loss, respectively. In PHH, the mechanical pressure from the
large ventricles distorts PVWM fiber organization, decreases cerebral perfusion, and initiates an
inflammatory cascade, which likely mediates axonal injury and loss185,210,242. These findings have
critical clinical implications as several studies have shown that progressive ventricular distension
in PHH is associated with higher rates of neurological disability. In a prospective study of 118
children, including 54 with hydrocephalus, Mangano et al. showed that changes in FA in the CC
and CST correlated with conceptual, general adaptive, and motor skills284. Strahle et al. found that
larger ventricular size was associated with impaired hippocampal development and worse
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cognitive scores at age 2 years in infants with PHH488. The findings of this study and the existing
literature demonstrate the deleterious impact of PHH and ventricular enlargement on white matter
integrity, brain development and its persistent neurodevelopmental effects. We also provide strong
support for utilizing DBSI to investigating the role of ventricular size – a readily modifiable factor
– in the neurodevelopmental disability of PHH.

3.3.9

Limitations

A primary limitation of this study is the small sample size in the PHH and, to a lesser extent, IVH
cohorts which may have limited our ability to observe subtle differences in dMRI parameters.
Notably, all PHH patients were male, which may have introduced a sex bias in the PHH group,
although there is a male preponderance in IVH reported in the literature 489,490. In addition, while
we were able to establish similarities between PHH and PIH in terms of VZ, SVZ and PVWM
disruption on postmortem neurocytology, we did not have any PIH subjects with dMRI data to
correlate to cytology. To minimize the effect of age on brain development, all scans were acquired
cross-sectionally at term-equivalent age, which precludes assessment of the relationships between
dMRI parameters and brain development over time. Almost all PHH infants had shunts in situ at
the time of dMRI acquisition, which may have caused through plane distortions and susceptibility
artifacts due to signal and geometric distortions. Critical steps and modifications to the imaging
pipeline such as aligning the relative frequency encoding directions to the shunt catheters, using
wider receiver bandwidths and reducing echo times may be helpful for decreasing geometric
distortions and minimize signal loss441,491. In the OPRA AD and RD measures did not consistently
differ between the PHH and non-PHH groups. While it is possible that the inflammation, edema,
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decreased fiber density and increased axonal spacing could have affected AD and RD measures,
the OPRA has relatively small tracts that in close proximity to many structures of varying signal
intensities. These signals may have inadvertently been included in OPRA segmentation, thereby
affecting the AD and RD measures due to partial volume artifacts. Due to the relative novelty of
the analysis techniques employed in this dissertation and the lack of concomitant histological
specimens in the same infants who underwent dMRI scans, our ability to directly link dMRI and
immunochemistry results limits the interpretability of some key findings (i.e., as neurobiological
or technical), such as the diffusivity measures in the OPRA. Another limitation is that our study
contained only term-equivalent scans with a cross-sectional design. Thus, we were unable to make
direct comparisons of measures in subjects with hydrocephalus studied during both the days before
and after neurosurgical intervention; information critical for evaluating what these approaches add
to our understanding of the reversible effects of neonatal hydrocephalus and optimal timing of
neurosurgical interventions. A longitudinal study including multiple scans at predetermined timepoints for each subject would allow more detailed evaluation of relationships between dMRI
parameters, frontal occipital horn ratio, and neurobehavioral correlates over time. In addition, the
neuroimaging measures from the LVP and DBSI analyses have not been related to
neurodevelopmental outcomes, limiting the interpretation of the clinical significance of our key
findings. Successfully linking the brain and behavioral measures in this high-risk population would
enhance the clinical relevance of our work and contribute to their validation as a biomarker. We
are planning future studies to investigate prospective associations between dMRI measures (DTI
and DBSI) in the LVP, FOHP and PVWM with subsequent neurodevelopmental outcomes to
elucidate the neurological mechanisms underlying impairment in high-risk VPT infants, as well as
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to potentially identify VPT infants in need of early referral to intervention services and longerterm follow-up care.

3.4

Materials and Methods

3.4.1

Participants

All patients were recruited after written informed consent was obtained from at least one parent of
every infant. Institutional Review Board approval for this study was obtained from the Washington
University Human Research Protection office. The FT infants were identified from a larger cohort
of infants undergoing neonatal neuroimaging scans as part of an existing contemporaneous fetal
monitoring study conducted at an adjoining maternity hospital. All VPT, HG-IVH/IVH and PHH
patients were recruited from a Level III Neonatal Intensive Care Unit. IVH diagnosis was made
within the first month of life by cranial ultrasound and graded using the Papile classification
system59. Well-established Hydrocephalus Clinical Research Network criteria were applied for the
diagnosis of PHH and the timing of neurosurgical treatment421, which included a reservoir or subgaleal shunt placement for temporary ventricular access, or permanent treatment with endoscopic
third ventriculostomy (ETV) or ventriculoperitoneal (VP) shunt. To ensure the FT group had no
confounding health issues at birth, additional exclusion criteria included acidosis (pH < 7.20) on
cord blood gas or blood gas obtained during the first hour of life or evidence of in utero illicit
substance exposure. Exclusion criteria for all four groups included inability to obtain informed
consent from an infant’s parent, presence of chromosomal abnormalities and/or proven congenital
infections (e.g., cytomegalovirus, toxoplasma, rubella).
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3.4.2

Perinatal Clinical Variables

To account for differences in medical status between groups, perinatal clinical information
obtained for each infant was used to calculate their clinical risk index score 470. The presence or
absence of each of 10 factors were scored as 1 or 0 respectively. There were 9 patient-related
factors, which included: 1) small for gestational age at birth or intrauterine growth restriction; 2)
received oxygen therapy at 36 weeks; 3) received postnatal steroids; 4) developed necrotizing
enterocolitis; 5) had a patent ductus arteriosus requiring indomethacin or ibuprofen therapy; 6) had
retinopathy of prematurity; 7) developed culture-positive neonatal sepsis; 8) weight-forheight/length ratio at the time of term equivalent MRI acquisition >3 standard deviations below
the measured ratio at birth; and 9) duration receiving total parenteral nutrition above the 75th
percentile. A point was also scored if the mother did not receive antenatal steroids. All scores were
collated to obtain a composite risk index score on a Likert scale of 10 - the higher the score, the
poorer the presumed neonatal health 470.

3.4.3

Imaging acquisition and preprocessing

Human infant diffusion MRI (dMRI) was acquired without sedation and during natural sleep or
when the subject was resting quietly following institutional neonatal guidelines

492

. Full-term

infants were scanned within the first four days of birth. To match the expected developmental stage
of the full-term infants, preterm infants were scanned at or near-term equivalent age (35-43 weeks
postmenstrual age). All scans were acquired using a 3-T Siemens TIM Trio System (Erlangen,
Germany), using an infant-specific, quadrature head coil (Advanced Imaging Research, Cleveland,
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OH, USA). Anatomical T1W with repetition time (TR) 1550 ms, inversion time (TI) 1100 ms,
echo time (TE) 3.05 ms, flip angle 15°, 1 × 1 × 1.25 mm3 voxels; and T2W sequences, sagittal,
magnetization-prepared rapid gradient echo sequence [TR 8210 ms, TE 161 ms, 1 × 1 × 1
mm3] voxels were obtained. Then, a diffusion-weighted image (DWI) [TR 13300 ms, TE 112 ms,
1266 Hz/Px bandwidth, 128 mm field of view, 1.2 × 1.2 × 1.2 mm3 voxels], with 27-48 b-directions
and amplitudes ranging 0-1200 s/mm2 was obtained.

3.4.4

Diffusion tensor imaging

Diffusion weighted image (DWI) data was processed using FSL tools493,494 and corrected for eddy
current distortions using Eddy495 susceptibility induced distortions using ApplyTopup495 and
motion corrected using FLIRT496,497. The diffusion signal attenuation curve was modeled as a
mono-exponential function plus a constant, and diffusion parameters were estimated using
Bayesian Probability theory498. FA, AD, RD and MD and Principal Eigen Vector maps were
generated with DSI studio(http://dsi-studio.labsolver.org).

3.4.5

Diffusion basis spectrum imaging

DWI data were processed using FSL tools
using Eddy

495

493,494

and corrected for eddy current distortions

, susceptibility induced distortions using ApplyTopup

495

, and motion corrected

using FLIRT 496,497. The CC, bilateral posterior limbs of the internal capsules, designated as CST,
and bilateral OPRA were selected a priori as our regions of interest (ROIs) as they have been
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shown to demonstrate improvement in dMRI indices following hydrocephalus treatment and relate
to PHH-related neuropsychological outcomes 272,284,452,499. For each subject, ROIs were manually
segmented on native diffusion parametric maps by three experienced reviewers (Fig. 1), with high
mean inter-rater reliabilities (range .70-.99). Each ROI was segmented on three contiguous axial
slices to minimize through-slice partial volume averaging using Analyze 10.0 software
(AnalyzeDirect, Inc., Overland Park, KS, USA).

The preprocessed 27-48 directional DWI images were analyzed via the DBSI pipeline

307,310

in MatLab® (MathWorks, Natick, MA, USA). As demonstrated in Equation 1, the DBSI model is
a sum of the multiple anisotropic diffusion tensors (first term) and a spectrum of isotropic diffusion
tensors (second term):
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Here bk is the kth diffusion gradient; Sk/S0 is the acquired diffusion weighted signal at direction of
bk normalized to non-diffusion-weighted signal; NAniso is the number of anisotropic tensors to be
determined; fik is the angle between the diffusion gradient bk and the principal direction of the ith
→

anisotropic tensor; 9𝑏! 9 is b-value of the kth diffusion gradient; l||i and l^i are the axial and radial
diffusivity of the ith anisotropic tensor under the assumption of cylindrical symmetry; fi is the
signal-intensity-fraction (non-diffusion-weighted) of the ith anisotropic tensor; a, b are low and
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high diffusivity limits of the isotropic diffusion spectrum; f(D) is the spectrum of signal-intensityfraction (non-diffusion-weighted) at all possible isotropic diffusivity D.

A priori division of isotropic components was established using an isotropic apparent diffusion
coefficient (ADC) cutoff of ≤0.3 µm2/ms representing restricted diffusion; ADC values between
0.3-2.5 µm2/ms representing hindered diffusion; and ADC ≥2.5 µm2/ms representing free
diffusion. Following DBSI analysis, ROI-specific metrics were obtained via voxel-based
computations. DBSI metrics included: fiber specific FA (fiber FA, FFA), AD (fiber AD, FAD),
and RD (fiber RD, FRD); axonal density (fiber fraction, FF); and non-fiber related restricted
fraction (RF), and non-restricted fraction (NRF).

3.4.6

Ventricular size Measurements

All ventricular size measurements were taken by two independent expert raters on axial T2W image
using the frontal-occipital horn ratio approach20, which sums the distance between the widest
lateral walls of the frontal and occipital horns, divided by twice the widest biparietal diameter at
the level of the foramen of Monro. Reproducibility of FRONTAL-OCCIPITAL HORN RATIO
measures was established across groups using measurements made by two independent raters, with
inter-rater comparisons demonstrating a high degree of agreement (intraclass correlation
coefficient=.91; p<.001).
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3.4.7

Human Postmortem Brains Immunohistochemistry

Autopsy specimens from preterm neonates were obtained from the St. Louis Children’s Hospital
(SLCH) at the Washington University School of Medicine, St. Louis, Missouri, USA. The relative
age of these patients was estimated from the time of expected fertilization and recorded as
Estimated Gestational Age (EGA). Brain specimens were dissected from regions of the frontal
cortex containing the corpus callosum. Formalin-fixed tissues were paraffin-embedded, and 15 µm
sections were immunostained with H&E to assess cellular structure, edema and cellularity,
synaptophysin to assess axonal integrity and GFAP (1:300, catalog #7260, Abcam) to assess
astrocytes. To examine associations between PVWM and the subjacent ventricular (VZ) and
subventricular (SVZ) zones, the VZ/SVZ regions of adjacent slides were stained with H&E to
assess cytoarchitecture, double-label immunostained with 4’6-diamidino-2-phenylindole (DAPI)
(#D1306 Thermo Fisher Scientific) and GFAP to assess immature ependymal cells and reactive
astrocytes, and with DAPI and Iba1 (1:100, #PA5-18039, Invitrogen) as a surrogate for microgliaand macrophage-associated products. All slides were examined with fluorescence microscopy
using Nanozoomer-XR (Hamamatsu Photonics). Qualitative comparisons were confirmed by with
a neuropathologist. Percent VZ disruption was quantified as the cumulative length of the disrupted
ependymal regions as a factor of the entire length of VZ available on the same slide.

3.4.8

Statistical analysis

Statistical analyses were performed with R version 3.5.0 (The R Foundation, Vienna, Austria)500
and SAS version 9.4 (The SAS institute, Cary, NC). Normality of data was assessed with the
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Shapiro-Wilk test, which determined the use of non-parametric methods for all data analyses.
Descriptive statistics of clinical factors including gestational age at birth, postmenstrual age at
MRI scan, birth weight and clinical risk index scores

470

, as well as measured factors, including

frontal-occipital horn ratio and dMRI measures in the LVP, FOHP, CC, CST and OPRA were
obtained. Kruskal-Wallis one-way ANOVA was used to determine between groups differences.
Wilcoxon signed rank test was used to perform family-wise comparisons, and all resulting p-values
were corrected with Benjamini-Hochberg adjustment. Correlations between ventricular size and
dMRI measures were examined using Spearman’s rank-order correlations because the patient
groups correspond with disease severity (ordinal ranking). To examine group differences in dMRI
measures between the LVP and FOHP, a linear mixed effect model with a random patient intercept
was fit to each measure. Specifications of the model included a main effect of region (LVP and
FOHP), group (FT, VPT, HG-IVH and PHH) and region-by-group interactions with Bonferroni
correction. Given the reported effect of age on dMRI measures 238, postmenstrual age at scan was
set as a covariate in the linear model. Where Mauchly’s test of sphericity was violated,
Greenhouse-Geisser correction was used to adjust degrees of freedom for the averaged tests of
significance. Similarly, FT, VPT, IVH, PHH groups were compared for all DBSI measures with
Kruskal-Wallis test, followed by Wilcoxon Rank-Sum tests when Kruskal-Wallis was statistically
significant. frontal-occipital horn ratio was compared to DBSI scalars for non-linear association
with Spearman’s rank correlation test. Bonferroni-corrected p value <.050 was considered
statistically significant. Statistically significant results were further subjected to an ANCOVA
where number of voxels, number of diffusion directions, and laterality were set as covariates to
limit any potential confounding effects of those factors on the results.
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Chapter 4: N-cadherin cleavage mediates VZ disruption in PHH and PIH
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SM, and Limbrick DD. Blood Exposure Causes Ventricular Zone Disruption and Glial
Activation In Vitro. J Neuropathol Exp Neurol 2018. 77: 803-813
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Limbrick DD. Preterm Intraventricular Hemorrhage In Vitro: Modeling the Cytopathology
of the Ventricular Zone. Fluids and Barriers of CNS 2020. FBCN-D-20-00029R2.
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4.1

Introduction

In the previous chapters, we identified key biological processes central to the pathophysiology of
PIH and PHH in humans. In CSF, we observed transcriptomic and proteomic evidence of
neuroinflammation and ependymal barrier damage in the context of VZ and SVZ disruption. We
confirmed those findings in human brain parenchyma in vivo and ex vivo utilizing dMRI and
immunohistochemistry, respectively. We also related VZ/SVZ/ependymal disruptions and
neuroinflammation to PVWM injury. While our findings to date provide insights on relating
neuroinflammation and brain injury, we have not yet probed the pathogenesis of PIH and PHH.
Strong evidence demonstrates that proteins of adherens junctions help to form and preserve the
ependymal barrier. Of the four classical cadherins, neural cadherin (N-cadherin) is the most highly
expressed in the ependymal layer. In addition to mediating cell-cell adhesion, N-cadherins
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stimulate CDC42, which mediates apical-basal polarity of neuroepithelial cells and ciliogenesis
during VZ/SVZ differentiation and ependymal barrier formation. Like other cadherins, N-cadherin
is susceptible to disruption by metalloproteases. Specifically, our collaborators228,501,502 and several
others503-507 have shown that the metalloprotease ADAM10 mediates inflammation and cleaves
cadherins to regulate several epithelial cell pathologies including the lung and liver injury in S.
aureus sepsis, and in cancer. Therefore, we hypothesized that ADAM10-mediated cleavage of Ncadherin is associated with VZ disruption, and pharmacological inhibition of ADAM10 will
ameliorate this disruption and preserve ependymal integrity. We developed a novel in vitro
ependymal cell culture model of IVH and ventriculitis to characterize the effect of blood and
pathogens on N-cadherin during VZ differentiation while modulating ADAM10 activity.

4.2

Results

4.2.1

Characterization of in vitro VZ differentiation to mature ependymal cells

I describe details of our cell culture model in the Methods section. Briefly, in P0/P4 mice, we
harvested VZ cells from the perimeter of the lateral ventricles and modulated their proliferation
and differentiation in media. First, characterized normal ependymogenesis in our in vitro model to
establish a baseline for future comparisons and to determine the precise timing for inoculating the
cells with blood or pathogens. To evaluate differentiation, we immunolabeled cells against the cilia
marker βIV-tubulin, which allowed us to discriminate between multiciliated, monociliated, and
nonciliated VZ cells. To determine the stage of ependymal cells maturation, we used the glial
marker GFAP. Ependymal cells exhibit GFAP-positive attributes in early stages and become
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GFAP-negative with maturation.197,508-510 This approach permitted identification of six different
cell types: 1) cells not expressing GFAP or βIV-tubulin, 2) cells expressing GFAP but not βIVtubulin, 3) monociliated βIV-tubulin cells not expressing GFAP, 4) monociliated βIV-tubulin cells
expressing GFAP, 5) multiciliated βIV-tubulin cells expressing GFAP, and 6) multiciliated βIVtubulin cells not expressing GFAP. At this stage, we measured successful VZ differentiation by
the number and quality of multiciliated ependymal cells (mature ependyma) (Figure 41).

Multiciliated ependymal cells developed from monociliated cells in a time-dependent fashion,
comprising 3.73 ± 4.29%, 23.01 ± 7.56%, and 52.29 ± 11.07% (p < 0.001) of all viable cells at 3,
5, and 7 days after addition of differentiation media. Overall, the total number of cells changed
very little at the same time points (day 3: 42.80 ± 7.64, day 5: 42.78 ± 8.61, day 7: 44.31 ± 6.87)
after the initiation of differentiation. This observation indicates that cells were changing from
progenitor-like VZ cells to those that are typically found in the well-differentiated ependyma.
Double-labeling was performed against βIV-tubulin and GFAP took place at days 5 and 7, when
a significant number of VZ cells had differentiated to ependymal cells. We found no significant
increase in the percentage of GFAP-negative cells from among all multiciliated cells (day 5; 29.45
± 18.84, day 7; 35.37 ± 33.77). At both time points, over 60% of the ependymal cells remained in
a premature stage (still expressing GFAP). In addition, the total number of GFAP-positive cells
did not change over time (day 5: 72.78 ± 9.42, day 7: 73.61 ± 12.47) (Figure 39).
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Figure 39: Differentiation of VZ cells in vitro.
Differentiation of VZ cells in vitro. Representative images of VZ cells at different stages of
differentiation and maturation. (A) VZ cells undergo differentiation into multiciliated ependymal
cells from day 3 to day 7, as identified by cilia marker βIV tubulin. (B) Quantification of
percentage of multiciliated ependymal cells during differentiation. Data represent means of the
percentage of ciliated cells from two experiments with at least n=3 wells at days 3, 5 and 7,
respectively. (C) Expression of GFAP (green) in cultures of multiciliated ependymal cells
identified by βIV tubulin (red) at days 5 and 7. (D) Detail of double-labeling of GFAP and βIV
tubulin showing a mixed population of cells, including those not expressing GFAP or βIV tubulin
(1), expressing GFAP only (2), GFAP-negative monociliated cells (3), GFAP positive
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monociliated cells (4), GFAP-positive multiciliated cells (5) and GFAP-negative multiciliated
cells (6). Scale bars = 50 μm in A and C; 10 μm in D.

4.2.2

N-cadherin mediates cell-cell adhesion mediates in VZ development

The plasma membranes of all VZ cells contained N-cadherin-based adherens junctions. This
phenomenon probably contributed to the characteristic polygonal shape that occurred regardless
of whether the ependymal cells were less (day 5) or more (day 7) differentiated. Interestingly, the
ratio of N-cadherin to total number of cells (N-cadherin expression) initially declined from day 5
to day 6 (2.93 ± 2.41 vs. 2.11 ± 2.03, respectively; p>0.05). However, levels stabilized by day 7
(2.22 ± 1.87). This observation suggests a possible heightened requirement for this cell junction
protein during early stages of normal differentiation. Double-labeling with GFAP and N-cadherin
showed that the polygonal shape existed independent of GFAP expression, indicating that GFAP
may not affect N-cadherin expression. The glial projections of the GFAP-positive cells did not
express N-cadherin. (Figure 40)

Figure 40: Cell-cell junction and astrocytic expression of differentiating of VZ cells in vitro.
Representative images of VZ cells at different stages of differentiation and maturation. (A) Ncadherin-based cell-cell junctions, with characteristic membrane marker localization and
polygonal morphology at day 5 and 7. (B) Expression of N-cadherin (red) and GFAP (green)
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showing that the glial projections do not colocalize with cell-cell junctions (arrowheads) (B). Scale
bars = 50 μm.

4.2.3

Effective dose and time of blood administration required to elicit VZ disruption

VZ cultures were used to assess whether blood exposure elicits neuroepithelial and ependymal cell
loss and to determine the effective timing and dosage of blood needed to elicit the pathology. At
day 5 of differentiation, we exposed VZ cultures to syngeneic blood, and evaluated treatment
effects over time. Pilot experiments using 25 (2.5%), 30 (3%) and 40 µL (4%) determined the
amount of blood needed for this model. After three hours of 40-µL treatment, the number of total
cells and N-cadherin expression obviously decreased, preventing observations on the
cytopathology of IVH beyond this time. Treatment with 25 or 30 µL of blood permitted long-term
experiments because the model offered a sufficient and reliable number of VZ cells even after 48
h, similar to the human condition. (Figure 41)
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Figure 41: Time- and dose-dependent response of blood exposure to VZ cells in vitro.
(A) Three hours of 40 µL of syngeneic blood treatment dramatically decreased the number of total
cells and N-cadherin expression, precluding observations of IVH cytopathology beyond this time.
(B) Treatment with 25 or 30 µL of blood permitted long-term experiments because the model
offered a sufficient and reliable number of VZ cells even after 48 h, similar to the human condition.
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4.2.4

Blood disrupts VZ cytoarchitecture and differentiation in a time-dependent manner

Based on findings from our dose- and time-response experiments, we used 30 µL of blood
treatment for the remainder of the experiments. To characterize VZ disruption, we evaluated the
total number of cells, the percentage of ependymal cells and programmed cell death over time.
After 3 hours of phosphate buffered saline (PBS) control or blood treatment, we found no
differences in the total number of VZ DAPI-positive cells per 0.0225 mm2 (38.62± 11.47 vs.
42.78± 8.614). However, we observed a significant reduction of total VZ cells after 24 hours
(41.45± 5.62 vs. 32.08± 10.68 p<0.05) and after 48 hours (44.31± 6.87 vs. 26.94± 7.50 p<0.001)
of blood exposure. A similar effect occurred in multiciliated cells, as shown by changes in βIVtubulin signal. We observed was no change in multiciliated cells after three hours of treatment, but
we noted a decrease after 24 hours (control 31.07 ± 7.78 vs. IVH 11.84 ± 7.86 p<0.001) and after
48 hours (control: 52.29 ± 11.07 vs. IVH: 14.65 ± 8.49 p<0.001). We then calculated the
percentage of total cell loss (loss of DAPI-positive cells) after blood exposure and compared this
value with the percentage of ependymal cell diminution (diminution of multiciliated βIV-tubulinpositive cells) at three, 24 and 48 hours of blood treatment. After three hours, we observed
essentially no discrepancy between total cell loss and ependymal cell diminution (-2.92 ± 28.72 vs
-8.60 ± 24.84, respectively). However, after 24 hours, the ependymal cell diminution was twice as
high as total cell loss (-59.68% ± 25.10 vs. -27.12% ± 21.94, respectively; p<0.05) and even greater
after 48 hours (-85.16% ± 9.15 vs. -36.90% ± 23.98, respectively; p<0.001). These results
demonstrated that the ependymal cell loss exceeded total cell loss, suggesting that cell loss does
not solely control the decrease of the multiciliated ependymal cells after blood treatment. Indeed,
other factors, such as alterations in neuroepithelial cell/ependymal cell differentiation may
contribute to the diminution in ependymal cells following blood exposure (Figure 42).
136

Interestingly, immunohistochemistry against active caspase 3, a marker of apoptosis, showed no
change in caspase 3-positive cells at the same time points (control vs. blood at 3 h: 2.93 ± 0.70 vs.
3.39 ± 2.63; at 24 h: 3.72 ± 0.42 vs. 2.50 ± 2.80; at 48 h: 3.19 ± 1.00 vs. 1.823 ± 1.16). These
results suggest that programmed cell death did not affect cell loss following blood exposure
(Figures 41 and Figure 42).

Figure 42: Time-dependent effect of blood in VZ cell cultures.
After 5 days of differentiation, samples were analyzed at 3, 24, and 48 h of control (Cont) or blood
exposure. (A & C) Controls exhibit normal differentiation from NSC to ependymal cells with
significant increases in the percentage of βIV-tubulin multiciliated cells (C). (B) Blood exposure
significantly reduces both the total number of cells (DAPI-positive cells/0.0225 mm2) and (C) the
percentage of multiciliated cells at 24 h and 48 h. * p<0.05; **p<0.01; *** p<0.001. (D) Double
labeling with active caspase 3 (green) and βIV-tubulin (red) showed no difference in the number
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of apoptotic cells. (E) Blood exposure-dependent proportional change of total cells vs. ependymal
cells (EC). EC decrease was twice as high after 24 h and even greater after 48 h than the cell loss,
showing a significant discrepancy between total cell loss and the lack of EC. * p<0.05; ***
p<0.001. Data represent means of the percentage of ciliated cells from two experiments with at
least n=6 wells at 3, 24, and 48 h, respectively. Scale bars = 50 μm in all panels.

4.2.5

VZ disruption occurs in the setting of cell-cell adherens junction damage

To gain insights into the contributing factors in VZ disruption following blood exposure, the
integrity of the cell-cell junctions was examined with N-cadherin expression as a surrogate
measure. N-cadherin expression was quantified as a ratio of the number of N-cadherin positive
cells to total number of cells. After three hours of blood exposure, we found no changes in Ncadherin expression (control: 2.29 ± 2.40 vs. blood: 2.76 ± 2.37). After 24 hours, the N-cadherin
signal profile became fragmented, with loss of the typical lattice-like cell membrane expression
and appearance of abnormal subcellular cytosolic depositions. However, the total amount of Ncadherin was not significantly different when immunodensity ratios were quantified (control: 2.11
± 2.03 vs. blood: 2.06 ± 2.10). After 48 hours, the abnormal deposition and fragmentation persisted
along with significant loss of N-cadherin signal (control: 2.21 ± 1.87, blood: 1.12 ± 1.07; p<0.05;
Figure 42 A to C). Western blots confirmed significant reduction of N-cadherin signal by
measuring the N-cadherin/GAPDH ratio (median of control: 0.47 ± 0.17 vs. blood: 0.22 ± 0.03;
p<0.05) after 48 hours of blood treatment. (Figure 43)
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Figure 43: Time-dependent effect of blood in N-cadherin expression in the VZ.
(A) Representative VZ cultures after 48 hours of control (left) or blood exposure (right). Compared
to the prominent expression of N-cadherin (red) at the cell membrane in controls (arrows), Ncadherin expression was weaker and cytoplasmically dislocated after blood exposure (asterisk).
(B) High magnification of VZ N-cadherin labeling in which 3 hours after exposure to blood, no
changes were found in the expression of N-cadherin (red). However, after 24 h of treatment, the
expression of N-cadherin fragmented, with loss of the lattice-like configuration. After 48 hours,
there was fragmentation, dislocation from the cell membrane, and loss of N-cadherin expression.
(C) Quantification and comparison of N-cadherin expression between control and blood exposure,
normalized by the total number of cells. There was a significant decrease in N-cadherin expression
after 48 h of blood treatment (p<0.05). Data represent means of the immunodensity/cells from two
experiments with at least n=6 wells at 3, 24, and 48 h, respectively (C) and protein levels (Ncadherin/GAPDH) by western blot (* p<0.05). (D) Data were analyzed from two experiments with
n=4 per condition. Scale bars = 50 μm in all A panels and 10 μm in all B panels.
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4.2.6

Reactive astrocytosis (neuroinflammation) occur with VZ disruption

We also used GFAP immunolabeling to investigate astroglial differentiation following blood
exposure. The percentage of non-ciliated GFAP-positive cells did not change after 3 hours
(control: 49.44 ± 12.96 vs. blood: 45.94 ± 16.33) or 24 hours (control: 47.16 ± 17.33 vs. blood:
59.94 ± 13.53) but increased significantly after 48 hours of blood treatment (control: 47.10 ± 13.21
vs. blood: 79.63 ± 11.81; p<0.05). GFAP-expressing cells also demonstrated morphological
changes from 3 to 48 hours of blood exposure. In particular, GFAP-positive cells exhibited branchlike projections and a larger GFAP-positive cytoskeleton; at 48 hours, the GFAP-positive
processes appeared elongated, consistent with reactive astrocyte morphology. Treating cells with
blood for 48 hours increased the GFAP/GAPDH ratio as measured by western blot (median of
control: 1.99 ± 1.01 vs. blood: 4.75 ± 4.1; p<0.05), further supporting the findings above (Figure
44).
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Figure 44: Glial activation in the VZ.
(A) Representative VZ culture immunostained for GFAP (arrowheads) after 48 h of blood
treatment. (B) High-resolution images of cells double-labeled with βIV-tubulin and GFAP
antibodies after 3, 24, and 48 h of blood treatment vs. control. After 48 h treatment, most GFAPpositive cells exhibited numerous long, thin projections (arrowhead) typical of reactive astrocytes.
(C) Quantification of non-ciliated GFAP-positive cells. After 48 h treatment, the mean number of
cells expressing GFAP increased significantly (***, p<0.001). Data represent means from two
experiments with at least n=6 wells at 3, 24, and 48 h, respectively (D) GFAP protein levels
quantified by western blot and normalized to GAPDH showing increased levels of GFAP after 48
h of blood treatment (*, p<0.05; the filled circle is an outlier). Data were analyzed from three
experiments with n=4 per condition. Scale bars = 50 μm in all A panels and 10 μm in all B panels.
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4.2.7

ADAM10 inhibition abrogates N-cadherin cleavage and VZ disruption

Under physiological conditions, ADAM10 cleaves N-cadherin, yielding a soluble isoform of Ncadherin.511 In multiple organ systems, regulation of ADAM10 activity512-514 causes pathological
shedding of cadherins, resulting in loss of adherens junctions, damage to epithelium, or disruption
of endothelium.228,505,515. Importantly, the ADAM10 inhibitor GI254023X protects against
epithelial disruption.516 To examine the role of ADAM10 modulation in IVH, we treated VZ cell
cultures with either blood alone or blood+GI254023X (20 μM, Catalog #260264-93-5, SigmaAldrich, St. Louis, MO). Treatment of blood elicited similar findings as before, including
significantly decreased N-cadherin expression compared to DMSO vehicle-treated cells. However,
the addition of GI254023X partially preserved N-cadherin expression. Accounting for number of
cells, N-cadherin expression did not change between inhibitor-treated and vehicle-treated cells,
both of which showed higher expression than the blood-treated cells (Figure 45)

Figure 45: Effect of ADAM10 modulation on blood treated VZ cells.
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A significant decrease in N-cadherin expression is observed in blood-treated VZ cells after 48
hours when compared to DMSO (vehicle)-treated cells. Addition of the ADAM10 inhibitor
GI254023X preserved N-cadherin expression similarly to DMSO-treated cells.

4.2.8

Bacterial toxin causes VZ disruption that can be modulated by ADAM10

To determine if N-cadherin-mediated VZ disruption and astrogliosis contribute to PIH
pathogenesis and to examine the effects of ADAM10 modulation on VZ cytopathology in
ventriculitis, we treated VZ cell cultures with ⍺-hemolysin. ⍺-hemolysin, the most cytotoxic
pathogen secreted by Staphylococcous aureus, commonly causes hydrocephalus-related
infections. In addition, mounting evidence suggests that ADAM10 carries a selective epitope
activated by ⍺-hemolysin during systemic S. aureus infection. This epitope activation leads to
cadherin cleavage and epithelial barrier disruption.512-514,516 Therefore, following differentiation,
we separated equivalent numbers of wells containing VZ cell-mounted coverslips into three
groups. Treatments included DMSO, 15 µg/mL of α-hemolysin, or 15 µg/mL of αhemolysin+GI254023X. We cultured the cells for a total of 3.5 hours following suspension.
Treatment with α-hemolysin severely reduced N-cadherin expression. In addition, GI254023X
treatment preserved N-cadherin structure, similar to DMSO. (Figure 46)
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Figure 46: Effect of ADAM10 modulation on toxin treated VZ cells.
Compared to the VZ cells of controls (A & D) treated with DMSO, those treated with (B & E) αhemolysin was associated with severely reduced N-cadherin expression and higher GFAP signal.
However, addition of (C & F) GI254023X to α-hemolysin-treated cells was associated with
preserved N-cadherin structure. (Right panel) The box and whisker plot demonstrate the relative
intensity of N-cadherin as a ratio of the total number of cells per well was lowest with the addition
of α-hemolysin when compared to control DMSO-treated cells. Addition of GI254023X in the
setting of α-hemolysin preserved the relative N-cadherin intensity, to levels similar to that of
controls. *** p<0.001.

4.3

Discussion

4.3.1

Summary of findings

In summary, we showed that exposing VZ cells to blood or a bacterial toxin triggers a timedependent chain of events starting with the dislocation of N-cadherin. This dislocation impairs
differentiation and induces loss of ependymal cells, culminating in reactive astrocytosis (Figure
49). The findings provide a mechanistic basis for PIH and PHH pathogenesis in support of our
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findings from previous chapters. Furthermore, results from existing literature on human and animal
models of hydrocephalus support our findings.171,172,175,176,178,183,197,215,216,223,517,518

Figure 47: Model summarizing the effects of the blood on the VZ.
During maturation, neural stem cells (NSC) with adherens junctions transform into multiciliated
ependymal cells (EC). Blood exposure produces a time-dependent chain of events starting with
the dislocation of cell junctions (N-cadherin) from the cell membrane into the cytoplasm and loss
of multiciliated cells. Subsequently, glial activation occurs, as evidenced by astrocytes with
numerous processes. In vivo observations suggest that glial activation occurs at the site of VZ
disruption.

4.3.2

The in vitro model mimics normal human VZ differentiation

Our murine in vitro model recapitulated the normal VZ cell differentiation that occurs across
species. In rats, differentiation of the dorsolateral wall of the lateral ventricle takes place
postnatally. At postnatal day one, the VZ comprises approximately 70% neural stem cells, 23%
non-ciliated cells and 7% multiciliated ependymal cells. Neural stem cells then differentiate into
multiciliated ependymal cells. However, the percentage of non-ciliated cells remains constant.518
A similar pattern of postnatal ependymal maturation occurs in mice.519 In humans, ependymal cell
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maturation occurs earlier in intrauterine life, and multiciliated ependymal cells appear in the
dorsolateral wall from 23-40 gestational weeks.197,518,520 To model the clinical timeline of VZ
development as closely as possible, we performed our experiments during the stage of
differentiation between in vitro days five and seven, when the cultured cells progressed from
approximately 20% to 55% multiciliated ependymal cells. During this time, the VZ also exhibited
preterm human-like features such as the presence of undifferentiated monociliated cells with or
without expression of GFAP, immature multiciliated ependymal cells expressing GFAP (~65% of
all ependymal cells), and mature ependymal cells not expressing GFAP (~35%). The presence of
monocilia characterizes neural stem cells123, and GFAP marks astrocytes and immature ependymal
cells. Thus, monociliated cells failing to express GFAP may belong to another lineage of stem
cells not committed to microglia.

4.3.3

N-cadherin cleavage underlies the cell-cell junction pathology in VZ disruption

Cell junction pathobiology may mediate VZ disruption in clinical and experimental
hydrocephalus.171,175,176,216-220,521 In areas of VZ disruption, N-cadherin localizes to the cytoplasm
rather than binding to the cell membrane.518 Furthermore, many genetic alterations directly or
indirectly

affecting

cell

junction

stability

associate

with

VZ

disruption

and

hydrocephalus.174,183,216,522,523 The blood component lysophosphatidic acid (LPA) also alters cell
junctions, disrupts VZ cytoarchitecture, and produces hydrocephalus.215,223 These authors noted
VZ disruptions in both the lateral ventricles and the cerebral aqueduct and therefore suggested that
aqueductal stenosis produced ventriculomegaly in their rodent model. Our in vitro IVH model
corroborates these well-known cell junction alterations; we observed dislocation of N-cadherin
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after 24 hours of blood treatment and significantly decreased expression of N-cadherin after 48
hours of treatment. Adherens junctions mediate VZ cell attachment. Therefore, impairment of
these junctions results in detachment and loss of those cells. Because cell junctions appear
fundamental to the genesis of cytopathology in many forms of hydrocephalus, modulators of those
molecules such as metalloproteases should play a role in the etiology of PIH and PHH.

4.3.4

ADAM10 Inhibition abrogates N-cadherin cleavage and VZ disruption

ADAM10 cleaves more than 40 transmembrane proteins in the extracellular region,524 most of
which are cell adhesion proteins including L1-CAM,525 E-cadherin, and N-cadherin (reviewed in
526

). ADAM10 activation disrupts lung epithelial cells in mice,228 presenting a pattern of cadherin

alteration similar to what we observed in our in vitro model. Interestingly, our group previously
reported that many of the proteins cleaved by ADAM10 such as amyloid precursor protein and
L1-CAM show increased levels in the CSF of both congenital hydrocephalus and PHH.246,249,527,528
In our model, exposure of VZ cells to the ADAM10 agonist α-hemolysin enhanced the activity of
ADAM10 and triggered VZ disruption by cleaving N-cadherin. Perhaps more importantly, we
prevented VZ disruption after both α-hemolysin and blood induction by using the ADAM10
inhibitor GI254023X. These observations support the potential for this inhibitor, or perhaps other
metalloprotease inhibitors, to have important direct therapeutic implications. However, future
studies need to rigorously examine pharmacological inhibition of ADAM10 as a potential
therapeutic strategy for preventing the development of PIH and PHH.
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4.3.5

Reactive astrocytosis (neuroinflammation) occurs at the site of VZ disruption

The in vitro model also resulted in fewer total VZ cells after 24 hours of treatment with blood or
bacterial toxin, possibly due to loss of adherens junctions. Interestingly, we observed fewer
multiciliated cells at 24 and 48 hours, suggesting that those cells may be more affected by this
detachment. However, the percentage of VZ cells lost was not proportional to the percentage of
ependymal cell diminution. We found that ependymal cells decrease twice as much as observed
cell loss, indicating that factors other than cell loss contribute to ependymal cell absence. Also,
impaired ependymal cell differentiation appears to take place, probably due to the aforementioned
blood- or pathogen-dependent N-cadherin effects. This observation is consistent with the findings
reported by Muniz-Talavera and Schmidt (2017)529 where mutant mice lacking the junctional
cadherin complex regulator (Jhy) showed protracted ependymal cell differentiation and developed
hydrocephalus. In both human and animal cases, VZ disruption relates to glial activation by
possibly forming a new layer to specifically repair the disrupted area.133,171,517 Our experimental
model corroborates this theory by displaying a significant increase in the number of GFAP-positive
cells at 48 hours and by exhibiting multiple projections reminiscent of a reactive astroglial
response. This glial response occurred 24 hours after disruption of N-cadherin, and we detected
loss of multiciliated cells, indicating that this reaction may respond to cell junction impairment
and VZ cell loss. These alterations seem to promote neural stem cell differentiation into reactive
astrocytes, even though these stem cells originally committed to an ependymal cell fate. This
altered program of VZ differentiation also explains the discrepancy between cell loss and
ependymal cell differentiation. Glial activation, especially the addition of branched processes,
influences the overall decrease of N-cadherin levels found after 48 hours of blood treatment
because glial projections do not express this junction protein.
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4.4

Materials and Methods

4.4.1

Animals and surgery

All animal procedures were approved by the Institutional Animal Care and Use Committee
(IACUC) of the Washington University School of Medicine. C57BL/6 mice at P0 to P4 were used.
Each pup was exposed to wet ice for approximately 2 minutes until circulatory arrest, then
sacrificed by removing the head and gently stripping the scalp. The brain was removed through a
combination of a lateral incision from the foramen magnum toward the external auditory canal (~3
mm) and a superficial sagittal incision from the foramen magnum all the way through the midline;
incisions were made using Metzenbaum scissors. The frontal and parietal bones were then
removed with curved surgical forceps. The brain was then deposited in a Petri dish with ice cold
Hank’s Balanced Salt Solution (HBSS), 1% PSA. Under a stereomicroscope, both hemispheres,
the brainstem, and the olfactory bulbs were dissected by cutting in the midline using a single edge
razor blade. The medial hemispheric side was positioned superiorly; using ultrafine forceps, one
tip was introduced into the lateral ventricle in an anteroposterior direction all the way through the
ventricle until reaching the parahippocampal gyrus. The opposite tip of the forceps was kept in a
ventral position and closed completely leaving the hippocampus and the thalamus over the forceps
and the lateral wall underneath. With a single twist of the wrist, the hippocampus and thalamus
were removed from the lateral wall. The meninges were then stripped off.
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4.4.2

Ventricular zone cell cultures

Cells were dissociated with an enzymatic digestion solution (17 µL of Papain #37A17241,
Worthington, Lakewood, NJ; 15 µL of DNAse, #EN0521, Thermo Fisher Scientific, Waltham,
MA; and 288 µg of L-Cysteine, #C7352, Sigma, Saint Louis, MO in 1 mL of DMEM (Dulbecco's
Modified Eagle Medium)/Glutamax) per brain for 1 h. Dissociated VZ cells were plated into 25
cm2 flasks and grown in proliferation media composed of DMEM/Glutamax supplemented with
10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (P/S) at 37 °C to select for
ependymal cells as described by Delgehyr et al. (2015). Half of the media was replaced the
following day. After the cultures were confluent (~4 days), the flasks were shaken at 250 rpm
overnight at room temperature to remove weakly attached cells, which were mainly differentiated
neurons. The remaining cells were rinsed with Ca2+/Mg2+-free PBS and incubated for 5 minutes at
37 °C with 1 mL of trypsin-EDTA (ethylenediaminetetraacetic acid) to detach them from the flask.
These cells were resuspended in proliferation media and re-plated onto 12 mm diameter round
glass coverslips in 24-well plates. The cell suspension (20 µL of 2x106 cells/mL) was carefully
placed onto the coverslip and incubated for 1 h, allowing the cells to adhere at high density, after
which 1 mL of the proliferation media was added to each well. The following day,
DMEM/Glutamax supplemented with 1% P/S (differentiation media) was used for continued
culture; cells progressively differentiated from neural stem cells to ependymal cells in this media.
519
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4.4.3

Alpha hemolysin and whole blood induction

Five days after differentiation was initiated, the VZ cells were submerged in either non-heparinized
whole blood (collected using orbital sinus puncture530 on animals within the same colony) or,
alternatively, in α-hemolysin. All samples were held at 4 °C for less than 5 minutes. Cells on
coverslips were treated with 25, 30, or 40 µL of blood or 15 µg/mL α-hemolysin with or without
the ADAM10 inhibitor GI254023X (#260264-93-5, Sigma-Aldrich, St. Louis, MO) for a total of
3, 24, or 48 h in the pilot dose-response experiment. This experimental group was compared to
control coverslips that were submerged in PBS under similar conditions. Subsequently, timerelated experiments were performed comparing exposure of cells to 30 µL of PBS, blood, or αhemolysin for 3, 24, or 48 h.

4.4.4

Immunohistochemistry and cellular imaging

At 3, 24, and 48 h after treatment, the coverslips were washed three times with PBS and fixed with
4% paraformaldehyde (PFA) in PBS for 7 minutes. After washing again in PBS, the cells were
permeabilized with 5% bovine serum albumin (BSA) in PBS and 1% Triton X-100 for 1 h;
subsequently the cells were incubated for 2 h with antibodies diluted in PBS supplemented with
0.1% Triton X-100. Antibodies and dilutions included: N-cadherin (#180224, Thermo Fisher
Scientific, Waltham, MA), 1:25; GFAP (#7260, Abcam, Cambridge, MA), 1:300; βIV tubulin
(#11315, Abcam, Cambridge, MA), 1:100; and active caspase-3 (#AF835, Novus Biologicals,
Littleton, CO), 1:100. After rinsing three times with PBS, the coverslips were incubated for 1 h
with the appropriate secondary antibody and diluted in PBS supplemented with 0.1% Triton X151

100. Secondary antibodies included goat anti-mouse Alexa fluor 488 (#A11001, Thermo Fisher
Scientific, Waltham, MA), goat anti-rabbit Alexa fluor 488 (#A11034, Invitrogen, Carlsbad, CA)
at 1:300 or goat anti-mouse Alexa fluor 555 (#AQ21422, Thermo Fisher Scientific, Waltham, MA)
at 1:300. Lastly, the cells were stained with DAPI at 1:5000 in PBS (#D1306, Thermo Fisher
Scientific, Waltham, MA) for 5 minutes to label cell nuclei. Images of immunostained tissue were
obtained using Pascal confocal microscopy at 20X (0.50 Zeiss, Oberkochen, Germany) and 63X
(1.4 Zeiss, Oberkochen, Germany). Leveraging the National Institute of Health’s ImageJ software,
we created an in-house script that quantified cell variations (total cells, number of cells expressing
specific proteins, and immunodensity) in areas of 0.0225mm2. (Supplementary Figure 6).

Supplementary Figure 6. ImageJ quantification of VZ cells of interest
Representative image (screenshot) of in-house script (A) incorporated into ImageJ for the
quantification of cells of interest. By selecting an area of 0.0225mm2 (A), the cells of interest, in
this case DAPI-positive (blue) cells are recognized (B). Cells in focus within the same plane are
automatically selected (C), demarcated (yellow circles), and quantified. Quantification measures
include total number of cells expressing the proteins of interest and their mean immunodensity.
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4.4.5

Western Blot

After 48 h of treatment, the cells were rinsed with PBS and then treated with 50 µL of
radioimmunoprecipitation assay (RIPA) buffer (#R0278 Sigma, Saint Louis, MO) to homogenize
the cultures. Proteins were denatured in lithium dodecyl sulfate (LDS) sample buffer (NP0007,
Invitrogen, Carlsbad, CA) and reduced using β-mercaptoethanol (#M7154, Sigma, Saint Louis,
MO). After heating at 95 °C for 5 minutes, each 30 μL sample was run on an SDS-PAGE gel (412% polyacrylamide) (#NP0321, Invitrogen, Carlsbad, CA) for 1 h at 120 V in SDS running buffer
(#NP0001, Novex, Carlsbad, CA). The proteins were then blotted onto a nitrocellulose membrane
(#LC2006, Novex, Carlsbad, CA) at 170 mA for 2.5 h in 15% methanol transfer buffer (#NP0006,
Novex, Carlsbad, CA). After blocking for 1 h in Tris buffered saline (TBS) with 5% powdered
milk, samples were incubated with primary antibodies in TBS and 0.1% Tween (TBST) at 4 °C
overnight. Primary antibodies and dilutions were GFAP (#7260, Abcam, Cambridge, MA),
1:1000; N-cadherin (#180224, Thermo Fisher Scientific, Waltham) 1:50, and GAPDH (#2118S,
Cell Signaling Technology, Danvers), 1:500. Detection was performed by enhanced
chemiluminescence (#7003, Cell Signaling Technology, Danvers, MA) after 1 h of incubation with
horseradish peroxidase-conjugated anti-rabbit (#70742, Cell Signaling Technology, Danvers,
MA), 1:10,000 or anti-mouse (#SC-2005, Santa Cruz Biotechnology, Dallas, TX), 1:5,000.
Western blot images were taken with the molecular imager ChemidocTM XRS+ using Image LabTM
3.0 from BioRad (Hercules, CA).
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4.4.6

Statistical analysis

One-way ANOVA followed by the Tukey post-hoc test or the Student’s t-test were used for
parametric data and a Mann-Whitney U test was used for non-parametric data. Results were
considered statistically significant if p < 0.05. Data are presented as group medians (nonparametric) or means ± SD (parametric) and were considered statistically significant at p < 0.05.
All analyses were conducted using Prism 5 (Graphpad software company, San Diego, CA).
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5

Chapter 5: Development of in vivo models of PIH and PHH

Adapted from:
1. McAllister JP, Castaneyra Ruiz L, Morales D, Isaacs AM, Ge X, Hartman A, Crevecoeur
T, Brown J, Engelbach J, Talcott M, Baksh B, Garbow J, Bayly P, Limbrick DD.
Development of a Novel Model of Intraventricular Hemorrhage and Post-Hemorrhagic
Hydrocephalus in Infant Ferrets. (In preparation)
2. Isaacs AM, Castaneyra Ruiz L, McAllister JP, Wu Y, Hamilton M, Yang R, Morales D,
Dunn J, Limbrick DD. Intraventricular Injection of Gram-Positive Bacterial Toxin as a
Mouse Model of Post-infectious Hydrocephalus. (In preparation)

5.1

Introduction

While cell cultures are ideal for testing disease mechanisms and manipulating biological processes
in a controlled fashion, they are not able to provide a complete physiological environment of an
intact organism. Therefore, we anticipate our future work beyond this thesis will require the use
of in vivo animal models, not only to establish the mechanisms we have identified in vivo but also
as a foundation for preclinical drug studies and easier translation into FDA–approved clinical
trials. Our primary objective was to create animal models of PHH and PIH that mimic the human
disease characterized by VZ disruption, impairment of neural stem cells differentiation, ependymal
denudation, and neuroinflammation occurring in the setting of IVH or infection.
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For PIH, we developed a mouse model because their small size, relatively cheaper cost, ease of
handling, and availability of transgenics make them more feasible for a disease with very limited
information on previous experimental models. On the other hand, PHH has many existing
experimental models including mice531,532, rats372,533-536, rabbits384,537-540, cats541, dogs378,542-548,
sheep378,542-548, and piglets379,380,549,550. Nevertheless, we developed a novel ferret model to
circumvent some of the major limitations of the existing models. Unlike the lissencephalic cerebral
cortex of rodents, ferrets have a gyrencephalic brain that is similar to a human brain, providing
investigators with access to very early stages of neural development551. Particularly important for
the investigation of preterm IVH, ferret brain maturation at birth is equivalent to the human brain
during the early second trimester552. Their smaller size in comparison to other USDA-covered
species makes them relatively easier to handle and cost-effective.

5.2

Results

5.2.1

Ferret model of PHH

5.2.1.1 Subjects

Thirty-two ferret kits (ages 14-21 days old) were included in this study. Five intact controls did
not undergo any surgery. Stereotactic intraventricular injection was performed in 4 sham PBS
induction controls, 13 autologous blood inductions, and 10 syngeneic lysed blood inductions.
Variations in age of induction, which occurred due to logistical challenges, were factored into
future analyses. (Table 9)
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Table 9. Summary of ferrets used in the development of an animal model of PHH

Days Postinduction

Injection Site

F19
44
Bilateral
F20
44
Bilateral
F21
44
Bilateral
F26
6
Unilateral
F27
23
Bilateral
F28
52
Unilateral
F29
52
Unilateral
F30
52
Unilateral
F31
35
Unilateral
F32
35
Bilateral
F33
35
Unilateral
F34
35
Bilateral
F36
28
Unilateral
* Calculated post-induction age based on induction at 20 days of age.

Syngeneic Blood

ID

Bilateral
Bilateral
Bilateral
Bilateral

Injection Site

48
48
48
48

Days Postinduction

F22
F23
F24
F25

Autologous Blood

ID

NA
NA
NA
NA
NA

Injection Site

Injection Site

29
121
7
44
54

Days Postinduction

Days Postinduction*

F3
F4
F8
F17
F35

Sham Control

ID

ID

Intact Control

F38
F39
F40
F42
F43
F44
F45
F63
F64
F66

28
28
28
28
28
28
28
22
22
22

Bilateral
Bilateral
Bilateral
Bilateral
Bilateral
Bilateral
Bilateral
Bilateral
Bilateral
Bilateral

5.2.1.2 Neurological Status and Health

None of the ferret kits developed post-operative neurological deficits or signs of discomfort. Jills
consistently provided normal maternal care and nourishment. Early in the study, one jill removed
the skin sutures within an hour after surgery; this experience prompted us to carefully place single,
interrupted subcuticular sutures and to cover the incision with skin glue. Subsequently, no incisions
were opened by the jill in the remaining cases. Except for the expiration of one kit at the end of an
MRI scan, probably from a thermoregulatory impairment, all kits recovered well after
neuroimaging. All groups exhibited body weight increases along a similar growth curve (Figure
48C).
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5.2.1.3 Ventriculomegaly

The extent of ventriculomegaly was variable within and among induction groups, with a clear trend
toward more frequent and more severe ventricular enlargement occurring in kits that received
syngeneic lysed blood compared to those receiving autologous blood. The volume of syngeneic
lysed blood injected into each lateral ventricle (150-250 μL) was considerably higher than the
amount of autologous blood delivered (10-50 μL). The pattern of ventriculomegaly was quite
consistent, with much greater enlargement of the occipital and temporal horns of the lateral
ventricles compared to the frontal horns. Often ventriculomegaly was asymmetric even though
equal volumes of blood were usually injected into both frontal horns. Unilateral injections rarely
produced bilateral ventriculomegaly (Figure 48).

Figure 48. Ventricular enlargement in ferret a model of PHH
(A) Representative T2-weighted coronal MRI images illustrating ventricular size in an intact
control (animal F035) and (B) following bilateral intraventricular injection of syngeneic blood
(animal F050). Selected images are viewed with the animals’ left corresponding to the reader’s
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left, arranged from anterior (left) to posterior (right) in each row and aligned at approximately the
same coronal plane. Note the extremely small size of the frontal (FH) and temporal (TH) horns of
the lateral ventricles in the control ferret (A). Following blood injections (in this case, 9 days), the
occipital (OH) and temporal (TH) horns of the lateral ventricles expanded dramatically, and a CSF
flow void (hypointense signal) was apparent in the cerebral aqueduct (CA). The needle trajectory
for injecting blood is drawn with a dashed line in (B). (C) Line plot depicting the progression of
mean body weights for each experimental group up to 25 days post-induction. All groups followed
similar growth curves, although the PBS-injected sham controls were lighter (non-significantly),
probably because they were selected for less traumatic procedures due to their lower initial
weights. (D) Bar plot depicting ventricular volumes for the controls (intact and sham) and bloodinduced (autologous and syngeneic) groups. While the ventricular volume of the blood injected
group was much greater than the control group, the difference was not statistically significant due
to large within-group variation.

5.2.1.4 VZ disruption and glial activation (neuroinflammation)

Histological and immunohistochemical methods confirmed the patterns of ventriculomegaly
detected with MRI and, importantly, revealed VZ disruption neuroinflammation. The pattern of
VZ disruption was quite similar to our observations in preterm humans with IVH and PHH197 and
with in vitro studies of maturing ependymal cells318, namely loss of ciliated ependyma, eruption
of VZ cells into the lateral ventricle, loss or spatial rearrangement of N-cadherin adherens
junctions, and the appearance of reactive astrocytes in the areas of VZ disruption. These
impairments, found as early as nine days following blood induction, were found throughout the
lateral ventricle, but seemed more frequent and prominent in the occipital and temporal horns
where the ventricular enlargement was greatest. It is important to note that the pattern of
cytopathology we observed occurred in all animals that had been injected with blood regardless of
the extent of ventriculomegaly (Figure 49).
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Figure 49: Immunohistochemistry in a ferret model of PHH
Representative photomicrographs comparing astrocyte (GFAP), ependymal cell cilia (βIV
tubulin), adherens junction (N-cadherin) proteins, and a known modulator of N-cadherin
(ADAM10) in the temporal horn (LVt) of PBS-injected control (A,C,C’,E,E’) and blood injected
IVH (B,D,D’,F,F’) ferrets. (A & B) In H&E-stained sections, the monolayer of ependymal cells
(Ep) is much thinner in IVH and contains a prominent area of disruption (*). (C/C’&D/D’) Viewed
at low (C & D) and high (C’ & D’) magnification, IVH is associated with a conspicuous reduction
in βIV tubulin-positive cilia, and the disrupted area contains numerous reactive GFAP-positive
astrocytes. (E/E’ & F/F’) Likewise, in IVH there is a reduction in N-cadherin-positive (Ncad)
adherens junctions and a conspicuous increase in ADAM10 immunostaining. Taken together,
these results demonstrate that ventricular zone disruption and reactive astrocytosis are associated
with IVH, even in mild forms of ventriculomegaly. (G) Box and whisker plots of the mean
immunodensity of N-cadherin and ADAM10 in the ventricular wall of control and IVH/PHH
ferrets. The decrease in N-cadherin expression and the increase in ADAM10 expression are both
statistically significant, suggesting a causative role for ADAM10 in the ependymal disruption that
occurs in PHH. Additional abbreviations: CP – choroid plexus; GFAP – glial fibrillary acidic
protein.

Lateral to the VZ/SVZ, the PVWM contained many more GFAP-positive astrocytes compared to
controls, and most of these cells had the classical appearance of reactive astrocytes, suggesting
neuroinflammation in the setting of VZ/SVZ disruption in the blood-treated group (Figure 50).

160

Figure 50. Reactive astrocytosis in a ferret mode of PHH
Representative histological and immunohistochemical images (of increasing magnification from
A-C) comparing VZ and periventricular white matter region cytology in control and blood-injected
ferrets. GFAP-positive reactive astrocytes cluster at the areas of ependymal denudation. LVlateral ventricle

5.2.1.5 Diffusion Basis Spectrum Imaging of ferrets

The brains of 13 age- and weight-matched female ferrets, including 7 blood-injected (IVH/PHH
group) and 6 PBS-injected (Control group), underwent ex-vivo DBSI scans following sacrifice at
~50 days old. The corpus callosum (CC) and bilateral anterior limbs (ALIC) and posterior limbs
(PLIC) of internal capsules were demarcated as regions of interest (ROIs). DBSI measures were
extracted from the ROIs. The IVH/PHH group exhibited a 50% proportional increase in nonrestricted fractions within the PVWM compared to controls (p=0.001) reflecting PVWM edema.
However, 68% of this change was due to an increase in the hindered fraction (p<0.0004), implying
that there was a component of increased cellularity in the PVWM, which would suggest
inflammation. The proportional increases in non-restricted and hindered fractions in the CC were
96% (p=0.002) and 120% (p=0.0006), respectively, and 49% (p=0.0006) and 51% (p=0.0005) in
the ALIC, respectively. There was no significant change in the PLIC. Assessing intrinsic PVWM
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injury, the CC and ALIC appear to sustain the most impact from PHH. This is evident as their
respective fiber density proportionally decreased by 7% (p=0.007) and 10% (p=0.03). In addition
to axonal fiber loss, the ALIC also demonstrated evidence of axonal injury by a decrease in axial
diffusivity of 8% (p=0.008) when compared to controls. While similar trends were observed in the
PLIC, none were statistically significant. (Figure 51)

Figure 51. Periventricular white matter dMRI characteristics in a ferret model of PHH
Proportional change in mean Diffusion Basis Spectrum Imaging (DBSI) of intraventricular
hemorrhage and posthemorrhagic hydrocephalic (IVH/PHH) from control ferrets in three white
matter tracts: corpus callosum (CC) and bilateral anterior limbs (ALIC) and posterior limbs (PLIC)
of the internal capsules. In the CC and ALIC, there was an approximately 50-90% increase in the
non-restricted fraction, reflecting PVWM edema in the IVH/PHH group. At the same time, there
was over a 100% increase in the hindered fraction, reflecting increased cellularity, typically as a
result of inflammation, contributed to the edema. No significant changes were observed in the
PLIC. ★ p< 0.05. Abbreviations: MA – mean diffusivity, FA – fractional anisotropy, AD – axial
diffusivity, FF – fiber fraction, RF – restricted fraction, NRF – non-restricted fraction, HF –
hindered fraction.
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5.2.2

Mouse model of PIH

5.2.2.1 Neurological status and health
Of 23 mice, 14 underwent bilateral intraventricular injection of ⍺-hemolysin (⍺-hemolysin group)
and 9 received PBS (Control group). There was no difference in pre-induction weights between
groups (p=0.66). There was a steep learning curve during the development of the model, as there
was no existing literature to guide the concentration and volume of ⍺-hemolysin that would yield
the desired endpoint (hydrocephalus). Injection of 25 µL/ventricle in the first cohort (5 controls
and 5 ⍺-hemolysin) had unacceptably high mortality (80-90%), with the ⍺-hemolysin-injected
mice dying within hours of surgery. The majority of control mice in that cohort died within 24-48
hours of injection, suggesting there was also a volume effect, perhaps causing delayed intracranial
hypertension, hydrocephalus, and death. Therefore, the volume was reduced for subsequent
injections. Further volume response trials showed that injections of 2-2.5 µL/ventricle was ideal,
as they did not cause any issues in the control mice. Additionally, ⍺-hemolysin injection at that
volume yielded hydrocephalus in 50% of the animals without acute issues.

5.2.2.2 Ventriculomegaly
For dose response trials, three concentrations of 𝜶-hemolysin were tested: low (27.4 µg/mL),
medium (54.8 µg/mL), and high (91.3µg/ml) doses. Likely due to technical reasons, early (<48h)
mortality rates in the low and high dose were similar (~15%), whereas mice in the medium dose
had no change in mortality. Neuroimaging was obtained 7 days after surgery. Approximately 50%
of mice developed hydrocephalus to varying severity of ventriculomegaly. However, there were
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no significant differences in ventricle size between the animals receiving different doses of ⍺hemolysin (p=0.403). The mice receiving medium and high doses mice did demonstrate significant
white matter T2W hyperintensity suggestive of inflammation/edema (Figure 52).

Figure 52. Ventricular enlargement in a mouse model of PIH
Representative T2W coronal images of mice undergoing bilateral intraventricular injection of PBS
(control) and low (27.4 µg/mL), medium (54.8 µg/mL), or high (91.3µg/ml) doses of α-hemolysin
at 2.5 µL/ventricle. Note the Hamilton syringe needle tract on the left (red dotted arrow). All α hemolysin-injected mice developed hydrocephalus as compared to the ventricular size of the
controls. However, there was significant white matter hyperintensity observed in the medium and
high dose mice in comparison to the hypointense signal seen in the low dose and control mice
(blue solid arrow).

5.2.2.3 VZ disruption and reactive gliosis (neuroinflammation)

Immunohistochemistry confirmed the pathology detected with MRI, revealing ependymal
denudation and astrogliosis (neuroinflammation). The pattern of ependymal disruption
recapitulated our observations in preterm humans, in in vitro studies of maturing ependymal cells
in both the blood and ⍺-hemolysin-treated cells, and in our ferret model of IVH/PHH. These
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findings provide further evidence that ependymal disruption and neuroinflammation are an
underlying pathophysiology that is common to PIH and PHH (Figure 53).

Figure 53: Immunohistochemistry in a mouse model of PIH
Representative photomicrographs comparing astrocyte (GFAP) and ependymal cell cilia (βIV
tubulin) in (A-C) non-disrupted and (D-F) disrupted regions of mice injected with intraventricular
α -hemolysin. Cell nuclei are stained with DAPI. Viewed at low (A & D), medium (B & E), and
high (C & E) magnification, the disrupted regions showed a conspicuous reduction in βIV tubulinpositive cilia and contained numerous reactive GFAP-positive astrocytes. These results
demonstrate that ventricular zone disruption and reactive astrocytosis are associated with PIH.
GFAP – glial fibrillary acidic protein.
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5.3

Discussion

5.3.1

Prevalence and time course of ventriculomegaly in PIH and PHH models

Our observations indicate that the progression of PHH and PIH begin with periventricular edema
followed by expansion of the lateral ventricles. In the mouse PIH model, animals that were scanned
within 24 hours of surgery demonstrated diffuse white matter hyperintense T2W signal suggestive
of edema. However, those that made it to 7 days to be scanned had developed much larger
ventricles compared to their initial perioperative scans. In the PHH ferret model, ventriculomegaly
typically occurred 10-15 days post-induction. Occasionally, ventriculomegaly occurred abruptly
and severely within 7-10 days post-induction. The frequency of ventriculomegaly in both the PIH
and PHH models was approximately 30% to 50%, which is similar to those reported in other
species 379,553,554 and quite consistent with the incidence of PIH and PHH in human neonates who
develop sepsis or IVH11,38,44,240,555. Thus, both the mice and ferret models appear to mimic the
clinical occurrence of PIH and PHH. This feature also raises the pertinent and unanswered question
of why some humans and animals do not develop ventriculomegaly after neonatal sepsis or IVH.

5.3.2

Cytopathology

Ependymal disruption in both models were characterized by ependymal cell denudation, loss of
motile cilia, and accumulation of reactive astrocytes, possibly in the same location as ependymal
alterations. In the ferret model, we also observed lost or spatial translocation of N-cadherin from
the cell membrane to the cytoplasm in addition to lost or misdirected radial glial cells. These
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features are consistent with those observed in human preterm infants182,197,556,557 and rabbits558,559
with IVH/PHH as well as rodents with congenital hydrocephalus182,183,560. Furthermore, a glial
response similar to reactive astrocytosis occurred in the ependyma and the PVWM. This finding
matches a growing line of evidence from in vitro and in vivo models of IVH/PHH, as well as the
observations from ferret kits receiving intracisternal injections of kaolin to induce obstructive
hydrocephalus561.

5.3.3

Surgical and Methodological Considerations

Several important lessons were learned during the development of the animal models. For the
mouse model, the main issues we encountered, which were later overcome, were related to finding
the optimal dose and volume to achieve ventriculomegaly without acute death. There remains the
limitation of bypassing the normal routes of human infection that lead to PHH when the
intraventricular route is used. Future work will include inducing PHH via systemic infection.

In the ferret model, a considerable volume of injected blood was required in order to promote
ventriculomegaly. Autologous blood, which could only be obtained in limited quantities from the
tail, seldom exceeded 25 μL/injection and the subsequent ventricular volumes in these preparations
were lower than when larger volumes of blood were injected. In order to obtain a sufficient
quantity of injectable blood, syngeneic cardiac samples had to be collected from a ferret littermate.
These preparations delivered 150-250 μL/injection and produced much larger ventricles. It should
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be noted that Whitehall and colleagues ultimately employed a second intraventricular injection of
blood with a raised hematocrit in order to increase their yield of rats with ventriculomegaly.562

The ferret model does not feature an expandable skull. Even though the sagittal and coronal sutures
appeared flexible during the injection surgery at 20 days of age, none of the kits demonstrated an
enlarged skull, even those with relatively severe ventriculomegaly. To our knowledge, there are
no reports on when the cranial sutures of the ferret ossify, but it may be that the sutures close
within a few days of our injections, prior to when intracranial pressure may increase. The lack of
an expandable skull and the prevalence of mild-moderate ventriculomegaly in this model are
important, especially because other models in infant-juvenile rats, cats, and rabbits do present with
a remarkably expansive skull and open anterior fontanelle.

A complete stereotaxic atlas of the adult or developing ferret is not available. As a result, we had
to rely on measurements and trajectories planned from MRI scans and gross brain dissections. In
addition, the short snout and relatively flat face of the infant ferret required a nose cone for
anesthesia, which interfered with the standard bite bar used in commercial stereotaxic frames.
Furthermore, the external auditory meatus of a 20-day-old ferret kit is still closed. We attempted
to carefully secure the animal in the usual stereotaxic planes with the ear bars directed toward the
openings of the external auditory meatuses and the dorsum of the skull perfectly horizontal, but
positioning can still be variable. Further studies with short-term post-induction neuroimaging are
still needed to determine the accuracy of intraventricular injections.
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None of the ferret kits, regardless of the severity of ventriculomegaly or the amount of blood
injected, developed detectable neurological deficits. This feature of the model may be
advantageous for long-term studies, but it appears that functional outcome assessments will have
to rely on more stringent behavioral, cognitive, and neurological tests. Such tests are not
impossible; however, as di Curzio et al. have demonstrated, quantitative open field tests can be
performed on ferret kits from 10 to 44 days old563. Depending on the outcome measures to be used
(e.g., advanced MRI), studies with the infant ferret IVH/PHH model can become quite expensive.
Because a ferret is a covered species by the USDA and Institutional Animal Care and Use
Committees, purchase from purpose-bred vendors, domestic and local transportation costs, and
per diem charges can amount to about $1500 for a lactating jill and a litter of 4-5 kits.

5.3.4

Limitations

This study has several limitations. As stated previously, the modest yield of, and relatively low
variability in ventriculomegaly in both models contributed to the low sample sizes, making it
difficult to draw firm predictions on the severity of hydrocephalus and to accumulate cohort sizes
amenable to statistics. The mice used in this model were older so we could assess the ventricular
zone as their ependyma had already developed. However, we used older mice in order to be able
to obtain neuroimaging as the small brains of immature rodents create difficulties for highresolution neuroimaging86,564. Ongoing experiments are utilizing P0/P1 mice for intraventricular
injections. We also recognize that an intraventricular injection approach bypasses the typical
systemic route of infection; however, as first steps we had to ensure adequate ventriculitis was
achieved, which can be further advanced to include systemic inoculation. The absence of an
169

expandable skull in the ferret may require inductions in younger kits; it may also indicate that
intracranial pressure measurements need to be taken, which was not the case in the present study.

5.4

METHODS

5.4.1

Ferret model of IVH and PHH

5.4.1.1 Subjects

Ferrets were delivered to the Washington University School of Medicine animal facility as a litter
of one jill and 4-6 kits when the kits were 12-14 days old. Following a 5-8-day quarantine period,
kits underwent a pre-induction baseline MRI 2-3 days prior to receiving intraventricular injections
to mimic IVH. Autologous blood or syngeneic blood obtained from an age-matched littermate was
used to induce IVH. Controls received intraventricular injections of sterile saline or phosphate
buffered saline (PBS) or no injections to serve as intact controls. All of the induction and control
procedures were conducted when the kits were 14-21 days old; these times were chosen to match
the age during which most premature humans present with IVH240,552,565. Post-induction MRI scans
were performed to document the development of ventriculomegaly, indicative of PHH. To
conclude each study, kits were euthanized with an overdose of Fatal Plus (sodium pentobarbital
95%, ketamine 5%; IM), and the brains were fixed by cardiac perfusion of 4% paraformaldehyde
in PBS. All procedures were conducted in accordance with National Institutes of Health Guide for
the Care and Use of Laboratory Animals and approved by the Washington University in St. Louis
Institutional Animal Care and Use Committee (IACUC protocol #2015005).
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5.4.1.2 Induction of IVH and PHH

Initially, IVH/PHH was induced in infant ferrets by unilateral or bilateral intraventricular
injections of heparinized autologous blood obtained from the tail vein of the animal. This method
was modified from procedures described previously by Whitelaw et al379,562. Approximately 20150 μL of autologous blood, depending on each animal, was obtained from the tail using a 22gauge hypodermic needle and drawn into sterile heparinized 70 μL glass capillary tubes. These
blood samples were kept on ice for about 10 minutes to allow heparin to be mixed with the blood;
this step proved to be critical to prevent blood clotting and obstruction in the microliter syringe.
About 20-50 μL of the sample was drawn into a sterile Hamilton 50 or 100 μL syringe, which was
then mounted on a stereotactic carrier for intraventricular injection.

In order to mimic larger hemorrhages (i.e., IVH grades III and IV566, unilateral or bilateral
intraventricular injections of syngeneic lysed blood were employed. Syngeneic blood was obtained
from an anesthetized, age-matched littermate by cardiac puncture using routine methods. This
approach yielded approximately 500-5,000 μL of blood, which was sufficient for induction of 4-5
littermates. The blood samples were placed immediately in 1.5 mL heparinized tubes and frozen
in liquid nitrogen. As needed, samples were lysed by 3 subsequent thaw-freeze cycles before being
drawn into a sterile 1.0 mL syringe for intraventricular injection into each animal.

For all intraventricular injections, the following procedures were performed using sterile
technique. Kits were anesthetized with 1-4% isoflurane vapor in 100% oxygen. Heart rate and
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oxygen saturation were monitored by pulse oximetry using a probe clipped to a rear paw.
Respiratory rate was monitored by manual observation, and body temperature was monitored with
a rectal probe. Kits were placed on a heating pad in the prone position and the head stabilized in a
stereotaxic frame. Blunt ear bars were placed against the external auditory meatus because the ear
canal was not patent at this age. The mouth was secured to a standard bite bar onto which the
anesthesia nose cone was taped. Because maintaining body temperature in ferret kits at this age is
very important for survival, towels were placed over the animal to keep it warm. The skin on the
dorsal neck and skull were alternately swabbed three times each with Betadine and 70% alcohol
to obtain sterility. The surgical field was covered with sterile drapes and a small hole cut in the
outermost drape for access to the dorsum of the skull. A small skin incision was made over the
dorsum of the skull and the skin retracted to expose bregma and the coronal suture. Based on
measurements taken from pre-induction MRIs and prior gross morphology dissections, stereotaxic
coordinates were set at 1.0-1.5 mm lateral to bregma, 2.0-3.0 mm anterior to bregma, and 5.56.5mm deep to the pial surface to target the frontal horn of the lateral ventricle. A small (~1.0 mm
diameter) burr hole was drilled in the skull. After bone and dura mater bleeding had been controlled
with saline flushes, bone wax and Gelfoam, the syringe was loaded with PBS, saline or blood and
advanced into the brain to the approximate depth. Initially this depth was 5.0 mm from the skull
surface, subsequently 10.0 mm proved to be more accurate. After a 30-second equilibration period,
the induction agent was injected slowly into each lateral ventricle. In general, the complete
injection process consisted of short (about 10 second) injections of about 5.0 μL of sample
followed by equilibration intervals of about 20 seconds. After the final injection, the needle was
left in place for about 30 seconds and then withdrawn. When bilateral injections were performed,
the same needle was used, having been pre-loaded with a sufficient amount of induction agent,
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and the same injection procedure repeated on the opposite side. The skin incision was closed with
absorbable suture using subcutaneous suturing techniques after surrounding tissue had been
infiltrated with a mixture of Lidocaine-Marcaine (2.0 mg/kg). The wound area was cleaned with
sterile saline and minimal amounts of skin glue applied to the incision to prevent the jill from
opening the incision. Post-operative analgesia and infection control were initiated with
Buprenorphine (0.01-0.03 mg/kg IM) and Cephalexin (10mg/kg SC). Isoflurane inhalation (but
not oxygen) was discontinued and the animal allowed to recover; once sternal and reactive, the kit
was returned to its litter.

Following surgery all kits were weighed daily and monitored for signs of neurological deficits
(ataxia, alertness, reflexes), general health (dehydration, lethargy), and discomfort (vocalization,
stiff hair).

5.4.1.3 Ferret Neuroimaging

5.4.1.3.1

In vivo

Anatomic MRI techniques, performed sequentially during the same setting or individually during
separate sessions, were used to determine gross morphological changes in the brain, especially
volumetric increases in the cerebral ventricles and the location of blood deposits and needle tracks.
Imaging was performed pre-induction or post-induction (5-75 days, depending on the experiment)
on an Agilent/Varian 4.7T small animal MR scanner equipped with a DirectDriveTM console
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(Santa Clara, CA), built around an Oxford Instruments (Oxford, United Kingdom) horizontal
magnet with a 40-cm clear bore diameter. MRI images were collected with a custom-built actively
decoupled transmit (volume, 9-cm inner diameter) and receive (surface, 3.3, 3.8 or 4.5 cm outer
diameter, depending on ferret head size) coil pair.

Ferrets were anesthetized with isoflurane/oxygen mixture (3-4% isoflurane) in an induction
chamber. When all reflexes had been abolished, the head of the ferret was placed in the prone
position and secured in a custom-built head-holder with a C-clamp on the head and a pallet bar. A
custom-built nose cone was taped in place for delivery of 1-3% Isoflurane for maintenance of
anesthesia during the scan. Isoflurane excavation was accomplished by a silicone suction tubing
placed next to the animal's head. The eyes were moistened with ophthalmic ointment. The ferret
body was placed prone onto a padded heating bed that circled warm water through a water pump
(Isotemp® 2100). A pulse oximeter (Nonin® 7500) secured to the ferret paw was used to monitor
heart rate and oxygen saturation during MRI scan. Ferret respiratory rate (a pillow attached to
animal abdomen) and body temperature (rectal probe) were monitored and heat-compensated with
a MR-compatible small animal monitoring & gating system (SA Instruments, Inc.). Total
preparation time was about 15-30 minutes. All monitored physiological parameters were recorded
every 15 minutes until the animal had been recovered and had assumed a sternal posture. The in
vivo MRI scans required 60-150 minutes, depending on the MRI sequences obtained. While
recovering from anesthesia, the ferret kits were placed on a heating pad and body temperature
monitored.
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For anatomical sequences, depending on brain size, 24-30 slices of T2-weighted transaxial images
were collected with a 2D fast spin-echo (fsems) sequence with an echo train length (ETL) of 8,
Kzero = 8, TR 3 S, effective TE 96-112 ms; matrix size 256 x 256 and field of view (FOV) 48 x
48 to 60 x 60 mm2 (depending on ferret brain size) with a slice thickness 1.0 mm. Total data
collection time for four averages was 6 minutes 48 seconds. The T2-weighted images were loaded
into MatLab (MathWorks®) and converted into NIfTI (.nii) format with zero-padding to a matrix
size of 512 x 512 as anatomic images. These T2-weighted images were used for ventricular volume
segmentation with ITK-SNAP.

5.4.1.3.2

Ex-vivo DBSI

To limit cost, the explanted brains of a subset of age and weight matched ferrets (n=13) sacrificed
at approximately 50 days old underwent DBSI to assess their PVWM integrity. The brains were
placed in a 35mL syringe tube in 4% PFA then scanned ex vivo in an Agilent® 4.7 Tesla magnet
with a solenoid coil. T2-weighted images, along with a multi-echo spin-echo diffusion weighted
sequence in 99 diffusion directions (TR 3000 ms, TE 60 ms, Matrix = 192 x 192, b-value max =
3000 s/mm2) was acquired for a total scan time of 14 hours per animal. The raw data files were
converted to NIfTI and registered to a single subject space.

All datasets were processed with our in-house DBSI pipeline described above. Two anisotropic
components were used to model primary and secondary direction of fibers within imaged voxels.
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For division of the isotropic components, 2.0 µm2/ms and higher ADC was chosen to represent
free diffusion, 0.6-2.0 µm2/ms hindered diffusion, and 0.6 µm2/ms and less for restricted diffusion.

ROIs of the white matter tracts we examined were drawn on de-noised T2W coronal images by
two independent blinded operators. The ventricles on de-noised T2W coronal slices were marked
as ROIs for ventricular volumetric assessment. PVWM ROIs were identified in coronal slices. The
genu – the anterior end of the corpus callosum was demarcated medial to the frontal lobes and the
anterior horns of the lateral ventricles, behind and below the cingulate gyrus. The internal capsule
was demarcated as a white matter structure that begins at the level of the thalamus, resting between
the caudate nucleus and the thalamus, connected to cortical white matter. Thus, in the same slice
as the genu, the anterior limb of internal capsule was identified. The most posterior end of the
corpus callosum the splenium was identified coming through the mid-region of the coronal slice.
The position was determined in the second to last slice in which the corpus callosum still existed,
knowing that fibers continued all the way through the structure still. Positioned between the
splenium and genu, the posterior limb of internal capsule was identified using the same guidelines
as the anterior limb, being sure to exclude the crus cerebri (cerebral peduncle). Rostrally, the crus
cerebri was observed as a bright, dense bundle of white nerve fibers emerging from the ventral
cerebral cortex.

All PVWM and ventricular volume ROIs were delineated using ITK-SNAP (open source software,
www.itk-snap.org). After delineation, the voxel intensity values of all ROIs were extracted and
analyzed.
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5.4.1.4 Sacrifice and Neurocytology

Routine histology and immunohistochemistry (IHC) of PFA-fixed brains collected at sacrifice
were used to characterize cytology and cytoarchitecture, as described previously197. Each brain
was blocked in the coronal plane and embedded in paraffin following routine methods. Coronal
sections were cut serially at a thickness of 10 μm, collected into staining groups in which sections
were mounted onto glass slides at intervals of approximately 100 μm and stained with Hematoxylin
and Eosin (H&E). For routine immunohistochemistry, primary antibodies directed against cilia
(βIV tubulin 1:100; catalog #11315, Abcam), immature ependymal cells and astrocytes (glial
fibrillary acidic protein, GFAP; 1:300; catalog #7260, Abcam), microglia (ionized calcium binding
adaptor molecule 1, Iba1; 1:100, catalog #PA5-27436, Thermo Fisher Scientific), and adherens
junctions (N-cadherin, Ncad; 1:25; catalog #180224, Thermo Fisher Scientific), were employed.
Secondary antibodies included goat anti-rabbit Alexa Fluor 488 (1:300; #A11034, Thermo Fisher
Scientific) and goat anti-mouse Alexa Fluor 555 (1:300; #AQ21422, Thermo Fisher Scientific).
Finally, the tissue was treated with 4’6-diamidino-2-phenylindole (DAPI 405, 1:5000; #D1306
Thermo Fisher Scientific) to label all cell nuclei. Sections were analyzed by light microscopy and
multiple fluorescence confocal microscopy. Quantification of immunohistochemistry was
performed with our in-house script that quantified cell variations (total cells, number of cells
expressing specific proteins, and immunodensity) per slide (Supplementary Figure 6). Relative
quantifications of the cells of interest were obtained as a ratio of the total number of DAPI-positive
cells
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5.4.1.5 Statistical analysis

All statistical analyses were performed using in-house Python v2.7 and R package v3.4.1 scripts.
Parameter map (PM) intensity values inside PVWM ROIs and ventricular volumes were analyzed
with Shapiro-Wilk test for normality. Paired and non-paired t-tests and non-parametric measures
(Wilcoxon signed rank tests) were used for between group comparisons as determined by tests of
normality. Correlations between PVWM and ventricular volumes were analyzed between and
within groups.

5.4.2

Mouse Model of Ventriculitis and PIH

5.4.2.1 Subjects and Experimental Design

Mice were delivered to the University of Calgary animal facility as a litter of 12 pups. Following
a 5-day quarantine period, pups underwent intraventricular injections to mimic ventriculitis and
PIH. ⍺-hemolysin (Medimmune, Mountain View, CA) provided by our collaborator was used.
Controls received intraventricular injections of saline. Post-induction MRI scans were performed
to document the development of ventriculomegaly, indicative of PHH. All procedures were
approved by the Calgary University Institutional Animal Care and Use Committee (IACUC
protocol #AC17-0151). Throughout the study, mice were monitored daily for neurological and
general health status until the time of euthanasia. In addition to routine assessments of alertness,
locomotion, hydration, pain, anxiety, and infection, special attention was focused on signs and
symptoms that typically accompany hydrocephalus and increased intracranial pressure.
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5.4.2.2 Induction

Mice were anesthetized with isoflurane 2−4% via inhalation through a nose cone. Their head was
secured in a stereotactic head frame in the prone position. A surgical plane of anesthesia was
obtained, as determined by multiple clinical signs such as limb withdrawal following paw pressure
and any response to painful stimuli. Buprenorphine hydrochloride (0.05 mg/kg) was administered
subcutaneously with a 27-gauge needle to maximize animal comfort during recovery. Strict aseptic
techniques were followed at all times during surgery. The skin on the dorsal neck and skull was
alternately swabbed three times each with Betadine and 70% alcohol to obtain sterility. The
surgical field was covered with sterile drapes, sterile instruments and materials were used, and
sterile surgical gloves were worn at all times.

A small skin incision was made over the dorsum of the skull and the skin retracted to expose
bregma. A small (~1mm diameter) burr hole was drilled in the skull 1.0 mm lateral to bregma and
0.5 mm posterior to the coronal suture. After bone bleeding had been controlled with saline flushes
or bone wax, the stereotactic frame was positioned to its coordinates for the frontal horn of the
lateral ventricle. A Hamilton 30-gauge needle connected to a 5-µL gas-tight glass syringe
(Hamilton, Reno, NV, USA) that was loaded with different concentrations and volumes of ⍺hemolysin in saline (27.4 µg/ml, 2.5 µl each side; 54.8 µg/ml, 2.5 µl each side; 91.3 µg/ml, 2 µl
each side; 68.5 µg/ml, 2 µl each side) was lowered to the predetermined depth so that the tip will
be located in the frontal horn of the lateral ventricle. The drug was then dispensed into the ventricle.
After a 1-minute equilibration period, the needle was withdrawn slowly, and any leaking CSF
stopped with a piece of bone wax. The similar process was performed on the opposite hemisphere.
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The incision was closed with absorbable suture, the wound was cleaned, and the animal was
allowed to recover prior to return to its cage. The induction procedure took ~30 minutes skin-toskin per mouse.

5.4.2.3 Imaging

Imaging was undertaken 7 days post-injection or sooner if the mouse showed signs of humane
endpoint. Imaging was performed on a Bruker BioSpin 9.4T MRI using a helium cooled cryocoil,
which is a dual channeled surface coil. Anatomical scans were obtained as T2W RARE sequences
(Matrix = 256 x 256, FOV =1.92 x 1.92 cm, slice thickness = 0.5 mm, TE = 30 ms, TR= 4000 ms,)
to determine morphological changes in the brain, especially volumetric increases in the cerebral
ventricles. Animals were anesthetized with isoflurane (2-4%) while in an induction chamber and
then through a nose cone while positioned in the MRI scanner. After the animal was sufficiently
anesthetized, the animal’s eyes were moistened by the application of ophthalmic ointment to
further reduce the amount of drying to the eyes. The animal was placed into the scanner headfirst
for imaging in prone position while lying on a bed of pillows with a heart rate and respiration
monitor. Core temperature (36°C) was controlled using regulated air flow and a feedback to a
rectal probe. Respiration was monitored and maintained by adjustments in anesthesia.

The total time in the MRI lasted 30-45 minutes after which the animal was removed from the MRI
and monitored until the anesthetic has worn off and normal movements had returned. While
recovering from anesthetic, the mouse was placed on a heating pad to keep body temperature as
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close to normal as possible. After normal movement has been restored, the animal was returned to
its litter.

5.4.2.4 Euthanasia

To conclude each study, mice were euthanized with an overdose of Sodium Pentobarbital (200
mg/kg). After all reflexes had been abolished, the pleural cavity was opened surgically, and a
transcardial perfusion was performed with PBS. The extracted brains were cryopreserved in
Optimal cutting temperature (OCT) compound prior to storage in -80 °C freezer.
Immunohistochemistry of coronal sections of the cryofixed brains were performed with primary
antibodies directed against cilia (βIV tubulin 1:100; catalog #11315, Abcam), and immature
ependymal cells and astrocytes (GFAP; 1:300; catalog #7260, Abcam). Secondary antibodies
included goat anti-rabbit Alexa Fluor 488 (1:300; #A11034, Thermo Fisher Scientific) and goat
anti-mouse Alexa Fluor 555 (1:300; #AQ21422, Thermo Fisher Scientific). The tissues were
treated with DAPI (405, 1:5000; #D1306 Thermo Fisher Scientific) to label all cell nuclei. Sections
were analyzed by light microscopy and multiple fluorescence confocal microscopy. However,
immunodensitometry was not performed.
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6

Chapter 6: Discussion of dissertation

6.1.1

Leveraging a translational neuroscience approach to PIH and PHH

In the past decade alone, over 11,000 hydrocephalus-related research articles have been published,
accounting for one third of all papers published on the subject since 1860. In this extensive volume
of data are many useful ideas that could potentially change the landscape of the field. However,
there seems to be a dichotomy of the domains of hydrocephalus research, i.e. experimental versus
clinical, and only a few studies have endeavored to merge the two approaches into a translational
framework87,102. In addition, the majority of studies tend to focus on a single variant of
hydrocephalus366,567-569, and those combining two or more forms of hydrocephalus are uncommon.
Since the 1990s, “Translational Neuroscience” has gained widespread recognition, facilitating
critical advances in many neurological conditions570. In addition to bridging the gap between
fundamental neurosciences (typically in experimental models) and human brain function, the
scope of translational neuroscience has widened to include multi-disciplinary consortiums, the
design and implementation of new technologies and the development of diagnostic, prognostic,
treatment and monitoring strategies570,571.

The studies presented in this dissertation epitomizes the use of translational neuroscience
principles to further hydrocephalus research. Rather than focusing on a single disease, two similar
variants of hydrocephalus (PIH and PHH) were examined together as sharing a common
pathophysiology. In addition, all experiments were performed within a cross-disciplinary, multiinstitutional and international consortium including samples and expert representations from North
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America and Sub-Saharan Africa. Furthermore, not only did we examine different anatomical
regions of the brain including the VZ, SVZ and PVWM, as well as CSF physiology, we defined
PIH and PHH with in-depth granularity by characterizing their pathophysiology at the gene,
protein and cellular levels. We also developed and/or implemented several novel experimental
approaches, including dMRI segmentation of the VZ/SVZ, DBSI, proteogeonomics and in vitro
cell cultures to understand the pathophysiology and underlying mechanisms of PIH and PHH.
Finally, we developed animal models that mimic the human disease and our findings, and are
amenable to the modulation of physiological processes to further understand the pathophysiology
of PIH and PHH, and perhaps more importantly, for utilization by animal trials that can be
transitioned into human clinical trials for PIH and PHH therapy.

6.1.2

A unifying pathophysiological mechanism for PIH and PHH

With a long-term goal of improving the care of infants affected by PIH and PHH, and identifying
strategies to prevent both conditions, the objective of this dissertation was to define the common
and unique pathways underlying the pathophysiology of PIH and PHH. With proteogenomics, we
established that both conditions are associated with the differential expression of genes involved
in neuroinflammation and brain-CSF barrier cell-cell junction structure in CSF. While the
neuroinflammation was predominantly innate, there was overlap with the adaptive immune system
through complement activation.
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Assessment of the ventricular perimeter of human infants with dMRI confirmed that, in the setting
of neuroinflammation, PIH and PHH are associated with microstructural disruptions of the neural
stem cell rich VZ/SVZ regions. The most aberrant dMRI measures were found in the FOHP
regions and were attributed to compounding mechanical injury caused by pressures exerted on
those regions by the expanded ventricles. The neuroinflammation and VZ/SVZ pathology were
confirmed with neurocytology in humans, ferrets and mice with PIH or PHH.

Utilizing in vitro cell cultures, we identified that the VZ/SVZ disruption was mediated by cleavage
of adherens junctional proteins (e.g. N-cadherin). N-cadherin cleavage was found to be facilitated
by activation of metalloproteases (e.g. ADAM10), which led to a reduction in the number of
VZ/SVZ cells available for differentiation into ependymal cells and neuroglia. In addition,
differentiation of the remaining cells was also impaired, culminating in a disrupted ependymal
barrier. Disruption of the VZ/SVZ and ependymal barrier was associated with injury to the
subjacent PVWM, in which axonal injury, reduced axonal fibers, increased cellularity and edema,
neuroinflammation, and myelin disruption of myelinated axons were observed in human and ferret
dMRI and immunohistochemistry.

Together, these findings confirm our central hypothesis and provide verifiable evidence to posit
the following regarding PIH and PHH: 1) the antecedent events of hemorrhage and infection and
the hydrocephalus activate neuroinflammation cascades that, while physiologically necessary,
inadvertently cause ependymal injury; 2) these events occur in the setting of alterations in geneactivated pathways of host immune-responses and also during a stage of active differentiation of
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VZ/SVZ neural stem cells, making neuroinflammation-related VZ/SVZ disruption central to the
pathogenesis of PIH and PHH; 3) VZ/SVZ disruption is mediated by ADAM10 cleavage of Ncadherin-based cell-cell junctions, leading to denudation of the ependymal barrier, which
compromises the brain-CSF barrier critical for CSF homeostasis; 4) PVWM injury occurs when
the brain-CSF barrier is damaged, which has been previously related to neurodevelopmental
deficits in affected infants, and even later in adult life; 5) pharmacologic modulation of ADAM10
represents a viable therapeutic approach to mitigating the deleterious pathogenesis of PIH and
PHH. (Figure 54)

Figure 54: A proposed unifying pathophysiological mechanism for PIH and PHH
The ventricular zone (VZ) and subventricular (SVZ) zones are the main neurogenic niche for brain
development. During fetal development, neuroepithelial cells in the VZ/SVZ migrate to
differentiate into cortical neurons, astroglia and ependymal cells, utilizing radial glial cells. During
this critical period, a systemic infection or intraventricular hemorrhage (1) may elicit a hostimmune response and activation of metalloproteases (e.g., ADAM10) (2), which in turn cleave
adherens junction molecules (e.g., N-cadherin) (3), leading to disruption of the brain-CSF
ependymal barrier (4). Together, the VZ/SVZ and ependymal disruption lead to impairment of
CSF dynamics (5), and the juxtaposed periventricular white matter to injury from persistent
neuroinflammation and CSF-laden toxins. Inhibition of ADAM10 abrogates the N-cadherin
mediated VZ/SVZ disruption in cell cultures. (Modified after Rodriguez et. al.172 and Gao et.
al.572).
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6.1.3

Neuroinflammation is central to PIH and PHH pathophysiology

Neuroinflammation has long been associated with the pathogenesis of infection-related
hydrocephalus. Earlier reports described inflammation-mediated granular ependymitis and
scarring of CSF pathways as the cause of infectious hydrocephalus573-576. Similar mechanisms of
host immune responses have been implicated in the pathogenesis of PHH following IVH242,577 and
congenital hydrodrocephalus.145,207,242 Indeed, reactive astrocytosis has been demonstrated
repeatedly in both congenital and acquired models of hydrocephalus, and has been further shown
to increase with the progression of hydrocephalus. Additionally, there is evidence to suggest that
in many forms of hydrocephalus, neuroinflammation has widespread deleterious effects on brain
function, including disturbances in oxidative metabolism, neurotransmission, periventricular cellcell junctional interaction, brain-CSF barriers, iron transport mechanisms, and choroid plexus
function.84,145,169,182,197,212,318,336,382,578-580 Bearing in mind the effects of neuroinflammation across
many variants of hydrocephalus, we elected to use non-hemorrhagic non-infectious hydrocephalic
infants as controls in order to detect molecular mechanisms that were more specific to PIH and
PHH.

Neuroinflammation can be mediated through many different pathways. The TLR system,
especially the TLR4 ligand for lipopolysaccharides (LPS), is perhaps the best understood. It
involves LPS binding to the lymphocyte antigen 96 which then triggers dimerization of TLR4 to
enhance cytokine and chemokine production downstream. TLR4 can also be activated by blood
products.581 In a rat model, Karimy et al. demonstrated that TLR4-mediated activation of SPAKNKCC1 led to hypersecretion of CSF by the choroid plexus epithelium, leading to
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hydrocephalus.145 While the TLR immune system pathway is commonly implicated in
hydrocephalus,145,198,336,582 the JAK-STAT pathway is considered the most efficient form of innate
immunity, especially to intracellular pathogens.201,202 In fact, protein mutations in the JAK-STAT
pathway have been implicated in poor inflammation mediation.201,202 For example, impaired JAK
function in severe combined immunodeficiency is associated with susceptibility to infections due
to the absence of natural killer (NK) cells, B cells or T cells.583,584 In our PIH and PHH human
cohorts, JAK-STAT-dependent processes predominated, likely because all the infants were less
than 3 months of age and had not had the antigenic exposure required to mount a detectable
humoral response.

The proteogenomics experiments validated our previous findings from immunometric assays
confirming that activation of the immune system in PIH and PHH increases cytokine and
chemokine production207. In addition, there was differential expression of products involved in the
innate immune system-related metabolism such as iron depletion and generation of reactive
oxidative species (ROS). During an acute infection585 or IVH586,587, there is a high rate of oxidative
metabolism and response to ROS such as hydrogen peroxide, superoxide radicals and nitric oxide.
ROS activation typically triggers cascades of cellular excitotoxicity targeted toward the bloodbrain barrier (BBB), which secondarily results in brain injury that impairs brain oxygenation,
leading to cerebral vascular dysfunction and ischemia.588 The role of BBB disruption in CNS
infections and IVH have been broadly studied. In sepsis, the BBB acts as a nexus for integrating
signals of the brain and periphery and permits extravasation of microbes and infection-related
mediators into the CNS (reviewed in 589-591). In IVH, BBB abnormalities identified as decreased
pericyte laminin, which is critical for maintaining their tight junctions 592,593 and type IV collagen
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that provide structural support for the capillaries

594

have been reported. However, it is unclear

whether the BBB abnormalities in hemorrhage or infections are triggers of hydrocephalus as there
are many inconsistencies in the literature on the role of BBB in hydrocephalus pathophysiology
39,595,596

. Nevertheless, our finding of abundant expression of neutrophil-generated ROS in PIH

and PHH infants raises important questions as to whether BBB disruption contributes to the
sustained (chronic) inflammatory milieu in PIH and PHH even months after the initial infection or
hemorrhage, when the CSF samples were collected.

6.1.4

Role of modulating neuroinflammation pathways to mitigate PIH and PHH

From CSF to neural stem cell organization, ependymal barrier structure and PVWM, across
human, mice and ferret species, and at both the gene and protein levels, our results consistently
supported host-immune response as being central to PIH and PHH pathophysiology. However, it
would be premature to suggest that our findings support the general use of anti-inflammatory or
immunosuppressive agents during neonatal sepsis or IVH to mitigate the risk of developing
hydrocephalus. For one, it remains unclear whether neuroinflammation drives the development of
PIH and PHH or vice versa. Moreover, the time course and permanence of neuroinflammationmediated brain injury have yet to be elucidated187. In experimental models, non-specific
modulation of immune response has yielded variable results. For example, minocycline, a
tetracycline antibiotic that has many undefined effects but has been shown to inhibit microglial
cells has been explored. In the H-Tx rat model of congenital hydrocephalus, intraperitoneal
administration of minocycline significantly reduced the numbers of astrocytes and microglia and
increased cortical mantle thickness

94,96

. It is important to note that minocycline has many side
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effects including tooth discoloration in children and long-term severe osteoporosis; which may
limit its translation to clinical use88.

The use of steroids remains a controversial topic in perinatal medicine, and in particular, in
neonatal sepsis and IVH597-600. There have been many attempts to use corticosteroids in treating
infants with acute bacterial meningitis, and despite a few notable exceptions such as Hemophilus
influenza and pneumococcal meningitis, there have been many failures, some with devastating
outcomes601-609. In experimental models, corticosteroids and glucocorticoids have been used for
decades with variable benefit in hydrocephalus88. For example, intravenous administration of
dexamethasone in kaolin-induced hydrocephalic dogs yielded a 40 % reduction in CSF flow.
However, the effect, was short-lived, lasting for approximately six hours. 610,611.

Neuroinflammation tends to involve several biological pathways, each of which encompasses
scores of mediators that are also involved in other related processes. As such, while it may not be
advisable to broadly modulate upstream ligands of neuroinflammation such as TLRs or JAK
receptors, specific mediators (e.g., TGF-β1) may be targeted to minimize inadvertent effects on
the patient’s physiology. A few decades ago, it was reported that compared to controls, the CSF
of preterm IVH infants expressed relatively higher levels of TGF-β1, which is released from
platelets at sites of blood clotting to regulate fibroblasts proliferation612. This line of work
prompted several experimental studies to explore specific targeting of TGF-β1 as a potential
therapy for hydrocephalus. In experimental models, transgenic mice with TGF-β1 overexpression
613,614

, and wild type mice who were injected with TGF-β1 into the subarachnoid compartment
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both had hydrocephalus615,616. Perhaps more importantly, the induced hydrocephalus mice could
be remediated with intraventricular infusion TGF-β1 antagonists617. In addition, Botfield et al.
showed that in kaolin-induced hydrocephalic rats with, treatment with decorin, a TGF-β1 binding
proteoglycan, at the time of Kaolin injection was associated with reduced inflammation and
fibrosis in the subarachnoid compartment and prevention of hydrocephalus 89. Other studies have
also shown that decorin has the therapeutic potential to decrease ventricle size and PVWM
microstructural damage, as well as cognitive outcome in rats90,92. While the experimental work on
TGF-β1 modularion is exciting, none of these studies have translated to humans. Another good
example of specific targeting is the recent work of Karimy et al145. In a rat model of PHH, Karimy
et al showed that IVH causes a TLR4 and NF-κB dependent inflammatory response in choroid
plexus epithelium, which was associated with an approximately three-fold increase in CSF
secretion and hydrocephalus. It was found then that the SPAK gene, which binds, phosphorylates,
and stimulates the NKCC1 co-transporter at the choroid plexus epithelium apical membrane was
responsible for TLR4-dependent choroid plexus CSF hypersecretion. To that effect, genetic
depletion of TLR4 or SPAK, as well as antagonism of TLR4-NF-κB signaling or the SPAKNKCC1 co-transporter complex all led to normalized CSF secretion rates145. Future studies are
needed to explore these specific targets in humans.

Our human proteogenomic work does point to novel intervention pathways and supports that
selective and targeted modulation of certain aspects of immune response pathways may be a more
successful approach in the prevention of hydrocephalus.For example, in addition to proinflammatory immune factors, we found a differential expression of IL-4 and IL-13, which
generally have anti-inflammatory effects. IL-4 and IL-13 can share a common receptor618-620 and
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typically work synergistically to decrease inflammation by counteracting the activity of proinflammatory cytokines such as IL-12.621,622 IL-4 and IL-13 are also considered neuroprotective
as they can induce death of microglial cells that mediate neuronal damage623-625. As a caution, Park
and colleagues reported that, in experimental models, IL-4 and IL-13 potentiate oxidative stressrelated injury to hippocampal neurons.626,627 Thus, one hypothesis is that the balance of IL-12 and
IL-4/IL-13 within the CSF contributes to the risk of PIH, suggesting that their targeted modulation
may be a potential therapeutic target. Further studies are needed to examine the role of
cytokine/chemokine modulators as potential adjunctive treatment targets to regulate the immune
response during such infections and IVH in an effort to reduce the chance of developing
hydrocephalus.

It is also critical emphasize that inflammation itself, at least in the acute phase of CNS injury, is a
physiologically helpful process for appropriately responding to and clearing microbes and toxins.
Since there are no set thresholds, it is challenging to define an inappropriate inflammatory response
and the point at which modulation would do more benefit than detriment. Time course and levels
of inflammatory markers in biological samples could be helpful, but more research is needed to
identify robust biomarkers and obtain normative data on appropriate levels of response.

6.1.5

Ependymal barrier damage is associated with PVWM injury

As we have consistently demonstrated in the setting of neuroinflammation, disruption of neural
stem cells in the VZ/SVZ compromises their differentiation into ependymal cells. While this
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dissertation focused on the ependyma due to its central role in hydrocephalus pathogenesis, we
acknowledge that VZ/SVZ disruption also negatively impacts neurogliogenesis via both the radial
and tangential migration streams572. With regards to ependymogenesis, the ependymal barrier,
which is responsible for many functions including brain-CSF homeostasis and immune
response232,233, is defective when the VZ/SVZ differentiation is disrupted, demonstrating regions
of denudation and heterotopias. As a result, the protective barrier properties of the ependymal layer
to shield the subjacent PVWM from injurious CSF toxins is compromised. With dMRI and
immunohistochemistry, we demonstrated ependymal layer microstructural damage was intimately
related to transependymal CSF migration, and PVWM dysmyelination and axonal loss across
species.

While VZ/SVZ injury involves the majority of the LVP, we found segmental variations in the
magnitude of injury. The FOHP regions tend to be more vulnerable than other regions, perhaps
due to relatively higher pressures exerted on the FOHP by the expanded ventricles. Across the
lateral ventricle there are regional differences in the cytoarchitecture of the VZ and in the
organization of neural stem cells within the SVZ.133,197,463 While radial glial cells are sequentially
replaced by ependymal cells along the LVP during fetal development, the lateral wall of the frontal
horn is the only region that retains these stem cells into infancy463, which may be associated with
adverse neurodevelopment when those specific regions are damaged by PHH. Our findings of
more aberrant VZ/SVZ and ependyma in the FOHP than in the rest of the ventricle are consistent
with the patterns of injury seen on conventional MRIs of hydrocephalus patients193-195,465, and
reflect the disproportionate distribution of stress and strain on the FOHP region.466-468 Indeed,
porohyperelastic finite element anatomical models have showed that, compared to the rest of the
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lateral ventricle, the FOHP is subjected to increased stress and strain and a 3.5-times increased
edema468. The disproportionate risk of injury at the FOHP has been attributed to the acute
anterolateral angles at those regions, which subject them to high ICP- and hydrocephalus-related
tensile forces466-468. In contrast to the convex shape of the body of the lateral ventricle, the concave
geometry of the FOHP is associated with expanded extracellular spaces, which makes those
regions more susceptible to free water accumulation and edema, leading to impairment of arterial
blood flow, venous stasis, ischemia-induced PVWM injury, dysmyelination, axonal
disruption.458,466-468,486,487 This segmental difference in VZ/SVZ injury is critical because it begs
the question as to whether therapeutic strategies should be focused on localized regions at the
highest risk of injury, and those most populated by neural stem cells that have the capacity to
regenerate (the FOHP).

In our cohort, ventricular size negatively correlated with the magnitude of VZ/SVZ and PVWM
injury, suggesting that the expansion of the ventricles likely has a negative effect on ependymal
and PVWM tissue integrity, speaking to whether ventricular size can be used as a surrogate marker
for disease severity in PIH and PHH. However, we must note that there is ongoing debate regarding
ventricular size-PVWM injury correlations, as variable results have been reported in the
literature.450,628,629 For example, Kulkarni et al. did not find any association between FRONTALOCCIPITAL HORN RATIO and PVWM injury in 23 pediatric patients with treated, stable
obstructive hydrocephalus629. Our findings are similar to those of Akbari et al.450 and Cauley et
al.628, who showed significant positive correlations between FRONTAL-OCCIPITAL HORN
RATIO and dMRI measures. At the very least, we can conclude that our findings and some of the
existing literature underscore the importance of evaluating the role of ventricular size – a readily
193

modifiable factor – on white matter integrity, brain development and neurodevelopmental
disability associated with PIH and PHH.

6.1.6

VZ/SVZ differentiation modulation and ependymal barrier and PVWM repair

Given the many downsides of broadly interfering with acute neuroinflammation, the paradigm
could probably be shifted towards mitigating chronic inflammation, which has an implicated role
in the perpetuation of brain injury following IVH and CNS infections198. ADAM10 has been
implicated in some chronic inflammatory diseases such as multiple sclerosis and
osteoarthritis.630,631 With our cell culture model, we established that ADAM10 activation led to
cleavage of N-cadherin, which impaired VZ/SVZ differentiation and ependyma cell-cell junction
adhesion. During systemic infections, ADAM10 dysregulates BBB function through ectodomain
shedding of barrier proteins such as LRP1, endothelial barrier damage and increased vascular
permeability632,633, which likely perpetuates chronic inflammation. As such, there is a growing
body of evidence involving ADAM10 therapy in the treatment of other conditions.526,633 For
example, the a-secretase activity of ADAM10 is presently being investigated as a potential
therapeutic target for limiting Aβ production in Alzheimer’s disease633-635. Administration of
ADAM10 inhibitors have also been shown to be effective at protecting against lung and liver
epithelia disruption during staphylococcal infection502,516. In our experiments, the inhibition of
ADAM10 enabled us to preserve VZ/SVZ cytoarchitecture in vitro in the setting of blood and
bacterial toxins inoculation. Therefore, there is potential for ADAM10 as a modifiable, therapeutic
target for preserving ependymal barrier cytoarchitecture, to limit progression to PIH and PHH
following an infection or hemorrhage. From a patient management standpoint, ADAM10 cleavage
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of N-cadherin yields soluble isoforms of N-cadherin,511 which can be detected in the CSF of human
PHH infants in addition to other ADAM10-related substrates such as L1CAM, NCAM-1, and
APP.245,247,636 Nevertheless, it must be noted that while the ADAM10/N-cadherin mechanisms we
tested in this dissertation brings necessary focus, there may be other proteases or important
pathways involved in the pathophysiology of PIH and PHH. In addition, the effect of hemorrhage
or infection on choroid plexus physiology, as well as the secretory/absorptive capacity of the
ependymal layer can be further explored.

In terms of PVWM, Del Bigio et al. demonstrated that in kaolin-induced hydrocephalic rats axonal
damage was in part mediated by increased levels of proteolytic enzymes mediated by intracellular
calcium637. This prompted modulation of calcium as therapy in experimental models of
hydrocephalus. Although rats treated with the calcium channel blocker nimodipine for two weeks
after hydrocephalus induction did not show a reduction in ventricular size, their corpus callosum
was relatively thicker and they performed better on motor and cognitive behavior testing when
compared to untreated hydrocephalic control rats97. In two-week-old ferrets, parenteral injections
of magnesium sulfate, a calcium competitor, was associated with lethargy and there was no
evidence for protection against the effects of hydrocephalus at the behavioral, structural, or
biochemical level364. In addition, administration of magnesium sulfate, with or without nimodipine
was associated with substantial side effects including dysregulation of systemic arterial blood
pressure, cerebral perfusion and intracerebral pulse pressure459. Nevertheless, it is worth
mentioning that there are several experimental therapies geared towards PVWM repair and
recovery of neurological function. For example, in rat models of PHH, Ballabh and colleagues
have explored therapies related to epidermal growth factor638, AMPA-Kainate Receptor
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inhibitors540, hyaluronidase and hyaluronan oligosaccharides639, thyroxine640, bone morphogenetic
protein641 and cox-2 inhibitors642. On the horizon, there are also other therapeutic strategies for
hydrocephalus that are focused on reparative or regenerative processes of already disrupted
ependyma. For example, Rodriguez and colleagues have explored neurosphere transplantation
therapy for the regeneration of denuded ependyma. Unilateral intraventricular implantation of
neurospheres obtained from normal HTx rats helped to repair VZ disruption in hydrocephalic
littermates643. McAllister and colleagues have also utilized Decorin, a proteoglycan capable of
inhibiting fibrosis in the subarachnoid space, to prevent the development of ventriculomegaly and
reduce reactive astrogliosis and inflammation in congenital hydrocephalus models89,90. While the
current non-surgical therapies for hydrocephalus are experimental, they provide a glimmer of hope
that the progression to PIH and PHH following infection or hemorrhage can be mitigated, the
outcomes of affected patients can be improved, and that PIH and PHH can eventually be prevented
by pursuing robust scientific discovery.
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